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DNA-directed RNA Polymerase II (Pol II) is highly conserved among eukaryotic 
organisms and plays a fundamental role in cellular life, specifically gene transcription. This 
process is universal and is at the core of gene regulation; therefore, understanding its molecular 
details will provide essential clues that could potentially lead to pharmacological manipulation of 
gene expression.  
In this work we reveal, for the first time, the nature of interactions between Pol II and a 
complete nucleic acid scaffold. The upstream double helix lies over a wedge-shaped loop from 
Rpb2862-874 that engages the minor groove, providing part of the structural framework for DNA 
tracking during elongation. Rudder and fork loop-1 residues insert in between the DNA/RNA 
hybrid and non-template strand at the upstream end of the bubble, suggesting a direct role in 
coordinating annealing of DNA strands. At the downstream end, interactions between the non-
template strand, Rpb11103-1112 and Rpb2501-510 support an open fork. These Rpb1 residues form a 
rigid domain with the trigger loop (TL), stabilizing its off, non-catalytic state, indicating that 
“on/off” conformational transitions, where the TL moves in close proximity to the matched 
nucleotide for catalysis, may be linked to interactions with the non-template strand. 
To further examine the role, structurally, of the trigger loop and bridge helix during 
translocation and catalysis, we characterized the gain of function T834P variant of Pol II. 
Structural studies of T834P in the presence of a matched nucleotide revealed the complete TL in 
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the on-state, a conformation only observed previously in two low resolution datasets. Our 
preliminary analysis suggests that kinking of the bridge helix potentially shifts equilibrium into 
the post-translocation state during the nucleotide addition cycle, which would prolong 
interactions of the trigger loop with the matched nucleotide in the insertion site. Elucidation of 
these structures was achieved through the use of X-ray free electron laser sources, which 
extended the resolution to 3.3 Å. Methodologies, like serial femtosecond crystallography and 
transmission electron microscopy, to aid in structural studies of highly relevant, and challenging 
protein targets, including multi-protein complexes of the transcriptional machinery are also 
discussed. 
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1.0  INTRODUCTION – EUKARYOTIC TRANSCRIPTION AND THE BIG 
PICTURE 
Discovery of DNA’s double-helical structure in the mid-1950s led to the postulation, by Francis 
Crick, of a central dogma that governs molecular biology (1, 2). This doctrine explains the 
transformation of the coded hereditary information inside DNA into RNA molecules, the latter of 
which encodes a readable program for the synthesis of proteins by the ribosome (3). While 
exceptions to this classical view have been touted in recent years through the discovery of 
functional RNAs and viral enzymes capable of reverting RNA back to DNA (4-7), the decoding 
of DNA to RNA is at the root of cellular function and survival. This universal process, termed 
transcription, is driven by RNA polymerases (RNAP) which are able to generate RNA from a 
DNA template, independent of a primer.  
While prokaryotes are capable of synthesizing all cellular RNA by a single polymerase, 
eukaryotic genomes code for three core polymerases: RNA Polymerase I (Pol I), II (Pol II), and 
III (Pol III). RNA polymerase I is responsible for the production of ribosomal RNA (rRNA), 
specifically the 5.8S, 18S, and 28S rRNA precursors, while 5S rRNA, transfer RNAs (tRNA) 
and small non-coding RNAs, are transcribed by Pol III. In addition to transcribing many small 
non-coding RNAs, the transcription of ~25,000 protein-coding genes in the human genome into 
messenger RNA (mRNA) is achieved by Pol II. Despite differing in function, promoter 
specificity, and localization, the 10-subunit core architecture of these enzymes is highly 
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conserved (8). Furthermore, conservation extends to the structure and functionality of a myriad 
of proteins, including the general transcription factors (GTFs), necessary for the recruitment of 
polymerases at DNA promoter elements. 
 
Figure 1. The central dogma of molecular biology 
The flow of genetic information from DNA to RNA to Protein (classic view) is essential for cell function & survival. 
 
In a coordinated effort, RNA polymerases engage transcription factors (TFs) and a host 
of nuclear proteins to either promote or inhibit transcription. In the context of Pol II, unregulated 
transcription can lead to aberrant gene expression patterns which potentially manifest in disease 
phenotypes. Indeed, there exist a copious number of disease-driven proteins that involve TFs or 
indirectly modulate TF activity (9, 10). For instance, recruitment of Pol II to the promoter by the 
general transcription factor IIB (TFIIB) and interactions with TFIID (including the TATA-
binding protein) are initial steps in transcription and represent the first chance at regulating gene 
expression. Biochemical studies have implicated TFIIB as a binding partner for many proteins 
associated with disease states. Specifically, both viral (Hbx, Vpr, EB1) (11-13) and oncogenic 
(Sp1, NFκB) (14, 15) trans-activators bind TFIIB enhancing its ability to recruit Pol II to begin 
transcription. Moreover, overexpression of TFIIB or the B-related factor Brf2 (utilized by Pol 
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III) is significantly correlated with tumor angiogenesis and poor patient survival in human 
hepatocellular and esophageal squamous cell cancers, respectively (14-18). Furthermore, the 
implication of Mediator, a multi-subunit complex that bridges TF and Pol II activity, as an 
instigator of cancer and developmental disease (19) begs the question: can we target transcription 
machinery in the treatment of human disease? 
This idea has remained an open question due to the lack of natural ligands and the 
challenges of targeting specific protein-protein or protein-nucleic acid interactions with 
traditional small molecules. Yet, in recent years, the use of structural information to rationally 
design therapeutic agents to target transcription machinery (ie. the p53-MDM2 complex or c-
Myc activity) has made the once undruggable, druggable (10, 20). However, to continue this 
trend in exploiting TFs as therapeutic targets, an increase in the detailed structural and 
biochemical knowledge of the interactions that govern their activity and stability is required. In 
this work, we provide detailed structural insights into the binding mechanism of yeast RNA 
Polymerase II with a complete nucleic acid scaffold in the presence of GTFs. Additionally, in 
later chapters we explore emerging techniques in structural biology to aid in the collection of 
high-resolution data of multi-protein complexes, which we applied to multiple Pol II – TF 
complexes in the presence of nucleic acid scaffolds. Increasing our understanding of the 
molecular details that govern transcription will provide essential clues that potentially lead to 
pharmacological manipulation of gene expression in disease states. 
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2.0  STRUCTURAL BASIS OF EUKARYOTIC TRANSCRIPTION 
Traditionally, x-ray crystallography has been the method of choice for protein structure 
determination, especially for large molecular weight proteins (21). Starting in the early 1990s, 
the first detailed structures of RNA Polymerases were revealed by examining the free enzyme of 
the single-subunit bacteriophage T7 RNAP (22), followed by the characterization of an 
elongating RNAP a few years later (23).  While unrelated in both sequence and structure to 
multi-subunit polymerases, the catalytic mechanism which governs nucleotide addition provided 
the first insights into transcription. It wasn’t until the next decade that the first atomic details of 
multi-subunit polymerases became available when the structures of the yeast and bacterial RNA 
polymerases were revealed (24, 25). In this chapter, our understanding of the mechanistic and 
structural details of Saccharomyces cerevisiae Pol II transcription will be discussed along with a 
brief examination of the techniques used to collect the experimental data. 
2.1.1 Structure of S. cerevisiae Pol II: a brief history 
In contrast to the single-subunit T7 RNAP, structural studies of eukaryotic polymerases are a 
challenging endeavor because of their size and complexity.  As shown in Figure 2, since their 
initial discovery in the late 1960s, almost three decades would pass before the first structural 
information could be collected. An initial hurdle to the study of eukaryotic polymerases was the 
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separation of an active enzyme from eukaryotic cells with the capacity to transcribe purified 
DNA (26, 27). Fortuitously, the isolation of a transcriptionally active form of Pol II from yeast in 
the 1980s, by the lab of Roger Kornberg, paved the way for extensive biochemical and structure-
function studies of the eukaryotic transcription machinery (28). Over the next decade, a series of 
attempts were made to crystallize Pol II. From these early two-dimensional crystallization 
experiments using lipid scaffolds two important conclusions were drawn. First, sample 
heterogeneity, due to sub-stoichiometric amounts of the heterodimer Rpb4/Rpb7, had deleterious 
effects on crystal order and growth (29, 30). Second, the use of a deletion strain (31, 32) which 
eliminated the Rpb4/7 heterodimer (Pol∆4/7) not only improved crystal growth, but also 
provided evidence that Pol II transitions between two distinct forms, an open/closed state 
necessary for the entry and retention of DNA, respectively (33, 34). 
From these early two-dimensional crystallographic results and a revamped large-scale 
fermentation protocol to natively purify the quantities of protein necessary for in vitro 
experiments (35), Fu et al. were able to promote Pol II crystallization in traditional vapor 
diffusion trials for single crystal x-ray diffraction experiments (36). Their findings, using a 6Å 
phased map derived from heavy atom clusters, led to a more robust understanding of cleft and 
clamp domain movements, but the atomic details of Pol II remained elusive. A breakthrough 
finally occurred in the following years when it was discovered that a special in situ dehydration 
treatment of Pol II crystals resulted in the shrinkage of the asymmetric unit that ultimately 
decreased non-isomorphism and improved crystal contacts along the clamp domain (37). As a 
result, atomic details of the 10-subunit Pol II core in the absence (25) and presence of a 
DNA/RNA hybrid (38) were revealed to resolutions of 2.8Å and 3.3Å respectively, providing for 
the first time structural insights into eukaryotic molecular machines, and paving the way for 
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future studies of transcription (Figure 2).  
 
Figure 2. Timeline of structural insights into transcription 
Timeline highlighting high-resolution structures which added to our understanding of transcription. Cartoon 
representation of structures were rendered in PyMOL using the referenced PDB ID. Models are color-coded to 
match their point in history, while the box at the end of the timeline represents the current period driven by the 
“resolution revolution” in single-particle cryo-EM (section 2.1.5). 
2.1.2 Free and elongating structures of Pol II 
At the time, these structures were an amazing feat considering Pol II’s molecular weight of >500 
kDa, along with the numerous technical and phasing challenges that were overcome to arrive at 
an accurate model (39, 40). What these combined structures revealed, in addition to the 
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prokaryotic Pol structure solved from Thermus aquaticus (24), was a common architecture by 
which the two largest subunits, Rpb1 and Rpb2 (comparable to ß and ß´ in bacterial Pol), formed 
a positively charged cleft capable of binding DNA. Along the periphery, smaller subunits 
contribute to core assembly and stabilization, with subunits Rpb3 and Rpb11 having similar 
homologs in bacterial Pol. Interestingly, Cramer et al. were able to capture Pol II in two different 
open states, driven by mobility in the clamp domain of Rpb1, compared to the closed state 
induced by the presence of a tailed DNA/RNA hybrid in the active center (38). This transition 
from open to closed states is mitigated by five “switch” regions which show conformational 
plascity in the absence of nucleic acids, but couple clamp closure upon DNA/RNA binding that 
helps to stabilize elongating complexes.  
In the years directly following these structures, two groups successfully captured the 
complete 12-subunit Pol II (41, 42). Interpretations of the models presented by both authors were 
virtually identical, as it was found that the Rpb4/7 sub-complex plays a role in Rpb1 clamp 
dynamics. Protruding from outside the core, the Rpb7 “tip” domain wedges between the clamp 
and the linker of Rpb1 C-terminal domain (CTD) inducing a conformational change in two 
switch regions that promote a closed Pol II state. For this reason, it was suggested that DNA 
loading occurs after melting above the cleft by other TFs since the closed clamp state prevents 
duplexed DNA from entering the cleft.  
Building on the results of Gnatt et al. which showed that the incoming DNA duplex 
bends some 90˚ upon reaching the active center, several transcribing structures were solved using 
synthetic tailed DNA/RNA hybrids (43, 44), as well as mimicked transcription bubbles (45) to 
provide insight into the nature of the interactions between Pol II and nucleic acids as shown in 
Figure 3.   
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Figure 3. Structure of free and elongating 10-subunit Pol II 
(a) Cartoon representation of 10-subunit Pol II (PDB:ID 1I50), with subunits color coded based on schematic 
below. (b,c) Top and side view, respectively, of elongating Pol II (PDB:ID 1R9T) with nucleic scaffold color coded 
as template strand (cyan); non-template strand (green); RNA transcript (red). 
 
 Collectively these structures show that the DNA is cradled between the two largest 
subunits through a larger network of H-bond driven interactions. The cleft is able to 
accommodate a 12-18 single-strand DNA template in the transcription bubble (TB), which is 
then free to base pair with the incoming nucleotides to form the basis of the DNA/RNA hybrid at 
the back of the cleft (38). The 3´- end of the nascent RNA transcript stays in contact with the 
active center, particularly the bridge helix domain that runs perpendicular to the DNA duplex. 
The 5´end of the RNA separates from DNA template around position i-7 to i-9 (where the i+1 is 
the addition site of the incoming nucleotide, and i-1 site is the position of the most recently 
added NTP), and is directed towards the exit tunnel (44, 45).  
2.1.3 Mechanism of nucleotide selection, catalysis, and translocation 
During elongation, Pol II catalyzes the reaction of an incoming nucleotide to the growing mRNA 
transcript in a multi-step process termed the nucleotide addition cycle (NAC), the basis of which 
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was identified first in T7 RNAP (46), followed by studies in bacterial (47) and eukaryotic 
polymerases in the presence of matched nucleotides in the A site (44, 45, 48, 49). To start, a 
post-translocated elongation complex provides access to the i+1 site for nucleotide base-pairing 
with the DNA template. The matched nucleotide is trapped by two highly conserved domains of 
RNA polymerases, the bridge helix and trigger loop (which will be discussed in more detail 
below). Discrimination of the correct nucleotide by residues on both domains and Pol II 
proximal domains induces folding of the trigger loop, which provides the catalytic residues for 
nucleotide addition.  
The addition of the nucleotide uses a two-metal ion mechanism as previously proposed 
from T7 RNAP experiments (46) and visualized in Figure 4A. Metal A in the active site is 
permanently bound, coordinated by three aspartic acid residues of Rpb1, whereas the Metal B is 
mobile and can bind the incoming nucleotide at either the β/γ phosphate (49). Pol II catalyzes the 
addition of the incoming nucleotide via a nucleophilic substitution mechanism (SN2), with the 3´-
hydroxyl group on the nascent RNA acting as the nucleophile that attacks the α−phosphate of the 
NTP.  After addition of the nucleotide to the 3´end of the RNA chain, release of a pyrophosphate 
ion (PPi) occurs before translocation across the nucleic acid scaffold to reach the next addition 
site. 
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Figure 4. Nucleotide catalysis and TL driven translocation 
(a) Reaction mechanism of nucleotide catalysis in RNA polymerases. (b) A working model of nucleic acid scaffold 
translocation. Left upper panel: After nucleotide addition, TL retreats to off-state conformation.  Right upper panel: 
A matched nucleotide binding to the post-translocated state (TL “off” conformation) is recognized by Gln1078. 
Right lower panel: high affinity interactions of a matched NTP result in morphing of the TL from “off” to “on” 
states. Left lower panel: NTP is incorporated into the nascent transcript (nucleotide addition), release of NAS 
interactions with jaw domain and proximal Pol II domains facilitate its translocation. 
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 The resulting complex is now in a pre-translocated state, with a matched NTP residing in 
the insertion site. Thus, Pol II must translocate to the  i+2 site to reveal the insertion site to repeat 
the NAC. To achieve this a number of interactions between Pol II and the nucleic acid scaffold 
(NAS) must be broken, which will be discussed in greater detail in Chapter 3. As mentioned 
above, however, the BH and TL play a critical role in NAS translocation. The BH is a 
structurally conserved domain comprising residues 815-845 of Rpb1 in yeast Pol II. Biochemical 
and structural data in bacterial polymerases (50, 51) suggested that the conformational “bending” 
and straightening of the BH underlies translocation. Indeed, in archaeal systems the bending of 
the bridge helix is critical for catalysis, since mutations to introduce kinks led to super active 
polymerases (52) which will be explored further in this work.   
Further biochemical and mutational studies showed that BH and TL residues function 
cooperatively during the NAC and subsequent translocation (53-58), leading to a proposed 
mechanism of a Brownian ratchet motion, in which an equilibrium between pre- and post-
translocation states exist as rearrangements of TL and BH domains occurs (Figure 4B) (53). 
Detailed structural analysis revealed the nature of TL mediated translocation by inhibiting 
translocation with α−amanitin (57). This structure revealed that in the intermediate step of pre- 
to post-translocation, the TL occupies a “wedged” conformation, bending the central BH. This 
helped to validate the proposed mechanism of the Brownian ratchet, as α−amanitin inhibits Pol 
II by trapping the TL and BH movements, which impairs DNA translocation (59).  
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2.1.4 Understanding Pol II – TF interactions from high-resolution data: start site 
selection, backtracking and arrest 
As technologies and biochemical methods improved, a determined effort began to understand the 
interplay between Pol II and the TFs that regulate its activity. The pre-initiation stage of 
transcription requires concerted interactions between RNA Polymerase II (Pol II) and the general 
transcription factors (GTFs) TFIIB, TFIID, TFIIF, TFIIE and TFIIH. Despite the plethora of 
TFs, few studies have examined the role of these factors in the context of a transcribing Pol II 
until very recently, which will be discussed in the next section. High-resolution structural studies 
using x-ray crystallography have been limited to a handful of Pol II complexes.  
Structural studies of Pol II in complex with TFIIS (Figure 5A) were some of the first 
structural studies to show an additional factor bound. These studies revealed the nature of 
TFIIS’s function in elongating complexes, particularly the ability of TFIIS to promote Pol II’s 
weak nuclease ability during transcriptional arrest (45, 60-62). This function is critical since Pol 
II has a tendency to oscillate between active and inactive states, driven by mismatched 
nucleotide incorporation (62, 63), DNA lesions (64-66), or intrinsic properties of polyA regions 
of DNA, which exhibit weaker A:U base pairing. Typically, pausing events are short-lived and 
Pol II is capable of restarting elongation without the aid of additional factors (67, 68), even when 
a few nucleotides are backtracked (62). However, prolonged pausing can lead to larger changes 
in the transcription register, resulting in arrest, which can only be overcome by TFIIS.  
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Figure 5. Architecture of Pol II - TFIIS and transcribing Pol II - TFIIB complexes 
(a) Crystal structure of Pol II – TFIIS (PDB:ID 1Y1V) showing how TFIIS (orange) threads into the active center, 
situating itself against the BH (cyan). (b) Structure of the transcribing Pol II – TFIIB (PDB:ID 4BBS) complex 
revealed interactions between TFIIB (blue) domains with Pol II and the nucleic acid scaffold.  
 
 Crystal structures of Pol II backtracked structures revealed how the 3´end of the RNA 
enters the nucleotide funnel and active site pore, until the backtrack site is reached (60). TFIIS 
domains are capable of threading into the pore, thus locking the TL away from the active site 
where backtracked RNA resides. A conserved TFIIS hairpin domain, also observed in 
GreA/GreB in bacterial homologs (69), engages with charged residues near the site of 
backtracked RNA to initiate metal-dependent cleavage of RNA, using a water nucleophile. After 
RNA cleavage and release, a new 3´ end is formed, TFIIS is ejected, and elongation can resume.  
Another factor that has been studied extensively, is the general transcription factor TFIIB. 
The role of TFIIB in transcription has been studied in greater detail than any other general 
transcription factor, as it has been shown to be indispensable for transcription initiation (70-72). 
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In eukaryotic systems, the core cyclin domains of TFIIB complexes with TATA-binding protein 
(TBP) on the promoter and interacts with upstream and downstream DNA (73). Once bound at 
the promoter, TFIIB acts as a bridge between promoter elements and Pol II utilizing its flexible 
zinc ribbon domain to recruit Pol II to the DNA providing directionality for transcription (71, 74, 
75). Given its importance in the recruitment of Pol II, it is no surprise that TFIIB or TFIIB 
related factors are conserved among eukaryotic and prokaryotic polymerases (8, 76, 77). In 
addition, the B-finger/reader domains play a role in scanning for a conserved thymine in 
eukaryotic systems to determine transcription start site (TSS) (78). 
To date, there exist four co-crystal structures of Pol II in complex with TFIIB, resulting 
in a detailed mechanism of how TFIIB functions in Pol II recruitment to DNA; transcription start 
site selection; and modulation of transcription within Pol II’s active center (74, 79-81). Briefly, 
the zinc ribbon domain (also termed the B-ribbon domain), engages Pol II’s dock domain in 
Rpb1, while the cyclin domains interact with the wall of Rpb2. These extensive interactions with 
Pol II allow for the engagement of the B-finger and B-reader domains (highly conserved 
domains between the cyclin and ribbon domains) with the active site (Figure 5B) (81). The B-
finger hairpin acts as a unidirectional extension of the B-ribbon and engages with the DNA/RNA 
hybrid at the base of the Pol II cleft. The B-linker helix locates against the NTS and may 
function in DNA opening or stabilization of the TB during early transcribing events. Moreover, 
the B-reader loop interacts with the TS to position the DNA for initiation by recognizing the 
TSS. In addition, contacts near the site of the RNA exit tunnel validates biochemical evidence 
that TFIIB assist in promoter escape after contacting the nascent 8-13 nucleotide RNA transcript 
and releasing the NTS for bubble collapse (81, 82). Importantly, these models indicate that 
TFIIB induces active site rearrangements of the metal ions, by potentially increasing the affinity 
 15 
for metal B and thus stimulating catalysis during the NAC (81). 
Remarkably, of all the general transcription factors that assemble into the pre-initiation 
complex, only TFIIB and TFIIF dissociate from the promoter upon the transition from initiation 
to elongation and must be recruited again, along with Pol II, for subsequent transcription re-
initiation (78, 83). A complex involving Pol II and a small domain of TFIIF was only recently 
revealed using crystallographic methods (84), despite being tightly bound and recruited to the 
promoter in complex with Pol II. As a factor, TFIIF is required for accurate transcription 
initiation, since it may play a role in NTS stabilization in transcribing complexes (85). Yet, the 
minimal amount of high resolution structural information in context with Pol II limits our 
understanding of its function, along with the additional GTFs that have yet to be elucidated. 
2.1.5 Characterization of the complete Pol II preinitiation complex 
Despite breakthroughs in the reconstitution of the entire yeast preinitiation complexes (PIC) (86) 
coupled with chemical cross-linking techniques to identify flexible domains (87), efforts to 
obtain large, well diffracting crystals of Pol II in complex with multiple transcription factors 
failed. In recent years, the emergence of low-resolution single particle cryo-EM studies have 
significantly enhanced our understanding of the entire eukaryotic PIC (84, 85, 88-93) (Figure 6).  
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Figure 6. Cryo-EM models of Pol II pre-initiation complexes 
(a) The cryo-EM structure of the human PIC core (PDB:ID 5IY9), and (b) the yeast minimal PIC in the presence of 
Mediator (PDB:ID 4V1O). Docking of x-ray crystal structures allow for a pseudo-atomic modeling of the entire 
PIC.  
 
What these structures have revealed is the nature of PIC assembly at the promoter. Briefly, as 
described above Pol II can bind DNA non-specifically but cannot initiate transcription. Instead, 
Pol II requires a set of GTFs to initiate transcription in a process which occurs in three distinct 
stages: 1) Pre-initiation: TBP binds to a TATA-box (at the promoter site) 30 nucleotides 
upstream of the TSS and recruits TFIIB which in turns recruits Poll II-TFIIF and the TFIIH-
TFIIE complex (Figure 6A) (85). Initial promoter melting is triggered by TFIIH helicases and 
generates a 7-9 nucleotide TB which passes through the Rpb1 rudder and Rpb2 fork loop 1 (FL1) 
residues towards Pol II’s active center (84, 92); 2) Early transcription: further unwinding to 18-
25 nucleotides is possibly assisted by TFIIB or TFIIF followed by synthesis of the initial RNA 
transcript (84, 90, 92). 3) Elongation: The third stage marks the transition from initiation to 
elongation; transcripts of 10 or more nucleotides result in promoter escape and stabilization of a 
mature TB (TFIIF dependent) that ultimately leads to dislodging of the GTFs leaving a poised 
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Pol II for entry into productive elongation. In addition, recent structures have shed light onto the 
importance of Mediator, a multi-subunit complex, and its function in transcriptional regulation 
(84, 93). As detector technologies continue to improve, higher resolution structures derived from 
cryo-EM may become attainable to help enhance our understanding of the overall architecture of 
the transcriptional machinery (94, 95). 
2.1.6 Open questions and the scope of this work 
Structural research on Pol II has focused on 1) Pol II-DNA/RNA interactions, 2) Pol II in 
complex with TFIIB, and 3) most recently, the entire pre-initiation complex. Such structures 
have revealed the nature of the DNA-RNA hybrid, the mechanisms of nucleotide selection and 
catalysis, as well as the mechanism of backtracking. However, details of a complete nucleic acid 
scaffold (including a full transcription bubble) have remained elusive. Indeed, debate 
surrounding the number of nucleotides unwound in a mature bubble is still an important issue 
since sizes ranging from 8-22 nucleotides have been reported for bacterial, archaeal and 
eukaryotic polymerases (82, 96, 97). In addition, the size of the bubble itself might not be fixed 
but depend on Pol II transcriptional stage, as evidence of a scrunched state (where template and 
non-template strand bases are compacted in space relative to relaxed conformations) has been 
proposed for the early stages of transcription initiation in bacteria (98, 99). These questions were 
addressed in this work by co-crystallizing Pol II with a complete nucleic acid scaffold 
comprising various length transcription bubbles in the presence of TFIIF. Moreover, limited 
knowledge about DNA translocation in a transcribing Pol II was addressed by examining the 
network of interactions across the complete NAS with Pol II pre- and post- nucleotide addition.  
Finally, despite the advances in single particle cryo-EM techniques, x-ray crystallography 
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still provides the best opportunity at garnering atomic-level details of the transcription 
machinery. Improvements in the ability to crystallize and collect data of large, multi-protein 
complexes (MPCs) is necessary. Therefore, one goal of this thesis was to optimize existing and 
novel crystallographic techniques for the study of MPCs, pertaining to the Pol II transcription 
machinery. To this end, transmission electron microscopy (TEM) techniques were developed to 
assay crystal quality and guide the optimization of Pol II crystallography experiments at 
conventional and novel x-ray free electron laser (XFEL) sources. Furthermore, unique multi-
crystal holders were created for fixed-target XFEL experiments of Pol II complexes to improve 
data efficiency and quality. 
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3.0  CRYSTAL STRUCTURE OF A TRANSCRIBING RNA POLYMERASE 
COMPLEX REVEALS A COMPLETE TRANSCRIPTION BUBBLE 
3.1 SUMMARY 
The co-crystal structure of Pol II bound to a complete nucleic acid scaffold (NAS) reveals for the 
first time the architecture of the upstream double helix, the non-template strand (NTS) and the 
full-transcriptional bubble (TB). The upstream double helix lies over a wedge-shaped loop from 
Rpb2 (residues 862-874) that engages the minor groove of the duplex providing part of the 
structural framework for DNA-tracking during transcript elongation. Locations of the rudder and 
fork loop-1 (FL1), which form the arch that is inserted in between the hybrid and NTS, at the 
upstream end of the TB, suggest that residues involved in the contacts may play a direct role in 
coordinating annealing of the template and non-template strands. At the downstream (or 
opening) end of the TB, the interaction between NTS and a stretch of Rpb1 residues (1103-1112) 
apparently unwinds the downstream duplex DNA. These Rpb1 residues form a rigid domain with 
the Trigger Loop (TL, Rpb1 1078-1092), in which the TL is stabilized in the open state.  These 
observations suggest that the conformational transition of TL (opening/closure) may be 
structurally linked to the downstream interactions with NTS, possibly in a synchronized 
ratcheting manner conducive to polymerase translocation. 
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M, Kaplan C, and Calero G. (2015) Crystal structure of a transcribing RNA Polymerase II complex reveals 
a complete transcription bubble. Molecular Cell, 59(2), 258-269. doi: 10.1016/j.molcel.2015.06.034 
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3.2 EXPERIMENTAL METHODS 
3.2.1 Purification of S. cerevisiae Pol II 
Ten-subunit S. cerevisiae Pol II ∆rpb4 deletion strain harboring a protein A-tagged Rpb1 was 
purified as previously described with minor modifications (37). Lysate was precipitated with 
0.2% polyethylenimine and clarified at 30,000g. A saturated ammonium sulfate solution was 
added to the clarified supernatant to a final concentration of 60% and allowed to equilibrate at 4 
˚C for 3 h before centrifugation at 30,000g. The resulting pellet was dissolved in a 10-fold 
weight:volume ratio of resuspension buffer: 1x TEZ (50 mM Tris pH 7.5, 10 µM ZnCl, 0.5 mM 
EDTA), 2 mM DTT, 10% glycerol, and 1x protease inhibtors (100x stock: 2.5 mg Leupeptin, 5 
mg Pepstatin A, 1.6 g Benzamidine, 0.85 g PMSF resuspended in 50 mL dry Ethanol) and 
adsorbed onto IgG resin. Pol II was eluted with overnight TEV cleavage at 4 ˚C, and further 
purified by heparin and size exclusion chromatography using well-established protocols (44). 
Reconstitution of 12-subunit Pol II was achieved using recombinantly expressed Rpb4/7 subunits 
as previously described (42). 
3.2.2 Pol II-TIC-Tfg2 and ∆4/7 Pol II-TIC-TFIIF assembly  
Tfg2 was purified as previously described (100). To assemble a Pol II transcribing complex 
(Figure 7), synthetic oligonucleotides, shown in Table 1, containing a single stretch of non-
complementary bases and a 9-mer RNA were annealed above their melting temperatures and 
allowed to cool slowly to 4º C. The resulting nucleic acid scaffolds (NAS) were mixed with Pol 
II (3:1 molar ratio) and excess scaffold was removed using size exclusion chromatography 
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(Superdex200, GE LifeSciences) against Buffer A (25 mM Hepes pH 7.5, 100 mM KCl, 5 mM 
DTT, 0.5 mM EDTA, 10 µM ZnCl2). A 5-molar excess of Tfg2 was mixed with the Pol II-TIC 
in the presence of 0.2% Zwittergent 3-10, and dialyzed overnight at 4º C against Buffer A. 
Removal of excess Tfg2 was carried out using a second size exclusion step (Superdex200, GE 
LifeSciences) against Buffer A. An SDS-PAGE of the final complex is illustrated in Figure 7B.  
 
Table 1. Synthetic nucleic acid sequences for transcribing complexes 
Oligonucleotide Sequence (5’  3’) 
                      NAS Sequences used for structural studies 
9mer RNA UCGAGAGGA 
Scaffold 1 TS^ CCTACCGATAAGCAGACGATCCTCTCGAACCACGGACTCTTTATATACAAGCG 
Scaffold 1 NTS CGCTTGTATATAAAGAGTCCGTGGAAGCTCTCCTAGCAGTGCTTATCGGTAGG 
   Scaffold 2 TS^ CCTACCGATAAGCAGACGATCCTCTCGAACCACGGACTCTTTATATACAAGCGCGC 
Scaffold 2 NTS GCGCGCTTGTATATAAAGAGTCCGTGGAAGCTCTCCTAGGTCTGCTTATCGGTAGG 
Scaffold 3 TS^ CTACCGATAAGCAGACGATCCTCTCGATGCATTGACTCATCGACG 
Scaffold 3 NTS CGTCGATGAGTCAATCGTAGCTCTCCTAGCACTGCTTATCGGTAG 
                         DNA Sequences for 2-AP Experiments 
9mer RNA UCGAGAGGA 
Comp NTS# GCCATAAAGATCCGTGCTTCGAGAGGATTTTTGCTTATCGGTACG 
Non-Comp NTS# 
(i+3) 
GCCATAAAGATCCGTGGAAGCTCTCCTAATTTGCTTATCGGTACG 
Non-Comp NTS# 
(i+5) 
GCCATAAAGATCCGTGGAAGCTCTCCTAAAATGCTTATCGGTACG 
i2TS* CGTACCGATAAGCAAAAPATCCTCTCGAAGCACGGATCTTTATGGC 
i3TS* CGTACCGATAAGCAAAPAATCCTCTCGAAGCACGGATCTTTATGGC 
i5TS* CGTACCGATAAGCAPAAAATCCTCTCGAAGCACGGATCTTTATGGC 
i8TS* CGTACCGATAAPGCAAAAATCCTCTCGAAGCACGGATCTTTATGGC 
^Nucleic acid scaffold (NAS) template strands used for crystallization where the underlined region denotes the non-
complementary stretch of base pairs to make an artificial bubble, and A represents the i+1 site 
#Non-template DNA strands used for 2 – aminopurine experiments, where compNTS represents the fully 
complementary strand, and non-comp NTS represents bubble DNA. 
*Template strand DNA where AP represents 2 – aminopurine, and A designates the i+1 site 
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Purification of TFIIF and assembly of ∆4/7 Pol II-TFIIF complex was achieved similarly to Pol 
II – Tfg2 transcribing complexes (Figure 7), with a more detailed protocol found in our previous 
publication (101). An SDS-PAGE of the final complex is illustrated in Figure 7C. Ethidium 
bromide staining of sample confirmed the presence of the NAS (Figure 7C, red arrow).  
 
Figure 7. Complex purification and assembly.  
(a) Schematic flow-chart of steps taken for protein purification and complex assembly. (b) SDS-PAGE of Pol II-Tfg2 
complex. (c) SDS-PAGE of ∆4/7 Pol II TFIIF complex, also depicting NAS after ethidium bromide staining (red 
arrow). (d) Crystals of ∆4/7 Pol II-TFIIF complex were washed with reservoir solution and 8X loading buffer was 
added to the drop containing crystals and subjected to SDS-PAGE.  The four largest proteins are easily discernible 
from the gel confirming the presence of the complex in the crystals. 
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3.2.3 2 – aminopurine fluorescence spectroscopy 
Experiments presented here were performed in tandem with Dr. Brian Graham from the lab of 
Dr. Michael Trakeselis. DNA and RNA oligonucleotides are listed in Table 1. DNA/RNA 
hybrids of the TS and RNA were made by annealing oligonucleotides with a 1:2.5 molar ratio. 
Excess RNA was removed using a Superdex75 10/300 column (GE Lifesciences) against Buffer 
A, and nucleic acid scaffolds were assembled by annealing equimolar concentrations of the 
TS/RNA hybrids with NTS. To assemble transcribing complexes, 350 nM RNA Polymerase II 
was incubated with 300 nM NAS for 1 h at room temperature in Buffer B: 50 mM Hepes (pH 
7.0), 120 mM NaCl, 5 mM βME, 2 mM MgCl2, 0.1 mM EDTA and 1 µM ZnCl2. Steady-state 
fluorescence measurements were acquired in buffer B using a Fluoromax-3 (HORIBA 
Scientific). Excitation wavelengths included both 280 and 315 nm and fluorescence emission 
was collected from 340-400 nm. The entrance and exit slits were adjusted for optimal intensities. 
Spectra were collected for buffer, DNA and polymerase alone to correct for background 
fluorescence as described elsewhere (102). All measurements were performed at 25 ºC in 
triplicate.  
3.2.4 Crystallization and Refinement 
Several conditions were used for obtaining crystals of Pol II – TICs (Table 2). Scaffold 1 (i+5) 
was the primary NAS used for structure determination and complexes were verified by SDS-
PAGE analysis of crystals (Figure 7D). The structures were solved by molecular replacement 
(MR) using 12-subunit Pol II PDB:ID 3FKI (103) for Pol II-TICs and Pol II-TIC-Tfg2 and 10-
subunit Pol II PDB:ID 1R9T (43) for ∆4/7 Pol-II-TIC-TFIIF as search models, respectively, in 
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Molrep (104). MR models were refined using the program Buster (105), Refmac (106, 107) and 
CNS (108) followed by several cycles of manual building with B-factor sharpening in COOT 
(109, 110). All figures were rendered using PyMOL (The PyMOL Molecular Graphics System, 
Version 1.5.0.4 Schrödinger, LLC). 
 
Table 2. Crystallization conditions for Pol II - TICs 
Complex Crystallization condition 
Pol-II-TIC-i+5 6% PEG 6000, 0.2 M ammonium acetate, 0.3 M sodium acetate, 0.1 M Hepes pH 7.0 
Pol-II-TIC-Tfg2-i+5 10% PEG 4000, 75 mM NaCitrate, 0.1 M MES pH 6.5 
Pol-II-TIC-Tfg2-i+2 12% Peg 4000, 75 mM potassium thiocyanate, 0.1 M MES, pH 6.5 
Pol-II-TIC-i+3 6-8% Peg 6000, 0.2 M ammonium acetate, 0.3 M sodium acetate, 0.1 M Hepes pH 7.0 
∆4/7 Pol-II-TIC-TFIIF-i+5 8% Peg 4000, 75 mM sodium malonate, 0.1 M Hepes pH 7.0 
^ All conditions include 10 mM DTT, and where cryo-protected into mother liquor + 32% glycerol. 
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3.3 RESULTS 
3.3.1 Design, Assembly, and Crystallization of a Pol II-TIC  
Assembly of a S. cerevisiae Pol II-transcribing intermediate complex (Pol II-TIC) was achieved 
by mixing Pol II with pre-assembled nucleic acid scaffolds (NAS, Table 1). The main scaffold 
used for our experiments (scaffold 1) consisted of two synthetic DNA oligonucleotides (53-
nucleotides long), featuring upstream and downstream duplexes, a non-complementary stretch of 
15 nucleotides to generate a synthetic transcription bubble, and a 9-mer RNA complementary to 
the template strand to form a DNA-RNA hybrid (Figure 8A). Structural analysis presented in this 
paper utilized scaffold 1 within the TIC. The use of a non-complementary NTS to generate a TB 
is analogous to use of chain-terminators or non-hydrolyzable substrates to examine Pol II-
substrate interactions or interpretation of Pol II inhibitor-bound complexes as translocation 
intermediates. Our current structure interpreted in similar light still allows for a number of 
valuable insights. The number of non-complementary bases used in the design of the TB was 
based on crystal structures of partial Pol II transcribing complexes including PDB:ID 1Y1W (45) 
and PDB:ID 2NVZ (49). These structures show at the downstream end, base complementarity at 
positions i+3 and i+5, respectively (where i+1 indicates the nucleotide addition site and i-1 the 
first base of the nascent RNA transcript), and at the upstream end, a partial template strand 
reaches position i-9 below arch residues (comprising rudder (Rpb1312-319) and fork loop 1 (FL1, 
Rpb2470-480)) (Figure 8B). However, steric clashes with arch residues at this position suggested 
that at least two additional nucleotides are required to allow template and non-template strand 
annealing. Collectively, these observations suggested an artificial bubble size with a minimum of 
14 nucleotides for in vitro structural studies of a transcribing Pol II.  
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Figure 8. Design of Pol II transcribing complex.  
(a) Schematic representation of scaffolds used in our structural studies, where the open circles represent the non-
complementary region to generate artificial transcription bubbles (template strand: cyan, non-template strand: 
green, RNA: red). (b) A conservative model of the size of the bubble could be estimated using PDB:ID 1Y1W), 
where complementarity was observed at i+3. Upstream clashes with the “arch” would require 2 additional bases 
before annealing could occur. (c) Electron density map 2Fobs-Fcalc contoured at 0.8σ of a crystal comprising Pol II + 
scaffold 1 in the absence of Tfg2 or TFIIF. Partial electron density is observed for the upstream duplex and for the 
downstream fork and duplex, however no density is observed for the non-template strand within the transcription 
bubble (TS: cyan, NTS: green RNA: red). (d) Example of B-factor sharpening on Pol II residues at the Rpb2 wedge, 
contoured at 1.0σ. Application of negative B-factors results in increased clarity for high resolution features, 
especially for large side chains (ie Arg, Lys, Phe, Trp, Tyr) at a relatively low resolution (111).  
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Initially, crystals of Pol II bound to scaffold 1 (15 nucleotide TB) showed weak electron 
density for the upstream duplex but none for the NTS (Figure 8C). In search for factors that 
could contribute to a stabilized transcription bubble, we assembled Pol II or 10-subunit Pol II 
(lacking Rpb4 and Rpb7 subunits, ∆4/7) transcribing complexes with TFIIF or its 45 kDa β-
subunit, Tfg2 (Figure 7B,C). Two sets of crystals were obtained using PEG 4000 and low salt 
(Table 2). The first transcribing complex comprises ∆4/7-TFIIF (heretofore referred as ∆4/7-TC 
for simplicity) and the second comprises Pol II-Tfg2 (heretofore referred as Pol II-TC). 
Structures were solved by molecular replacement (MR) using ∆4/7 or Pol II as search models 
(see section 3.2.5). An initial unbiased Fobs-Fcalc map revealed the presence of extra density 
corresponding to upstream dsDNA, the NTS (Figure 9A) and three previously disordered regions 
of Rpb2 (Figure 13A,B). Unfortunately, any additional density for Tfg2 or TFIIF was non-
interpretable due to either high mobility or partial occupancy in the crystals. Nevertheless, the 
presence of TFIIF within the crystals (Figure 7D) was essential to reveal the full structure of the 
transcription bubble in our complexes, suggesting an important role in non-template strand 
stabilization. 
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Figure 9. Architecture of the complete nucleic acid scaffold.  
a) Difference Fobs-Fcalc electron density map contoured at 2σ. The following color scheme for the NAS will be 
used throughout: cyan, template strand (TS); green, non-template strand (NTS); red, RNA transcript. b) Front and 
side views of the Fobs-Fcalc map for the final refined map contoured at 1.0σ. c) Cartoon representation of the 38-
nucleotide refined nucleic acid scaffold (NAS); downstream and upstream duplexes form an angle of approximately 
130º degrees. d) Surface representation of the overlay between ∆4/7-TC (blue) and Pol II-TC (grey). The two 
structures overlay remarkably well with  minor structural differences occur at the downstream fork. 
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The MR model was refined using the programs Buster (105), Refmac (106) and manual 
building with B-factor sharpening in COOT (see Table 3) (109, 110). The NAS was built into the 
electron density using the characteristic features of the DNA-RNA hybrid as register (Figure 
9A). The final refined 2Fobs-Fcalc map for ∆4/7-TC is illustrated in Figure 9B. The full observable 
DNA scaffold (38 nucleotides long) spans the length of Pol II and comprises: the downstream 
duplex, the DNA-RNA hybrid and two previously uncharacterized regions, an upstream duplex 
and the full transcription bubble including the non-template strand (Figure 9B,C). Overlay 
between the DNA scaffolds from ∆4/7-TC and Pol II-TC, show minor differences mainly located 
at the downstream fork (Figure 9D). Pol II regions involved in DNA binding include: 1) The 
previously described Rpb5 “jaw” and Rpb1 “clamp” residues that interact with the downstream 
duplex (38); 2) Rpb2 “wedge” residues (Rpb2862-874) that interact with the upstream duplex; and 
3) “arch” residues that interact with the upstream fork (Figure 10A,B). For clarity, the 
presentation of our structural findings is based on the 10-subunit Pol II (∆4/7) transcribing 
complex comprising TFIIF and scaffold 1, which has been labeled as ∆4/7-TC unless otherwise 
noted. 
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Figure 10. Overall structure of Pol II transcribing intermediate complexes.  
(a) Surface representation (side view, Rpb2 removed) illustrating the position of the NAS inside Pol II. Wedge, jaw 
and arch interactions with the NAS lie on almost a perfect plane, possibly to minimize strain during elongation. 
(b,c) The NAS binds asymmetrically inside Pol II’s cleft, more prominently at the downstream end where observed 
clamp-DNA distances of ~6 Å vs. lobe DNA distances of ~14 Å are due to interactions with clamp and jaw residues. 
(d) Surface electrostatic representation calculated using the APBS (112) suite in PyMOL to illustrate how the NTS 
follows a path of positively charged residues inside Pol II’s cleft (lobe and protrusion). 
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Table 3. Crystallographic Data and Refinement Statistics 
 Pol II-Scaffold 
1 (i+5)a 
(APS-GM/CA) 
∆4/7 –TC (i+5)a 
(APS-GM/CA) 
Pol II-TC (i+5)a                                            
(SSRL-11.2) 
Pol II-Tfg2 – 
Scaffold 2 (i+2)a 
(SSRL-11.2) 
Pol II-Scaffold 
3 (i+3)a          
(APS-GM/CA) 
Data 
Collectionb 
     
PDB:ID 5C44 5C4J 5C4X 5C4A 5C3E 
Nucleic Acid  Scaffold 1    Scaffold 1 Scaffold 1 Scaffold 2 Scaffold 3 
Space Group C2221    C21 C2221 C2221 C2221 
Unit cell (Å) 220.2 391.8 
282.3 
280.7 223.3 
156.4 
220.7 393.3 
281.6 
219.8 396.7 
273.6 
 
219 390.9  
278 
α, β, γ (°) 90 90 90 90 98.1 90  90 90 90 90 90 90 90 90 90 
Wavelength 
(Å) 
1.03 0.979 0.979 0.978 1.03 
Resolution 
(Å)c 
120-3.9 174-4 50-4 200-4.2 178-3.7 
Unique 
Reflections 
106,511 80,485 103,153 80,062 126,815 
Completeness  
(%) 
96 (93.8) 97(96.1) 97.3(96.4) 99(98.3) 94.88(78) 
Redundancy 4.3 (3.2) 5.1(4.3) 3.8(3.4) 4.5(3.7) 3.6(2.8) 
<I/σI> 8.2(1.2) 10.3(3.7) 12.5(1.95) 14.2(2.1) 8.5(1.1) 
Mosaicity (º) 0.6 0.6 0.35 0.55 0.35 
Rmerge (%) 13.8(49) 14.7(61) 9.1(42) 8.5/(47) 12.5(56) 
Refinement  
 
     
No. Atoms 33086 30259 33673 32281 33086 
Rcryst/Rfree (%) 22.3/25.4 21/26 21.5/23.2 23.53/27.47 23.2/27.62 
Refinement 
Program 
Buster/CNS Refmac/CNS Buster/CNS 
 
Refmac/CNS Refmac/CNS 
aIndicates the position of complementary base pairing in the downstream bubble. 
bNumbers in parentheses correspond to the highest resolution shell 
cResolution limits were extended to include weak intensity data (113). Using the traditional criterion of I/σI > 2.0, 
resolution limits are 4.15 Å and 3.9 Å for Pol II-Scaffold 1 and Pol II-Scaffold 3 complexes, respectively. 
3.3.2 Pol II interacts with the minor groove of upstream and downstream DNA duplexes 
using two domains located 90 Å apart. 
Our refined models show that Pol II interacts with the upstream duplex, which appears as if 
propped by a hairpin loop or “wedge” (Rpb2862-874) –a vertical extension of wall residues 
(Rpb2855-861)– that engages the minor groove of the double helix (Figure 10A). At the tip of the 
wedge, Met868 lies between template and non-template strands, while the amide backbone of 
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Gly867 appears to form hydrogen bonds (H-bond) with two contiguous phosphates on the non-
template strand (Figure 11A). No crystal contacts that could potentially stabilize the 
conformation of wedge residues or the upstream duplex were present in the two different crystal 
forms (Figure 12A,B). The framework of the wedge –a hairpin loop within a long concave five-
strand β-sheet– is conserved in all multi subunit DNA-directed RNA polymerases (Figure 11B). 
Moreover, overlay of the human mitochondrial polymerase elongation complex (mtRNAP) (114) 
and our structure shows that the upstream duplex and fork adopt similar conformations (Figure 
11C). This is particularly interesting given the scarcity of conserved structural elements between 
the two structures (Figure 12C). 
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Figure 11. Rpb2 Wedge Residues: Structure, Conservation, and Function (see also Appendix A) 
(a) Interaction of wedge residues with the minor groove of the upstream duplex. A refined 2Fobs - Fcalc map 
contoured at 1.0 σ is also illustrated. (b) Conservation of wedge structure: yellow, T. thermophilus (47); hot pink, 
archaea (S. sulfactarius) (115); sand, S. cerevisiae; blue, S. pombe (116); and purple, 14-subunit Pol I (S. 
cerevisiae) (117). (c) Overlay of mtRNAP-upstream duplex (PDB: 4BOC) with our structure about template strand 
i+1 and i+2. (d) In vitro elongation rate of WT Pol II and an rpb2 wedge deletion mutant (K864G/K865G/D866-
871). Elongation rate determined on nucleic acid scaffolds at a number of NTP concentrations followed by non-
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linear regression of the rates for determination of maximum elongation rates (bar graph, error bars indicate range 
of 95% confidence interval). e) In vivo apparent elongation rates for WT Pol II and the rpb2 wedge deletion mutant 
at a galactose-inducible reporter gene determined by ChIP upon glucose shutoff of transcription (schematic of 
reporter in panel f). Values are normalized to 0 min of glucose and error bars represent SD of the mean for three 
independent experiments. f) Steady state occupancy for wt Pol II and the rpb2 wedge deletion mutant at a galactose 
inducible reporter gene under galactose induction determined by chromatin IP (schematic of reporter with positions 
of PCR amplicons shown below) (n=3 independent experiments). g) Steady state RNA levels of reporter used in F 
for wt Pol II and the rpb2 wedge deletion mutant. Values were normalized to SCR1 levels (a Pol III transcript) and 
averaged (n=3) with error bars representing standard deviation. h) Primer extension analysis for ADH1 transcripts 
in rpb2 wedge alleles (left) with quantification on right showing average change in fraction of ADH1 starts in 
various positions relative to wild type. Error bars represent standard deviation of the mean (n=3). 
 
To assess a role of Rpb2 wedge residues during in vivo transcription, a number of alleles 
were constructed and characterized for growth phenotypes consistent with transcription defects 
in collaboration with the lab of Dr. Craig Kaplan (see Appendix A, Figure 12D, left panel). We 
observed sensitivity to mycophenolic acid (MPA), which can be indicative of IMD2 
transcriptional phenotypes (118).  Indeed, we found that Rpb2 wedge alleles were generally 
defective for induction of IMD2 gene expression in the presence of MPA (Figure 12D, right 
panel). In order to more directly assess the role of the Rpb2 wedge, the lab of Dr. Kaplan 
examined the K864G/K865G/Δ866-871 rpb2 wedge allele for in vitro or in vivo elongation 
phenotypes (see Appendix A, Figure 11D,E). We found that this particular rpb2 wedge allele 
did not confer robust elongation defects in vitro or in vivo, though it did confer very strong 
defects in steady state Pol II reporter gene occupancy and expression (Figure 11F,G). The defects 
observed are consistent with strong defects in initiation, and we observed altered transcription 
start site selection consistent with altered initiation in vivo (Figure 11H) (118). 
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Figure 12. Pol II –TIC crystal contacts and the role of Rpb2 wedge residues in upstream duplex stabilization 
(see also Appendix A) 
(a,b) Crystal symmetry of Δ4/7-TC crystallized in C21 space group and Pol II-TC in space group C2221. Symmetry 
molecules were visualized in PyMol with upstream DNA positions highlighted (black arrow). The upstream duplex 
is solvent exposed indicating that the DNA architecture was not an artifact of crystal packing. (c) Ribbon and 
cartoon representation of the overlay between the elongating human mitochondrial RNAP (red) PDB:ID 4BOC 
(114) and our structure (grey) about positions i+1 and i+2 on the template strand. (d) Left panel – Serial dilutions 
of yeast strains containing Rpb2 wedge alleles (mutations as designated on figure) on various media. Right panel – 
Quantitative analysis of Northern blotting for IMD gene expression (normalized to SED1 as loading control) in 
presence or absence of 20μg/ml mycophenolic acid (MPA). Error bars are standard deviation of the mean (n=3).  
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Pol II contacts with the downstream duplex encompass Rpb5 (jaw) and Rpb1 (clamp-
head) domains (Figure 10B,C). Specifically, Rpb5 jaw residue Pro118 (from helix 118-124) is 
positioned inside the minor groove of the DNA double helix and Thr117 (from loop 112-117) and 
Ser119 locate within H-bond distance to non-template strand positions i+15 and i+16 (Figure 13, 
also observed in PDB:IDs 1R9T, 2NVQ and 2NVZ). Rpb1 clamp-head residues Lys100, Lys101, 
Lys143, and Arg175 locate within H-bond distance of the phosphate chain of non-template strand 
positions i+8 to i+10 (Figure 13D). As a result of these interactions, the downstream duplex is 
asymmetrically positioned inside the cleft (Figure 10B,C). Interestingly, contacts resembling 
clamp-head interactions in T. thermophilus polymerase, are located on a helix-loop-helix domain 
in its β’ subunit (Figure 13E) forming H-bonds with non-template strand i+8 to i+9. However, 
interactions with jaw residues are observed only in archaeal and eukaryotic polymerases, since 
bacterial polymerases lack Rpb5 homologues.  
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Figure 13. Pol II contacts with upstream and downstream duplexes. 
a) 2Fobs-Fcalc electron density map contoured at 1.0σ to illustrate the presence of traceable electron density for 
previously disordered Rpb2 regions. b) Cartoon representation of the overlay of our structure with PDB:ID 1Y1W 
(illustrated in sand and blue, respectively); template and non-template strands are illustrated in cyan and green 
respectively. Presence of TFIIF or Tfg2 allowed tracing of two previously unfolded regions of Rpb2, the first one 
folds into a 3-strand beta sheet that resembles a catcher’s glove (Rpb2 glove) and includes residues 71-90 and 131-
164. The second one includes loop 436-443 from Rpb2 protrusion domain. Overlay between our structure and 
PDB:ID 1Y1W illustrate conformational changes in helix 443-465 (red arrows) possibly elicited by the close 
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proximity of the upstream duplex. c) Cartoon representation of Pol II stabilizing the downstream duplex illustrates 
that Rpb1 (silver) and Rpb5 (magenta) helices “thread” the major and minor grooves of the DNA respectively. d) 
Cartoon and ball & stick representation of Pol II interactions with the downstream duplex, where positively charged 
residues of Rpb1 clamp domain (silver) contact the i+7 to i+9 phosphates of the non-template strand. e) Contacts 
resembling head-clamp interactions in T. thermophilus polymerase (PDB:ID 2PPB) are located on a helix-loop-
helix domain in the β ́ subunit. These include: 1) Val107 which is inserted in the minor groove of the double helix, 2) 
the backbone nitrogen of Ser110 interacting with i+8 phosphate of the non-template strand and 3) Lys106 
interacting with phosphate template strand i+4. 
 
3.3.3  Strand annealing and 3-way coordination of TS, NTS and RNA at the upstream 
fork 
The transcription bubble in our complexes lies within upstream and downstream duplexes and 
was enforced by non-complementarity between the template and non-template strands at 
positions i+5 through i-10 (Figure 8A, scaffold 1). At the upstream “closing” end of the bubble, 
rudder and fork-loop 1 (FL1) residues come in close proximity to form an “arch” located 25-30 
Å above the bridge helix (Figure 10A). The arch is situated in between the template and non-
template strands, and physically marks the upstream boundary of the bubble (Figure 14). Arch 
residues adopt unique conformations that allow simultaneous coordination of the nucleic acid 
scaffold (Figure 14A). As the template strand separates from the RNA transcript (i-8) and 
emerges from Pol II’s active site, non-specific packing interactions with FL1 residues and 
potential salt bridges between the phosphate chain and arch residues guide the template strand in 
a straight conformation towards its junction with the non-template strand (Figures 14A,B and 
15A).  
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Figure 14. Architecture of the upstream fork junction 
(a) Stereo-view of the tripartite coordination of the three nucleic acid chains. Arch residues at the back, top and 
bottom adopt unique conformations – with respect to apo- and elongation structures – that interact with TS, NTS 
and the RNA transcript respectively. Rpb1 residue Arg320 forms a H-bond with the 2’-OH of the nascent transcript 
at position i-8. (b,c) Front view (b) and side view (c) of the upstream (closing) end of the TB. Rudder (silver) and 
FL1 (sand) residues reach within 4 Å across the midline to form an arch that provides a scaffold for TS and NTS 
annealing at i-12. Contacts include packing interactions between TS i-8 and Tyr459 and potential H-bonds between 
Rpb2 residues Thr463 with TS i-8, Glu469 with TS i-10 and Lys470 with TS i-9. Lys317 participates in contacts with 
NTS i-11 and i-12 (see also Figure 15) 
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Once above the arch, template strand nucleotides anneal with the non-template strand at 
i-12 (Figure 14B,C). Stabilization of the nucleic acid scaffold by arch residues include, 
interactions between template strand i-8, i-9 and i-11 with FL1 residues, and between non-
template strand i-11 and i-12 with rudder residue Lys317 (Figures 14 and 15B) (119). In addition 
to contacts that arch residues make with the template and non-template strands, rudder residue 
Arg320 reaches within H-bond distance of the 2´ hydroxyl of the 8th RNA base of the nascent 
transcript (Figures 14A and 15B, observed also in PDB:ID 1Y1W). This interaction is conserved 
in bacterial polymerases, where rudder Arg598 forms a H-bond with the 2´ hydroxyl group of the 
7th base on the nascent transcript (Figure 15C, (120)) and has been corroborated by cross-linking 
experiments (121). 
 42 
 
Figure 15. Comparison of eukaryotic and bacterial RNA polymerases 
(a,b) Architecture of the transcription bubble at the upstream (closing) end with (a) template strand (blue) and arch 
residues. (b) non-template strand (green), RNA (red) and arch residues. A refined 2Fobs-Fcalc electron density map 
(contoured at 1 σ) was calculated around both regions. c) Interactions between rudder residues Arg320 (S. 
cerevisiae, silver) or Arg598 (T. thermophilus, yellow) with the 2  ́hydroxyl of the nascent transcript (S. cerevisiae, 
red, T. thermophilus, yellow) are structurally conserved (observed also in transcribing complex PDB:ID 1Y1W). 
FL1 residues are not present in bacterial polymerases, instead a flexible β ́ rudder (residues 583-603, yellow) (47) 
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reaches towards the mid-line forming a dome-like structure that spatially organize the junction of the two strands. 
(d) Structure overlay between σA factor region 2 (yellow) and open promoter complex (purple) from PDB:ID 4G7O 
and TFIIB bound to Pol II (PDB:ID 3K7A) (blue). Residues from σA region-2 and B-linker differ significantly. While 
σA can recognize specific bases at i-11 and i-7 (DNA scaffold in purple), the B-linker reaches within 6Å to interact 
with template and non- template strands at the opening end of the transcription bubble and could play a role in 
scaffold loading. 
3.3.4 Strand separation at the downstream transcriptional fork. 
Strand separation in our structure appears to take place at i+5 where base-pair distance begins to 
increase progressively. However, it was not possible to define its exact location since our 
artificial bubble enforced non-complementarity precisely at i+5 (see below). However, our 
structure gives possible insight into the mechanism by which Pol II residues promote and sustain 
DNA strand separation. The template strand interacts with switch 1 and switch 2 residues driving 
it towards the active site as originally described (38), while the non-template strand interacts 
with two groups of Pol II residues. The first involves a positively charged cleft formed by Rpb1 
residues Arg1386-His1387-Arg1391 (switch-1), and Lys1102-Lys1109-Asn1110, (located in a structurally 
conserved U-loop) in the vicinity of non-template strand i+5 and i+6 (Figures 16A and 17A, (45, 
60)). The second involves interactions with Rpb2 fork loop 2 (FL2) residues 501-510 (Figure 
16A) providing packing contacts with the non-template strand i+3 to i+1, and Arg508 reaching 
within H-bond distance of the non-template phosphate chain (Figures 16B and 17B).  
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Figure 16. Architecture of the Downstream Fork Junction 
(a) Stereo-view of the architecture of the down- stream fork. Relevant interactions include U-loop (UL) and switch 1 
residues with non-template strand i+5 and i+6, FL2 residues with non-tem- plate strand i+2 to i+3, and Rpb2 
residues 221– 282 (forming a 5 strand b sheet, Dome) with non- template strand i+1 to i 2. (b) Unbiased Fobs - 
Fcalc electron density map contoured at 3 s (FL2 residues 498–512 were not included in map calculation). (c) 
Structural overlay of published FL2 conforma- tions during different stages of transcription. D4/7- TC (sand), PDB: 
1Y1W (blue, elongation complex), PDB: 3HOW (cyan, backtracked complex), and PDB: 3PO2 (red, backtracked 
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complex). (d) Representative spectra of 2AP probes at i+2 or i+3, bound to complementary non-template strand in 
the absence (open red circles and squares, respectively) and presence (blue circles and squares, respectively) of Pol 
II. The excitation wavelength was 315 nm and the fluorescence emission (shown in counts per second ×106) was 
collected from 340 to 400 nm. (e) Normalized fluorescence values for polymer- ase bound to ssDNA (primer-
template) where 2AP is at the i+2, i+3, i+5, or i+8 position (red) and polymerase bound to dsDNA (primer-
template annealed to fully complementary non-template strand) (blue). Error bars are SD of the mean (n = 3). 
 
Structural overlay of FL2 residues from published crystal structures suggests they could 
be grouped in two major states (Figure 16C). The first one, an “open” state represented by 
PDB:IDs 3PO2, 1Y1W and 3HOW, where FL2 residues interact with NTS i+2 or i+3, 
respectively, allowing access to a non-specific nucleotide-binding pocket (48). The second, a 
closed state where FL2 residues appear to rotate about Pro501 and Pro510 (our structures, PDB:IDs 
3FKI and 3K7A) blocking access to the pocket. Positioning of FL2 residues in the latter 
conformation appear to guide the non-template strand under a 4-strand β-sheet dome (Figure 
16A) towards its junction above the arch. Other interactions include contacts with Rpb2 β-strand 
245-255 residues (Figure 17B) and a patch of positive charges from the Rpb2 protrusion helix 
(Figure 10C). 
3.3.5 Fluorescence and structural experiments suggest that the downstream fork is 
dynamic. 
Given that the precise location of strand separation was not possible to be determined from the 
structure –and in light of previous structural studies showing a closed bubble at i+2 and i+3, 
respectively (45, 60), as well as fluorescence studies where the use of a 35 nucleotide scaffold 
with a partial (17 nucleotides) non-template strand showed complementarity at i+2 (120)– we 
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wished to ascertain whether it was possible to detect an open bubble in the presence of a 45 
nucleotide scaffold bearing a fully complementary non-template strand  (Figure 17C). 2-
aminopurine (2AP) is a fluorescent nucleotide analog that is significantly quenched upon base 
pairing to either T or C, as well as by stacking interactions with adjacent nucleotides (122, 123). 
Therefore, we placed 2-AP in the template strand at positions i+2, i+3, i+5 (at the boundary of 
strand separation) and downstream at i+8, where the two DNA strands were likely to be paired 
(Figure 17C). As expected when the primer-template is annealed to a complementary non-
template strand, full quenching is observed consistent with stable base pairing of 2AP (Figure 
16D,E). When polymerase was added to the scaffold with a fully complementary non-template 
strand, we see a 4.5-fold increase in fluorescence for the i+2 substrate and a 2.8-fold increase in 
fluorescence for the i+3 (Figure 16D,E). This increase in fluorescence indicates a disruption in 
stable 2AP base pairing at both locations and could suggest that Pol II can unwind the non-
template strand at i+3. There is 1.2-fold fluorescence enhancement for i+5 and none for i+8 
suggesting 2AP is more stably base paired at those positions (Figure 16E). Moreover, crystal 
structures of Pol II bound to scaffolds 2 and 3 bearing non-complementary transcription bubbles 
with strand separation at i+2 and i+3, respectively, both showed base-pairing at i+5, 
recapitulating the results of 2-AP experiments (Figure 17D,E). 
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Figure 17. Investigating the dynamics of the downstream fork 
(a) Solvent accessible surface electrostatic representation calculated using APBS (112) in PyMOL to illustrate how 
non-template strand elements (green) trail a crevice of positive charges (blue) at the opening end of the 
transcription bubble. Interactions between Pol II elements (U-loop and Switch 1) and the non-template strand 
phosphate backbone suggest that the region from i+3 to i+6 has the potential to be non-duplexed. (b) FL2 
interactions with the non-template strand phosphate backbone lift the strand towards a short tunnel-like structure 
whose “dome” is a four-strand β-sheet from Rpb2. Electron density for non-template strand position i-2 is shown in 
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blue. (c) Cartoon schematics of DNA represents the final annealed product used for each 2AP experiment, where 
yellow stars highlight the position of the 2AP probe, the template strand is in cyan, non-template strand in green, 
and RNA in red. d,e) Electron density maps countered at 1σ of Pol II transcribing complexes composed of scaffold 2 
+ Tfg2 (d) and scaffold 3 alone (e) bearing non-complementary nucleotides at position i+2 or i+3 respectively. FL2 
is disordered in i+2 but ordered in i+3 and is primed to engage with the non-template strand at the opening end of 
the transcription bubble. FL2 residue Arg504 reaches in close proximity to the nucleotide at i+3 position. (f) 
Normalized fluorescence values for polymerase bound to ssDNA (template/RNA hybrid) where 2AP is at the i+2, 
i+3, i+5 or i+8 position before addition of the non-template (green) and after addition of non-template strand 
(blue). Error bars are standard deviation of the mean (n=3). (g) Comparison of 2AP fluorescence against non-
complementary (bubble) DNA shows that when non-complementarity is extended to the i+3 or i+5 position, 
fluorescence measurements increase significantly compared to their complementary counterparts (panel F). Error 
bars are standard deviation of the mean (n=3). (h) Refined 2Fobs-Fcalc electron density map (green, contoured at 
0.8σ) calculated around the opening end of the non-template strand in the Pol II-TC. Evidence of a scrunched state 
–where template and non-template strand bases are compacted in space relative to relaxed conformations – has 
been proposed during the early stages of transcription initiation (98, 99). Similarly, other transcriptional events 
such as backtracking or interactions with elongation or termination factors might alter the number of bases (and 
location) in the mature transcription bubble. i) Cartoon and surface representation of a front view (left) and front 
view rotated 60° counterclockwise (right) of the overlay between PDB:ID 3K7A (124) and Δ4/7-TC. The B-linker 
region of the general transcription factor TFIIB reaches within 6 Å at the downstream fork junction and could 
interact with the non-template strand and assist transcription bubble loading during initiation. The electrostatic 
surface representation calculated using APBS in PyMOL illustrates that one face of the B-linker is positively 
charged and could possibly allow interactions with non-template strand phosphate chain. FL2 residues could 
potentially assist during bubble loading via interactions with the non-template strand. 
 
To observe a full non-template strand it was necessary to utilize a bubble with non-
complementary DNA to i+5, since Pol II transcribing complexes bearing non-complementary 
bubbles at positions i+2 and i+3 showed minimal non-template strand density (scaffolds 2 & 3, 
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Figure 8A).  Thus, we analyzed whether forced non-complementarity at i+5 in the transcribing 
complex contributed to increased mobility of the non-template strand and its subsequent capture 
in our scaffold 1 complex. Consistent with this possibility, 2AP experiments of non-
complementary bases at positions i+3 and i+5 showed an increased fluorescence signal when 
compared to bases that are complementary at these positions (Figure 17F,G). This might indicate 
increased motion of the non-template strand bearing non-complementary bases. It is possible that 
by forcing non-complementarity at i+5 in our structure, we allowed a kinked conformation of the 
non-template strand in Pol II-TC structure (Figure 17H). It is also possible, while highly 
speculative, that the presence of Tfg2 (without Tfg1) in the cleft induced such conformation.  
 
3.3.6 Interactions with the NTS are associated with the off (non-catalytic) state of the 
trigger loop  
A highly conserved loop comprising Rpb1 residues 1078-1097, the trigger loop (TL), has been 
shown to play a fundamental role in nucleotide selection and catalysis, while also proposed to 
govern translocation (49, 53, 56, 58, 118, 125, 126). Evidence from single molecule studies on 
Pol II indicates that mutation of TL residues alters Pol II translocation properties, consistent with 
these models (126). Structurally, the TL locates between Rpb1 helices 1064-1078 (TLα1) and 
1097-1106 (TLα2), which in turn are part of a universally conserved five-helix bundle, 
(heretofore known as TL bundle (TLB)), that includes Rpb1 helices 826-846 (bridge helix), 
1340-1357 (TLα4) and 1365-1379 (TLα5) supported by packing of hydrophobic residues at the 
bundle core (Figure 19A). 
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Figure 18. Trigger loop (TL) and nucleic acid scaffold interactions during translocation 
On-, off- state residues will be indicated in blue and grey, respectively. A modeled UTP (PDB:ID 2NVZ) is indicated 
in light grey/orange. (a) Conformational changes observed between off and on (structural overlay with PDB:ID 
2NVZ) states of the TL and Rpb1 funnel helices. A 2Fobs-Fcalc map rendered at 1.0 σ is contoured around TL and 
funnel residues. (b) Conformational changes observed between TL off and on states. Red arrows indicate motion. 
During off/on state conformational changes, most TL stabilizing interactions are disrupted, including: 1) Release of 
Met1079 from its hydrophobic pocket. 2) Disruption of α2-Bridge Helix H-bonds, resulting in bridge helix 
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displacement. 3) Disruption of Thr1095-Thr1113 H-bonds allowing counterclockwise TL motion. 4) Disruption of non-
template strand – U-loop bonds, possibly leading to non-template strand release and translocation. (c) Mutations of 
residues that disrupt Met1079 hydrophobic pocket result in gain of function phenotypes (56). TLB residues are 
represented as a solid silver surface. Motion of Met1079 might occur through a defined pathway on the protein 
surface (orange trace). Mutations of Ala1076 and Gly1097 (red surface) for bulkier residues, can potentially disrupt 
the vestibule of the hydrophobic pocket (58). (d) Possible coupling of the global translocation of the scaffold to local 
motion of the TL. Pol II regions in contact with upstream and downstream duplexes, Rpb2 (sand) and Rpb5 
(magenta), respectively, are coupled through TLB residues (dark gray). TL off and on conformations are illustrated 
in yellow and blue, respectively (see also Figure 19). 
 
 The Pol II TL is intrinsically mobile and has only been detected in X-ray structures when 
bound to small molecules (such as a matched NTP or α-amanitin) or protein-ligands (TFIIS) that 
each stabilize a particular conformation (49, 57, 59, 61). Observed conformations define a closed 
“on” state where TL residues interact with a matched nucleotide in the addition or “A” site 
(effectively isolating a reaction chamber, and blocking access to additional substrates (58, 125)); 
or an open “off” state where TL residues move away from the A site. During advanced stages of 
refinement, electron density for the full TL backbone was clearly discernible (Figures 18A and 
19B) and partial residue placement was feasible with help of map sharpening in Coot. TL 
backbones were found in novel off states that differ from previously reported conformations (49, 
61, 62) such as the Pol II-TFIIS complex, where direct contacts with TFIIS displaced and 
stabilized TL residues (Figure 19C). Interestingly, our structures show two distinct off state 
conformations: The first one present in the ∆4/7-TC closely resembles the TL loop in the “on” 
conformation (PDB:IDs 2E2H and 2NVZ, (49)) but rotated counter-clockwise approximately 
60° away from the addition site (Figure 18A).  
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Figure 19. Conformational changes associated with DNA translocation in trigger loop and Rpb5 residues 
(a) Cartoon and surface representation of the Rpb1 5-helical bundle comprising the trigger loop-bundle (TLB). α1, 
residues 1063-1077; α2, residues 1098-1106; Bridge helix, residues 810-845; α4, residue 1341-1357; and α5, 
residue 1365-1377. TL, TL helices α1-α2 (hinges), and the U-loop are illustrated in yellow (Inset, also shows non-
template strand i+5 and i+6). The core of the bundle is held together by hydrophobic interactions. (b) 
Conformational changes observed between “off” and “on” (structural overlay with PDB:ID 2NVZ, blue) states of 
the TL and Rpb1 funnel helices. All “on” state residues are indicated in blue, “off” state residues are indicated in 
grey for Pol II-TC. A 2Fobs-Fcalc map rendered at 1.0 σ is contoured around TL and funnel residues. (c) 
Conformational changes observed between various “off” states of the TL: Δ4,7-TC, silver; Pol II-TC, yellow; 
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PDB:ID 1Y1V, red; PDB:ID 3CQZ, magenta; PDB:ID 2NVX, green. Differences in secondary structure for TL 
residues 1093-1098 in Pol II transcribing structures, suggests that we were able to capture “off” state 
intermediates. (d) Cartoon representation of Rpb5 residues during “off” (illustrated in magenta) and “on” 
conformations, (illustrated in blue). During “on” state three loops of the jaw domain become disordered, suggesting 
that this region “moves” during this stage facilitating translocation of the nucleic acid scaffold. Additional 
conformational changes are observed in Rpb5 wedge residues. These changes could be related to motion in TLB 
residues. 
 
The second one, observed in Pol II-TC resembles a hairpin loop and its shape is similar to 
previously reported off state structures (Figure 19A-C, (45, 49)). Both conformations induce 
considerable changes in funnel and neighboring residues (Figures 18A and 19B). Albeit these 
differences in the positions of the TL’s off state, a common set of interactions can be observed 
among these structures and all structures crystallized with a DNA scaffold (exclusive of the on-
state structures). These include: 1) interactions between TL hinge regions (TLα1 and TLα2 
helices) with neighboring Rpb1 residues, and 2) the burying of Met1079 inside a small 
hydrophobic pocket at the core of the TLB (Figure 18B). 
            Structural overlay between off and on states suggest substantial rearrangements in TLB 
helices and TL residues during the nucleotide addition cycle (Figure 18B). Transition to the on 
state involves TL residues swinging towards the addition site, where hinge contacts are disrupted 
and Met1079 moves out of its pocket at the core of the TLB (Figure 18C). Genetic interactions and 
gene expression profiling of substitutions of Rpb1 Ala1076, Gly1097 and Leu1101 with residues that 
disrupt the Rpb1 Met1079 hydrophobic pocket (127), support a model where the integrity of the 
pocket is critical for stabilization of the off state in eukaryotic (56, 57) and archaeal (55) 
polymerases. Such substitutions are highly related to those that hamper off state conformations 
by destabilization of the C-terminal TL hinge region; therefore, these substitutions are similarly 
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predicted to alter translocation rate and catalysis (49, 56-58, 128) suggesting that the TL “off” 
state is specifically required for proper transcription. 
3.3.7 Structurally linked DNA-interacting domains: Upstream (Rpb2), downstream 
(Rpb5) and TLB residues could possibly coordinate NAS translocation 
Three regions of Pol II furnish residues that can potentially form H-bond contacts with the 
nucleic acid scaffold (Figure 20A). These include (from upstream to downstream): 1) wedge, 
wall and FL1 (Rpb2) with the upstream duplex, template strand and the non-template strand 
(respectively); 2) TLB, rudder, switch (1 and 2) and clamp residues (Rpb1), with DNA-RNA 
hybrid, template strand, downstream fork and downstream duplex (respectively); and 3) jaw 
residues (Rpb5) with the downstream duplex (Figures 18D and 20A,B). Remarkably, these 
regions have substantial interactions among them: TLB helices (TLα4 and TLα5) and Rpb1 
residues from a seven-helix bundle (Rpb1846-1064) form a large pocket that buries a two-strand 
hairpin from Rpb5193-214, which is in the immediate neighborhood of the jaw motif. Similarly, 
TLB contacts (via the bridge helix) with Rpb2 are extensive and involve “wall” residues (with 
the phosphate chain of the template strand) in the immediate neighborhood of Rpb2’s wedge 
(Figures 11B and 18D). Since these regions are coupled extensively, it is possible that they could 
play an important role during translocation. 
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Figure 20. Network of Pol II - NAS interactions 
(a) Illustration of residues that potentially contribute to hydrogen bond stabilization of the nucleic acid scaffold. 
Rpb1, Rpb2 and Rpb5 residues are illustrated in silver, copper and magenta respectively. Over 40 potential H-
bonds are disrupted during each translocation cycle (H-bond distances of 3.5 Å or less). (b) Surface representation 
of a transcribing Pol II complex. Cyan regions highlight interactions between Pol II and the nucleic acid scaffold, 
which may comprise the structural framework for high fidelity DNA tracking. 
  
 56 
3.4 DISCUSSION 
3.4.1 Molecular basis for high-fidelity DNA-tracking 
Real time microscopy experiments demonstrated the ability of RNA polymerases to rotate DNA 
by tracking with high fidelity its right hand helix (129). Our structures suggest that it is possible 
that engagement by wedge (upstream duplex), arch (closing end of the bubble) and jaw and 
clamp (downstream duplex) residues (Figures 10, 13 and 20F) could comprise the structural 
framework that explains such tracking mechanism. The interactions that Rpb1 (head clamp) and 
Rpb5 (jaw) residues make with the downstream duplex were described in several published 
crystal structures (43, 49). However, since contacts with the upstream duplex and arch were not 
previously observed, the correlation between DNA tracking, and its structural underpinnings 
could not be established. Moreover, given that the crystal structures of Pol II transcribing 
complex and mtRNAP show interactions with upstream and downstream duplexes, it is possible 
that tracking mechanisms are conserved in transcription (Figures 11C and 12). Furthermore, 
overlay of the archaeal RNAP clamp domain in complex with the heterodimer interface of the 
Spt4/5 complex (PDB:ID 3QQC, (130)) with the Rpb1 clamp domain of Δ4/7-TC shows that the 
upstream duplex is situated between the wedge domain and position of the Spt5 NusG domain 
(Figure 21A). While speculative, the observed location of the duplex in our structure is 
consistent with previous biochemical data and Pol II – Spt4/5 elongation models (130-132). 
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Figure 21. Modeling NAS interactions with initiation and elongation factors 
(a) Overlay of Δ4,7-TC with the archaeal P. furiosus clamp-Spt4/5 complex, PDB:ID 3QQC (Martinez-Rucobo et 
al., 2011) about the clamp coiled coil domains of Pol II Rpb1 (grey) and RNAP A′ (orange), suggests that the 
upstream duplex is positioned between the NusG domain of Spt5 (olive) (arrow 1) and Rpb2 wedge domain (arrow 
2). While speculative, our model suggests that Spt4/5 locks the upstream duplex in place and may play a role in 
maintaining bubble integrity during elongation. This is in agreement with previously published models (130, 131). 
(b) Structure overlay with initially transcribing Pol II-TFIIB structure, PDB ID: 4BBS (81) illustrate possible 
interactions between wedge residues (copper) and Cyclin-like domain residues (blue).  Comparisons between a 
model of the closed promoter complex (61, 62) and the structure of the transcribing complex suggest that transition 
from closed to open promoter entails a clockwise rotation (approximately of 90º degrees) of the upstream end of the 
DNA. Wedge residues Met868 and Ser869 interact with TFIIB residues 148-153 and 178-183 from the cyclin-like 
domain, such interactions could participate in Pol II duplex loading. It is possible that this rotational motion 
induces steric clashes that ultimately result in ejection of TFIIB and TBP allowing the axle to engage the minor 
groove. The close proximity of these two regions could allow loading of the duplex on the wedge during the 
initiation to elongation transition. 
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In collaboration with the lab of Dr. Craig Kaplan, we assessed multiple rpb2 wedge 
alleles to ascertain the role of these elements in vivo. The strongest growth effects observed in 
vivo required removal of the loop (Figure 12D), which may be considered an extensive 
perturbation to the Pol II structure. However, our interpretation of the direct or indirect functions 
of this loop is based on what is known about other Pol II mutants. We found that wedge alleles 
were MPA sensitive and shifted start sites downstream (Figures 11H and 12D). This profile is 
relatively rare for Pol II alleles or known general transcription factor alleles (reviewed in (118)), 
especially for mutants unrelated to the active center (Rpb1 N488D within the Pol II active site 
has this phenotypic profile (128)). Recent crystal structures of Pol II-TFIIB structures show that 
the wedge domain interacts with the TFIIB core N-terminal cyclin fold (81). Since TFIIB is 
necessary for start site selection, it seems plausible that changes in Pol II-TFIIB interactions 
could affect this process. Deletion of the wedge loop confers a strong defect in occupancy of Pol 
II at a reporter gene, consistent with an initiation defect. However, the wedge mutants do not 
phenocopy TFIIB (sua7) alleles in relation to MPA-sensitivity or IMD2 expression (Figure 12D), 
suggesting that some functions may be independent of TFIIB or relate to a novel initiation defect 
not observed in particular sua7 alleles. The wedge domain may possibly have a role during 
transition from initiation to early elongation by providing interactions with the upstream duplex 
that could assist TFIIB ejection (Figure 21B).  
3.4.2 Downstream fork flexibility 
The downstream fork is a dynamic region and different conformations of the non-template strand 
could be allowed during different stages of transcription. Structural overlay of the non-template 
strand from our structures and published structures crystallized in the presence of a nucleic acid 
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scaffold show small positional differences from i+5 to i+7, which are anchored by U-loop and 
switch 2 residues (Figure 17A). However, positions i+2 to i+4 differ in all crystal structures and 
can be found paired or un-paired to the template strand. These observations suggest that there 
may be a range within which the leading edge of the downstream fork can move; hence, fluidity 
within this region could be required to promote bubble opening and maintenance. Moreover, 
non-template strand flexibility correlates with FL2 flexibility (Figure 16C), which adopts 
multiple conformations (48, 49, 80, 103) to allow interactions with the non-template strand 
during the various transcriptional stages. The size of the bubble itself, which appears to be 
dynamic, might not be so critical due to the fact that Pol II can accommodate different lengths 
and possibly different locations of the transcription bubble inside the cleft (82). 
The crystal structure of the ternary complex between T. thermophilus polymerase 
(RNAP), σA and an open promoter complex (133) shows that FL2 residues fold to form part of a 
2′-deoxy-GTP “selectivity-pocket” for non-template strand i+2 during initiation. Also, the crystal 
structure of the RNAP ternary complex revealed that promoter recognition, melting and bubble 
loading are carried out by σA region-2 residues (Figure 15C). Thus architecture of the 
downstream fork in RNAP during initiation is determined by σA as well as FL2 residues.  
The recent crystal structure of E.coli RNAP holoenzyme in complex with a 15-nucleotide 
bubble at 6 Å resolution revealed for the first time the architecture of the RNAP transcription 
bubble stabilized by σ elements (134). However, overlay of RNAP bubble structure with our 
structures show different trajectories of the non-template strand and also different position of the 
upstream duplex. Such differences could be explained structurally since, on the one hand FL1 
residues (not conserved in RNAP) would clash with the non-template strand of RNAP; and on 
the other, the presence of σ, which itself interacts with the non-template strand, in the RNAP 
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cleft shifts dramatically the position of the upstream duplex. 
Interestingly, overlay of the co-crystal structures of Pol II in complex with TFIIB (74, 79, 
80) with the our structure shows that TFIIB linker domain reaches within 6.5 Å of the fork 
junction and could assist bubble loading (80, 81) and prevent re-annealing of downstream fork 
during initiation (Figure 17I). Thus, σA and TFIIB could sustain an open fork (during initiation) 
using different mechanisms.  
3.4.3 TL allosteric effects and DNA translocation 
It has been proposed by a number of groups that TL movement contributes or controls 
translocation (53, 56, 59, 125, 126). Our structures show Pol II in a post-translocated state, with a 
TL in the off state due to interactions with neighboring Rpb1 residues (Figures 18A,B and 19B). 
It is possible that a matched NTP at the i+1 position might disrupt these interactions leading to 
an on state. The on-state structure (49) shows Gln1078 as one of the key residues stabilizing a 
matched nucleotide through formation of H-bonds with the ribose. Structural overlay of TL 
residues between off and on conformations shows that Gln1078 moves approximately 3 Å to form 
H-bonds with the matched nucleotide (Figure 18B, see also (60). The position of this residue 
might be critical since on the one hand, it could constitute part of the nucleotide selection 
mechanism (55, 135). On the other hand, displacement of Gln1078 could trigger extraction of the 
neighboring Met1079 from its hydrophobic pocket, initiating a cascade of events that would lead 
into the full on state. Along with our observations, genetic evidence has shown that mutations of 
Gln1078 have a comparable effect on Pol II elongation activity as mutations on the catalytic 
His1085 (56). Importantly, Gln1078 and His1085 are genetically distinguishable suggesting a 
multistep process in TL function, consistent with initial substrate-Gln1078 interactions and 
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subsequent TL movement or folding. Moreover, Pol II activity is also exquisitely sensitive to 
substitutions around the Met1079 hydrophobic pocket (Figure 18C) (56, 58). These substitutions 
invariably lead to genetic phenotypes, genetic interaction and gene expression profiling 
phenotypes consistent with increased Pol II activity, most likely due to destabilization of the TL 
off state (127).  
Critical questions for the Pol II mechanism are how translocation occurs and what are the 
molecular determinants of its linkage to the nucleotide addition cycle? Our structure reveals that 
a second pivotal role played by TLB residues could possibly include stabilization of the non-
template strand. Crystal structures of Pol II bound to partial or full nucleic acid scaffolds (43, 45, 
49, 60) show that TLα2 and UL residues Lys1102, Asn1106, Lys1109 (amide backbone) and Asn1110 
locate within H-bond distance to the phosphate chain of non-template strand i+5 and i+6 (Figure 
17A). Overlay of the two states shows that the hinged motion of the TL during matched 
nucleotide binding results in conformational changes leading to increased U-loop – non-template 
strand distance and hence disruption of potential H-bond contacts (Figure 18B,C). Although 
speculative this could suggest that TL “off/on” transitions are allosterically coupled to “latch and 
release” (respectively) events of the non-template strand phosphate chain by U-loop residues. 
Furthermore, comparisons between on and off state conformations show that on-state Rpb5 jaw 
residues (interacting with the downstream duplex) become disordered, hence decreasing the 
number of effective contacts with the duplex (Figure  19D). Since TLB, Rpb5 (jaw residues) and 
Rpb2 (wall, wedge) regions could be coupled, through extensive observed interactions, it is 
possible that TL conformational changes are transferred allosterically to downstream and 
upstream duplexes to assist global translocation (Figures 18D and 20). 
Our refined structure sheds light into four fundamental mechanistic aspects of 
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transcription: 1) In addition to hybrid interactions (38), Pol II has four major contact points with 
a nucleic acid scaffold: wedge, arch, clamp and jaw domains (Figure 10A,B). Engagement of the 
minor groove by Rpb2 wedge (upstream), arch (closing end of the bubble) jaw and clamp 
(downstream) residues could comprise the structural framework that explains the mechanism for 
high fidelity DNA “tracking” observed using real-time optical microscopy (129). 2) Pol II 
residues define the architecture of the transcriptional fork. Arch residues coordinate annealing of 
template and non-template strands at the upstream fork; the downstream fork is a highly dynamic 
area where FL2 residues accommodate different conformations of the non-template strand. 3) 
The structure also suggests that Gln1078 is positioned to couple extraction of Met1079 out of the 
hydrophobic pocket to interactions with an incoming matched NTP, initiating a cascade of events 
leading to a full on state of the TL, followed by nucleotide incorporation and subsequent 
DNA/RNA translocation.  4) Finally, our structure shows that Pol II regions in contact with the 
nucleic acid scaffold are connected as rigid bodies (from Rpb1, Rpb2 and Rpb5) and that TL 
on/off state conformational changes could possibly be tied to global translocation. 
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4.0  STRUCTURAL STUDIES OF MULTI-PROTEIN POL II COMPLEXES: 
CHALLENGES AND DEVELOPMENTS 
While macromolecular complexes are biologically prevalent and important, their structural data 
is sparse when compared to isolated single proteins (136). To perform and regulate critical 
cellular processes, such as transcription, proteins form interacting heterogeneous assemblies 
(multi-protein complexes or MPCs). Estimates for the number of interacting protein pairs ranges 
from ~7,000 in E. coli to greater than 45,000 in S. cerevisiae, (137) whereas in higher order 
organisms it may exceed half a million (138). These interactions form the basis of the quaternary 
structure of MPCs and represent one of the most complex levels of structural organization in 
biological molecules. Out of the more than 100,000 entries in the PDB, just over 8% are protein-
protein or protein-nucleic acid complexes with a fraction of that representing complexes of three 
or more proteins (139). The structural specificity of protein-protein interactions is of crucial 
importance to fully understand the underlying mechanisms that govern cellular functions, and in 
the case of the transcription machinery, provide a blueprint for structure-guided therapeutics (as 
discussed in Chapter 1). While the advent of single-particle cryo-EM techniques have 
successfully allowed the study of MPCs from low – medium resolutions (see section 2.1.5), x-
ray crystallography still presents the best opportunity at garnering the atomic-level details along 
the protein-protein interfaces for therapeutic design. Therefore, examination of the bottlenecks 
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that prevent MPC crystallization and methods to overcome these challenges will be discussed in 
the proceeding chapters.  
4.1.1 Methods to overcome inherent challenges with MPC crystallization 
Co-crystallization of Pol II with the various TFs that regulate its activity has been limited to only 
a handful of high-resolution structures. The stubbornness of complexes to crystallize may be in 
part due to conformational disorder, or flexibility often associated with structural rearrangements 
involved with function and/or complex formation (140). This is not unique to Pol II complexes, 
as conformational flexibility resulting in unstructured regions of 40 amino acids or more in 
length, is present in at least 50% of eukaryotic proteins (141) and significantly correlates with the 
probability of crystallization failure (142).  In addition, affinities between the individual 
components of MPCs are weak, due to the transient nature of their interactions, and often result 
in complex disassembly during the crystallization process. Such incorrect stoichiometry can 
interfere with crystallization; evident by early Pol II crystallization experiments where sub-
stoichiometric Rpb4/7 led to poor crystal growth (see section 2.1.1).  
 Indeed, complex integrity is likely the main reason that MPCs are more difficult to 
crystallize than individual soluble proteins. A restricted set of chemical conditions must both 
stabilize the MPC and simultaneously promote the weak interparticle interactions required for 
the spontaneous nucleation of the MPC into an ordered lattice (Figure 22). While the boundaries 
of chemical space are reported to be more restricted (143) the sensitivity to this space is far 
higher. Considering that the majority of crystallization screens were developed for the 
crystallization of single, soluble proteins, it is not surprising that these same screens are 
inherently less effective for the crystallization of MPCs. Thus, a major effort is underway to 
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develop methods which improve complex stability, and possibly expand the chemical space for 
MPC crystallization.  
 
Figure 22. The crystallization process 
A flow scheme, representing the crystallization process of Pol II. The spontaneous nucleation of homogeneous Pol II 
particles (left panel) into an ordered crystal lattice (middle panel) is often the rate-limiting step in crystallization 
experiments. Conditions which promote growth lie at the interface of nucleation, and must be optimize to produce 
large, single-diffracting crysals (right panel). Degradation of sample overtime can prevent crystal growth, limiting 
crystals to nanometer sizes (middle panel).  
 
Advances in molecular biology and biochemical techniques have allowed for the 
expression, purification and stoichiometric reconsitution of MPCs and pharmacologically 
relevant protein targets (144-146). Similarly, innovations in synchrotron technology, including 
development of micro-focused X-ray beams, advances in X-ray area detectors, as well as the 
development of user-friendly crystallography software have significantly shortened crystal-to-
structure time frames. Recent efforts towards improving sample “crystallizability” using 
techniques such as alanine scanning mutagenesis (147-150) or the use of chimeric proteins to 
promote/improve crystal packing (150, 151) have also led to structures of important targets (148, 
151-155). 
The more common crystallographic practice of crystal microseeding, where crushed 
 67 
crystals are introduced into new drops using a probe, has also been instrumental in promoting 
crystal growth (156-158). This technique, along with similar adaptations like microseed matrix 
screening (MMS) or cross-seeding using one component of a MPC (159, 160), has proven useful 
for the production and optimization of high-quality, diffracting crystals. Furthermore, the 
emergence of synthetic Fab fragments to stabilize MPCs which have avoided crystallization has 
shown great promise at expanding the chemical space for crystallographic trials (161-164).  
4.1.2 TEM as a tool to guide crystallography experiments 
Even if crystallization is successful, diffraction from MPCs is problematic. Crystals are typically 
small, fragile, and difficult to physically manipulate, and present additional challenges that 
include twinning and diffraction that can be both anisotropic and limited to low resolution. In 
addition, a major hurdle is the inability to identify conditions that promote crystallization, 
especially when crystal growth is limited to nano-meter sized dimensions. Emerging techniques 
utilizing second-order nonlinear optical imaging of chiral crystals (SONICC, (165)), UV- 
microscopy (166), and negative-stain TEM (167, 168)) have shown that protein nanocrystals are 
ubiquitously present in granular aggregates of crystallization drops, which would usually be 
overlooked by the experimenter. Using TEM we showed that in many occasions, such 
nanocrystals contained well-ordered lattices (168), which may represent ideal material for novel 
injector-based serial femtosecond crystallography (SFX) experiments at x-ray free electron laser 
(XFEL) sources or micro-electron diffraction (microED) experiments. The advent of these 
techniques has significantly altered the field of structural biology, as atomic- resolution structural 
information can now be obtained from nanocrystals (169-173). However, limited access to these 
instruments and the preparation of crystalline samples still represents a major roadblock for 
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experimenters.  
In the proceeding chapter, we build on our previous work in identifying protein 
nanocrystals and employ negative stain TEM as a tool to study and optimize crystallization in 
three ways. First, we use a fragmentation protocol applied to crystals or nanocrystals (observed 
in UV-positive granular aggregates) to generate crystal fragments. The detection of Bragg spots 
calculated from TEM images of such fragments correlates positively with successful X-ray 
diffraction. Second, we demonstrate the benefits of TEM to study the process of crystallization, 
from sample analysis to estimations of solvent content to crystal optimization (i.e., TEM-guided 
crystal growth). Third, we establish the usefulness of high quality crystal fragments from crystals 
or nanocrystals, to grow reproducibly larger size crystals. 
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5.0  TRANSMISSION ELECTRON MICROSCOPY FOR THE EVALUATION AND 
OPTIMIZATION OF CRYSTAL GROWTH 
5.1 SUMMARY 
Crystallization of protein samples remains the most significant challenge in structure 
determination by X-ray crystallography. Here we demonstrate the effectiveness of transmission 
electron microscopy (TEM) analysis to aid in the crystallization of challenging protein targets 
and MPCs, including several Pol II transcribing complexes. We found the presence of well-order 
lattices with higher order Bragg spots, revealed by Fourier analysis of TEM images, as a good 
predictor of diffraction-quality crystals. Moreover use of TEM allowed 1) comparison of lattice 
quality among crystals from different conditions in crystallization screens; 2) detection of crystal 
pathologies that could contribute to poor X-ray diffraction, including crystal lattice defects, 
anisotropic diffraction and crystal contamination by heavy protein aggregates and nanocrystal 
nuclei; 3) qualitative estimation of crystal solvent content to explore the effect of lattice 
dehydration on diffraction; and 4) selection of high quality crystal fragments for microseeding 
experiments to generate reproducibly larger size crystals. Applications for X-ray free electron 
laser (XFEL) and micro electron diffraction (MicroED) experiments are also discussed. 
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Work presented in this chapter was reproduced with permission from the International Union of Crystallogarphy: 
 
 
Stevenson HP*, Lin G*, Barnes CO*, Sutkeviciute I, Krzysiak T, Weiss SC, Reynolds S, Wu Y, Nagarajan V, 
Makhov AM, Lawrence R, Lamm E, Clark L, Gardella TJ, Hogue BG, Ogata CM, Ahn J, Gronenborn AM, 
Conway JF, Vilardaga JP, Cohen AE, Calero G. (2016) Applications of TEM for the evaluation and 
optimization of crystal growth. Acta Cryst. D72(5), 603-15. doi: 10.1107/S2059798316001546  
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5.2 EXPERIMENTAL METHODS 
5.2.1 Protein purification, crystallography, and UV fluorescence screening  
We utilized crystals derived from various protein samples, which were categorized into four 
different protein classes: 1) Soluble, 2) Membrane, 3) Multi-protein Complex, or 4) Viral. 
References for protein purification and crystallization conditions are summarized in Table 4, 
which was conducted in collaboration with multiple laboratories. 
Table 4. Protein Purification and Crystallographic Conditions 
Proteina Class Crystallization Conditionb Avg. Order 
Bragg Spot 
Maxc 
Resolution (Å) 
Pol II Δ 4/7 
(Cramer et al., 2001) 
Soluble 0.4 M Ammonium/Sodium Phosphate 
pH 6.5, 6-10% PEG 6000, 50 mM 
Dioxane, 10 mM DTT  
3rd  3.2 
Wt Pol II  
(Pullara et al., 2013) 
Complex 0.1 M HEPES pH 7.0, 0.3 M Sodium 
Malonate, 0.2 M Ammonium Acetate, 
3-6% PEG6000, 10 mM DTT 
3rd  
 
3.5  
 
Pol II – TFIIF – DNA  
(Pullara et al., 2013) 
Complex 0.1 M HEPES pH 7.0, 0.1 M Sodium 
Malonate, 8-12% PEG4000, 10 mM 
DTT 
3rd  
1st  
3.8 (Aniso) 
5.0 
Pol II – Spt4/5 – DNA  
(Cohen et al., 2014) 
Complex 0.1 M MES pH 6.0, 0.2 M 
Magnesium Chloride, 10-14% 
PEG2000, 10 mM DTT 
3rd  
2nd  
 
3.9 (Aniso) 
4.5 
Pol II – TFIIB – DNA  
(Cohen et al., 2014) 
Complex 0.1 M HEPES pH 7.0, 30-35% 
Tacismate pH 7.0, 10 mM DTT 
N/A 3.4 
Pol II – GFP   
(Cohen et al., 2014) 
Complex 0.1 M HEPES pH 7.0, 0.8 M Sodium 
Citrate, 10 mM DTT 
3rd 
2nd  
3.6 (Aniso) 
4.3 
Pol II – CD3Δ   
(Cohen et al., 2014) 
Complex 0.1 M MES pH 6.0, 1.4 M Sodium 
Malonate, 10 mM DTT 
3rd 
2nd 
4.4 (Aniso) 
5.7 
UNG2-DCAF-DDB1-
Vpr 
(Ahn et al., 2010) 
Complex 0.1 TRIS pH 7.5, 0.1 M Sodium 
Acetate, 15% PEG 4000 
3rd 
  
3.7 
DCAF-DDB1-Vpr 
(Ahn et al., 2010) 
Complex 2.0 M Sodium Chloride, 12 % 
PEG6000  
3rd  3.6 
PTHR 
(Pullara et al., 2013) 
Membrane  0.1M Sodium Phosphate, 12% 
PEG4000, 5 mM TCEP, pH 6.2 
2nd  N/A 
BRIL-PTHRd Membrane 0.1 M Sodium Citrate, 10% PEG8000, 
0.1 M Calcium Chloride, 10 mM 
DTT, pH 5.8 
1st  N/A 
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2,3 – HPCD  
(Botha et al., 2015) 
Soluble 0.1 M MES pH 5.8, 0.1 M Calcium 
Chloride, 12-14% PEG6000 
4th  1.55 
Globin-Xe Soluble 0.2 M Sodium Malonate pH 7.0, 20% 
PEG3350 
1st  <10 
APOBEC 
Adapted from (Byeon 
et al., 2013) 
Soluble 0.1 M MES pH 6.2, 1.5 M Sodium 
Citrate 
0.1 M HEPES pH 7.0, 0.2 M 
Magnesium Acetate, 10% PEG4000 
1st  
 
2nd 
 
<10 
 
6.3 
Rtf1 
(Dermody & 
Buratowski, 2010) 
Soluble 0.1 M MES pH 6.0, 0.1 M 
Magnesium Chloride, 15% PEG3350 
1st  7.3 
dGTPasef Globular 1.6 M Potassium/Sodium Phosphate 
pH 8.5 
4th  2.8 
Sindbis Virus Viral  1st  <10  
aPurification and complex assembly protocols were performed as previously described for all proteins or complexes 
where a reference is provided. 
bIn all cases, crystallization was achieved using vapour diffusion with drop sizes between 1-2 µL. 
cMaximum resolutions were visually estimated from diffraction patterns collected at synchrotron sources (APS –  
Chicago, IL or SSRL – Stanford University, CA) 
dSf9 cells infected with BRIL-PTHR1 baculovirus and grown for 41 hrs were lysed by sonication in presence of 300 
nM  LA-PTH, a long-acting analog of parathyroid hormone and 2mg/mL iodoacetamide. Isolated membranes 
were extracted with 1% n-Dodecyl β-D-maltoside (DDM) and 0.1% cholesteryl hemisuccinate. Extractant was 
incubated with Ni Sepharose 6 Fast Flow (GE Healthcare) and eluted with 250 mM Imidazole after exchanging 
1% DDM to 0.1 % Decyl Maltose Neopentyl Glycol (DMNG). Pooled elution fractions were batch bound with 
anti-FLAG M1 agarose affinity gel (Sigma), eluted with 10 mM EDTA and 0.1 mg/mL Flag peptide (Sigma) 
before being subjected to gel-filtration chromatography (Superose 6, GE Healthcare). 
dPurified Globin-X from Zebrafish was a generous gift from the lab of Dr. Mark Gladwin. 
eTransformed BL21(DE3) cells were grown at 37 °C to an optical density of 0.6 at 600 nm, induced with 0.4 mM 
IPTG for 16 h at 18 °C. Purification was first performed by Ni-NTA chromatography (GE Healthcare) followed 
by a gel-filtration chromatography (Hi-Load Superdex20016/60, GE Healthcare) equilibrated in 25 mM sodium 
phosphate, pH 7.5, 150 mM NaCl, 1 mM DTT, 10% glycerol, and 0.02% sodium azide. 
 
Subsequent visual inspection of crystallization drops was achieved using an Olympus SZX16 
bright-field microscope. Granular aggregates, as previously defined in (174, 175), and visible 
crystals that may be used for nanoseeding experiments were assayed for UV tryptophan 
fluorescence with a Jansi UVEX microscope. UV-positive samples were visualized using the Jan 
Scientific CrystalDetect software.  
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5.2.2 Microcrystal fragmentation  
Crystals were washed with a total volume of 10 µL mother liquor to remove excess protein from 
the crystallization drop (this is highly recommended to prevent bubble formation during 
vortexing). Initial fragmentation of microcrystals using a 3 mm Teflon ball (Hampton Research) 
and vortexing, revealed minimal and highly irregular crystal fragments (see main text section 3.1 
and Figure 23C). To achieve better fragmentation, we utilized smaller diameter (0.1, 0.5 and 1.0 
mm) glass beads (Research Products International) or stainless steel beads (Jinan Huawei 
Industry Manufacturing and Trading Co. Limited) that are routinely used for bacterial or yeast 
cell lysis. Approximately 25-30 mg of beads were placed inside a 1.5 mL microfuge tube and 
washed twice with water followed by stabilizing solution. Crystalline material from several 
crystallization drops (with over 30-50 crystals/drop ranging from 20-100 µm) was added to 
beads on ice, and diluted with 30 µL stabilizing solution (sufficient to cover the glass beads). 
Beads and sample were vortexed twice for 10 s, followed by centrifugation at 1,000g for 30 s. 
After centrifugation, the solution was pipetted gently to resuspend crystal fragments and 
aspirated to a clean 0.5 µL microfuge tube for subsequent experiments. Two microliters of the 
crystalline solution were evaluated using brightfield and UV microscopy to determine the 
efficiency of fragmentation (see main text, section 5.2). Ensuing TEM analysis of crystal 
fragments or crystal optimization via previously well-established seeding methods (156, 159) 
were performed immediately following the fragmentation protocol. Briefly, 0.3 – 0.4 millimeter 
loops (Hampton) were used to deposit ~50 nL of nanoseed solution into 1 µL crystallization 
drops. 
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5.2.3 Nanocrystal Fragmentation 
Conditions containing UV-positive granular aggregates, as previously described above and 
elsewhere (175), were selected for TEM imaging to confirm the presence of nanocrystals. To 
ensure sufficient material for fragmentation and TEM analysis, crystallization conditions 
yielding nanocrystals were repeated to generate larger volumes of nanocrystals for fragmentation 
experiments. Material from 4-12 1 µL crystallization drops (depending on the granular aggregate 
density) containing nanocrystals were pooled and fragmented as described above with the 
following caveats: 1) Approximately 8-10 0.5 mm glass beads, or stainless steel beads were used 
with a total volume limited to 15 µL of stabilizing solution; and 2) samples were vortexed for 5 s 
once, to avoid sample destruction. Fragmented nanocrystals (heretofore known as nanoseeds, 
since TEM analysis revealed crystal lattices with nanometer dimensions) were evaluated with 
bright-field and UV fluorescence microscopy, which was of paramount importance to 
qualitatively estimate nanoseed concentration for future TEM or seeding experiments. 
5.2.4 Fragmented crystal quantification using UV microscopy 
Crystal fragments were diluted with stabilizing solution in different ratios, including 1:1, 1:2, 
1:5, 1:25 and 1:125 in order to determine seed concentration. A 5µL aliquot from each dilution 
was placed on a haemocytometer (Hausser Scientific) and covered with a 22 mm glass coverslip 
(Hampton Research). Bright-field and UV-microscopy images were acquired for 0.1 and 4 s, 
respectively, with a Jansi UVEX microscope. Crystal images collected under nominal 15x 
magnification were recorded using the Jan Scientific CrystalDetect software. Manual 
quantification of crystal fragments was performed using the Cell Counter ImageJ software plugin 
 75 
and the protocol for counting crystal fragments followed standard cell counting procedures (176). 
5.2.5 Transmission electron microscopy experiments (TEM) 
All crystals generated from proteins listed in Table 4 were subjected to analysis by negative-stain 
TEM. Approximately 5 μL of nanoseeds were applied to 400 square mesh copper grids covered 
with a thin continuous carbon film (Electron Microscopy Sciences) and made hydrophilic by 
glow discharge (EmiTech) for 1 min at 25 mV under atmospheric conditions. Samples were 
incubated on the grid for 30 sec before blotting and staining with a 2% uranyl acetate solution. 
Grids were mounted on a standard room-temperature specimen holder and inserted into an FEI 
Tecnai T12 microscope (FEI, Hillsboro OR) operating at 120 keV. Images were collected on a 
Gatan Ulstrascan 1000 CCD camera (Gatan, Pleasanton CA), and FFTs were generated using 
Digital Micrograph version 3.9.4 software (Gatan Software Team, Pleasanton, CA). Preparation 
of sample grids, data collection, and evaluation of crystal images can be achieved in ~2 hours. 
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5.3 RESULTS 
5.3.1 Crystal fragmentation analysis using UV-microscopy and TEM 
Generally, crystal sizes resulting from crystallization screens are too large (Figure 23A) for 
direct observation of lattices by TEM, which is limited to < 3 µm along the dimension 
perpendicular to the electron beam (172). 
 
Figure 23. Crystal fragmentation analysis using UV-microscopy and TEM 
(a) Intact crystals used for fragmentation experiments. (b) Crystals fragmented using 0.5 mm beads (see main text 
section 2.2) which resulted in homogeneously sized fragments measuring less than 5 μm in size. (c) Crystal 
fragments resulting from use of a single 3 mm Teflon bead according to the manufacture’s protocol (Hampton). 
Fragments were 2-5 times larger than in (b). (Scale bars: 100 μM).  
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Thus, a fragmentation protocol was established to generate crystal sizes capable of TEM analysis 
(see section 5.1.2 and Figure 23). Initially, we tested the effects of various glass or stainless steel 
bead diameters on crystal sizes after fragmentation. Use of 0.5 mm and 1.0 mm beads resulted in 
homogenous populations of crystal fragments of low-micrometer sizes (Figure 23B). In contrast, 
the standard 3.0 mm bead yielded inhomogeneous fragmentation with large crystal sizes still 
present in the solution (Figure 23C), while no UV-detectable crystals were observed with 0.1 
mm beads. While no differences in crystal fragmentation were observed for glass or stainless 
steel beads, employing stainless steel beads may allow a more efficient recovery of nanoseed 
slurry, as beads can be readily removed via a magnet. 
 
Figure 24. Crystal fragments of Pol-GFP 
Comparison of Pol II-GFP crystal plates crushed with either (a) 0.5 or (b,c) 1.0 mm beads illustrating the effect of 
bead size on nanoseed size. Using the same starting material and vortexing time (5 s), crystals in (a) were almost 
completely destroyed with the use of 0.5 mm beads. Crystal morphologies such as plates or needles are highly 
susceptible to bead disruption and milder protocols should be attempted.  (Scale bars: (a) 20 nm; (b) 20 nm; (c) 50 
nm). 
 
After the presence of crystals was initially confirmed with optical or UV microscopy, to 
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ensure a sufficient concentration for adequate visualization, we utilized negative-stain TEM to 
analyse our fragmentation protocol with 0.5 and 1 mm beads. Crystal fragments typically ranged 
from 50 nanometers to a few micrometers in length, and were composed of single to multiple 
layers (Figure 24). Interestingly, the use of a mild disruption protocol with 0.5 mm beads 
resulted in the almost complete obliteration of thin crystal plates of Pol-GFP (Figure 24A). 
Adjusting the protocol to use slightly larger beads was necessary to obtain useful crystal 
fragments for TEM analysis and crystallization experiments (Figure 24B,C).  This suggest that 
bead size, quantity, and vortexing time are all contributing factors that affect crystal fragment 
size, as fewer beads with larger diameters and shorter vortexing times yielded larger crystal 
fragments, and vice versa. However, optimization of these parameters may be necessary 
depending on crystal type, morphology, and size.  
5.3.2 Evaluation of crystal quality using TEM 
Since crystalline lattices were clearly visualized with TEM, calculating Fourier transforms from 
the images allowed qualitative evaluation of crystal lattices (Bragg spots) (Figure 25 and Table 
4). In addition, it was possible to establish a correlation between the order of Bragg spots 
detected and the quality of subsequent X-ray diffraction data. In general, lattices with three or 
higher order Bragg spots showed diffraction at the synchrotron, whereas crystal fragments with 
fewer orders of Bragg spots show poor or no diffraction (Figure 26).  
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Figure 25. TEM images of fragmented crystals 
(a) and (d) Pol II. Fracture planes (arrows) and individual Pol II particles can be observed. (b) and (e) DDB1-
DCAF-UNG2-Vpr crystal fragments. (c) and (f) Sindbis virus crystals showing partially ordered (c) and disordered 
lattices along two different directions. (g) Crystallization of the DDB1-DCAF1 complex showed multi nucleation 
that was resistant to conventional optimization protocols. (h,i) TEM images showing protein aggregation and 
nanocrystal nuclei growing next to crystal fragments with well-ordered lattices. Use of detergents to decrease 
protein aggregation resulted in single crystals with improved diffraction to 3.5 Å (see Fig. S3c,d). (Scale bars: (a) 
50 nm; (b) 200 nm; (c) 50 nm; (d) 50 nm; (e) 200 nm; (f) 50 nm; (g) 50 µm; (h) 50 nm; and (i) 20 nm). 
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Figure 26. Correlating Fourier analysis of TEM images with single crystal x-ray diffraction 
Fourier transforms of lattices (left panels) positively correlate with diffraction images observed at synchrotron 
sources (right panels), with higher order Bragg spots being a good indicator of higher resolution diffraction. (a,b) 
Rtf1 (c,d) E. coli dGTPase, post- dehydration protocols (see Table 4), (e,f) wild-type RNA Polymerase II.  
 
For example, TEM analysis of the multi protein complex comprising human damage-
specific DNA binding Protein 1 (DDB1), DDB1-cullin 4 associated factor 1 (DCAF1) uracil-
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DNA-glycosylase (UNG2) and HIV VPR (DDB1-DCAF-UNG2-Vpr) crystals revealed high 
quality lattices (Figure 25B,E), whereas initial screening of such crystals showed poor to very 
weak diffraction at the synchrotron (Figure 27A). The presence of well-ordered lattices led us to 
believe that these crystals could potentially diffract to a higher resolution, which was indeed the 
case after optimizing cryo-protectant conditions (Figure 27B).  
 
Figure 27. Optimizing x-ray diffraction 
(a) For UNG2-Vpr-DCAF1-DDB1 crystals, characteristic diffraction images of crystals in similar cryo-conditions 
as previously published structures revealed poor diffraction to ~9 Å. After TEM revealed lattices (see Figure 25) 
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showed high-ordered Bragg spots, (b) changes in cryo-protectant resulted in improved diffraction to ~3.7 Å. (c) 
Similarly, DCAF1-DDB1 crystal clusters (inset) diffracted to ~6 Å, but upon the addition of additives (d) single 
crystal (inset) diffraction improved to beyond 3.6 Å. As seen in Figure 25, the presence of well-ordered lattices for 
these crystals also suggested improvements in crystallization could result in improved diffraction.  
 
In contrast, poor x-ray diffraction of partially ordered lattices with low quality Fourier 
transforms were observed for both Sindbis virus (Figure 25C,F) and the parathyroid hormone 
receptor (Figure 28), a cell surface G protein-coupled receptor (GPCR) that has proven 
challenging to crystallize. Taken together with all other protein samples tested (Table 4), these 
results suggest that crystallization conditions that yield higher order Bragg spots should be 
pursued to obtain high-resolution structural information.  
 
Figure 28. TEM analysis of parathyroid hormone receptor (PTHR) crystals 
(a) Wild- type PTHR1 and (b) Bril-PTHR1 show poor quality lattices. Large crystals of this target have not been 
reported, but fragmentation of granular aggregates from crystallography experiments showed nanoseed lattices that 
could be detected by TEM. These crystals may be starting material for matrix-microseeding. (Scale bars: 50 nm).  
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In addition to lattice evaluation, TEM provided clues on sample quality and the 
crystallization process itself. In some instances, crystal lattices were surrounded by multiple 
nanocrystal-nuclei (of few nanometer sizes) and protein aggregates (Figure 25G-I and Figure 
29A-C). In cases where high quality lattices were observed, we tested whether the addition of 
additives to decrease protein aggregates may improve crystal diffraction. Our results for crystals 
of the DCAF-DDB1-Vpr complex indicate that such improvements are achievable (Figure 
27C,D). Moreover, TEM revealed several cases of protein aggregation, filaments and 
nanocrystal-nuclei from UV-positive granular aggregates across different crystallization 
conditions and samples (Figure 29D-F). The capability of TEM to differentiate crystalline 
material from these other particles is ideal for eliminating false positives that potentially stifle 
crystal optimization. 
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Figure 29. Examples of TEM observed protein aggregates common amongst nanocrystals 
(a-c) The presence of protein aggregates and nanocrystal nuclei among Globin-X crystals compromise small areas 
of partially ordered lattices (FFT of boxed area, panel (c)). Aggregates found in drops with  (d) Pol II-GFP, (e) 
Wild-type PTHR1 and (f) Bril-PTHR crystals. (Scale bars: (a) 100 nm; (b) 50 nm; (c) 20 nm; (d-f) 50 nm).  
 
Next, we tested whether anisotropic diffraction could be detected using TEM for crystals 
where X-ray diffraction data showed prominent anisotropy. Anisotropic X-ray diffraction occurs 
when the resolution of the diffraction spots varies along crystal axes, and severe anisotropic 
diffraction can have significant impact on a dataset by limiting its overall resolution. Our results 
from three different Pol II protein complexes showed anisotropic Bragg spots by TEM, as well as 
anisotropic X-ray diffraction (Figure 30).  
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Figure 30. FFT calculation of crystal lattices to predict anisotropy 
Anisotropic Bragg spots (left panel-inset) with corresponding anisotropic X-ray diffraction (right panel). (a) Pol II-
GFP, (b) TFIIF, and (c) Pol II SPT4/5 complex (Scale bars: (a) 100 nm; (b) 200 nm; (c) 50 nm. Diffraction rings 
(resolution in Å): (d) 20, 9, 6, 4.25; (e) 19, 8, 5.5, 4; (f) 19, 9, 5.5, 3.8. 
 
Moreover, for one such complex, where different orientations of the crystal lattice were 
observed by TEM, we could visually align the crystal packing revealed by TEM with the crystal 
packing after solving the structure using molecular replacement (Figure 31A,B & D,E). TEM 
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images showed imperfections of the lattice along the direction of anisotropic diffraction due to 
the presence of scarce crystal contacts (Figure 31 C,F – arrows).  
 
Figure 31. Crystal fragments of Pol II-GFP complex show isotropic and anisotropic Bragg spots along two 
different orientations 
(a-c) isotropic profile, (d-f) anisotropic profile. Lattice defects can be observed in (d) (arrows). (b) and (e) crystal 
packing in the C2221 space group (cell parameters A=221 Å, B=394 Å, C=211 Å) illustrating solvent channel 
dimensions (indicated in angstroms). The preliminary model was generated from low resolution data using 
molecular replacement (177), and rigid-body refinement in Buster (105). Defects in crystal packing (d, arrows) and 
the large solvent channels (e) could explain poor X-ray diffraction along the anisotropic direction in (f). (Scale 
bars: (a) 100 nm; (d) 50 nm. Diffraction rings: (c) and (f) 15, 7.6, 5.1 and 3.7 Å). 
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Another example of successfully using TEM to detect crystal lattice defects allowed us to 
explain uneven diffraction during crystal rastering at the synchrotron for Pol II – Spt4/5 crystals 
(Figure 32A). For such crystals, a protocol for X-ray rastering was determined after discovering 
areas of inconsistent diffraction along the crystals as described previously (178).  TEM images of 
crystal fragments revealed the presence of well-ordered regions interspaced with patches of 
blurred lattices elements (Figure 32B). These lattice features were not typically observed for 
other samples.  
 
Figure 32. Crystal fragments of a transcribing Pol II – Spt4/5 complex 
(a) X-ray rastering using a highly attenuated beam showing diffracting (red) and non-diffracting (blue) areas within 
the crystal. (b) TEM images showing well-ordered areas interspersed with poorly-ordered areas as evidenced by 
calculation of Bragg spots. (Scale bars: (a) 20 μm;(b) 50 nm). 
 
Furthermore, lattice inspection using TEM is useful for qualitative estimate of solvent 
content, in particular for crystals of large molecular weight proteins (Figure 33). Such samples, 
where relatively large solvent channels are observed, may benefit from the use of dehydration 
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protocols to manipulate crystal solvent content and potentially improve diffraction (173). Indeed, 
the use of post-crystallization dehydration protocols was paramount in the structure 
determination of RNA Polymerase II crystals (25).  
 
Figure 33. Qualitative evaluation of crystal fragment’s solvent content 
(a) Wild type Pol II, (b) Pol II-Spt4/5, (c) dGTPase and (d) H200Q variant of homoprotecatechuate 2,3-
dioxygenase. Calculated solvent contents after Matthew’s coefficient calculation are 78%, 65%, 58% and 50% 
respectively.  (Scale Bars: 50 nm). 
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Thus, we tested whether improvements in lattice quality could be visualized after the 
dehydration of RNA polymerase II (∆4/7 Pol II) and E. coli dGTPase crystals. Such dehydration 
protocols resulted in higher resolution diffraction at the synchrotron for the dGTPase sample 
(Figure 34). TEM analysis of pre- and post-dehydrated crystals revealed improved lattice quality, 
as indicative by higher-ordered, isotropic Bragg spots for both samples (Fig. 34).  
 
Figure 34. dGTPase dehydratin diffraction comparison 
Characteristic diffraction images of dGTPase crystals pre- (a) and post- (b) dehydration protocols. Arrows 
represent maximum observed reflections of ~ 4.3 and 2.9 Å, respectively.  
 
 
 
 90 
 
Figure 35. Evidence of lattice quality (order of Bragg spots) improvement upon implementation of crystal 
dehydration protocols 
(a) ∆4/7 Pol II nanocrystals before dehydration experiments showing anisotropy, (b) crystals undergoing 
dehydration (protocol adapted from (25)) show isotropic Bragg spots. (c) and (d) dGTPase crystal fragments pre- 
and post- dehydration (respectively), showing overall improvement of Bragg spots after dehydration. A decrease 
from 63% to 58% in solvent content was calculated for the different dGTPase crystal forms. Corresponding X-ray 
diffraction of crystals (before and after dehydration) are illustrated in Figure 34. (Scale Bars: 50 nm). 
 91 
Lastly, since nanocrystals can be commonly found in crystallization drops (174), we used 
TEM to determine whether if it were possible to find nanocrystals with higher ordered lattices 
among different conditions in a crystallization screen. To this end, APOBEC nanocrystals were 
first identified using UV-microscopy as described previously and applied to EM grids for 
visualization. TEM analysis revealed differences in crystal quality from several crystallization 
conditions where crystalline lattices were observed (Figure 36). Similar to the identification of 
protein aggregates or filaments from UV-positive crystal drops (Figure 29), these data suggest 
that utility of TEM for providing the highest quality starting material for subsequent crystal 
optimization experiments. 
  
 
Figure 36. Crystal fragments of Apobec obtained from two different crystallization conditions 
(a) 1.5 M Sodium Citrate (b) 200 mM Magnesium Acetate + 10% PEG4000 (Scale bars: 50 nm). Crystals in (a) 
show a poorly ordered lattice with no Bragg spots while the crystal lattice in (b) shows 2nd-3rd order Bragg spots, 
which may be indicative of a condition which will produce high resolution crystals. 
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3.3 Quantification and nanoseeding experiments of crystal fragments 
The presence of well-ordered crystal lattices for various Pol II complexes (as observed by TEM) 
led us to utilize these crystal fragments for microseeding experiments. Traditional microseeding 
relies on serial dilutions of seeds used in optimization experiments to control the quality, 
concentration and size of crystals that develop in the drop (156). However, these dilution series 
traditionally vary in seed concentration with every preparation, and so limiting their 
reproducibility. Given that the size of crystal fragments were fairly homogeneous, we developed 
a protocol to quantify the size and number of crystal fragments using UV microscopy and a 
haemocytometer (see methods section 5.1.4 and Figure 37). Using the nominal 15X 
magnification, we were able to quantify crystals whose smallest dimension was >2 µm (Figure 
37A-C). Not surprisingly, dilution series of detectable crystal fragments by UV-microscopy 
resulted in characteristic changes in crystal size and number (Figure 39A). Moreover, 
implementation of a quantification protocol allowed reproducible, high-quality crystal growth for 
the several Pol II complexes tested, as illustrated by the overall improvement in crystal size, 
resolution and mosiacity of the Pol II – TFIIB – DNA complex (Figure 38A).  
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Figure 37. UV tryptophan fluorescence image of seed concentration determination using a haemocytometer 
Seeds were counted by pipetting them into the counting chamber of the haemocytometer, covering with a thin UV 
transparent coverslip, taking a UV fluoresce microscopy image and counting visualized seeds using ImageJ 
software (see main text section 2.4). (a) Undiluted seeds, (b) 1:4 dilution of seeds. Total seed counts calculated for 
the 1x stock taken from (a) and (b) were on average of 330 seeds per μL. (c) Lower magnification (5x) image of 
haemocytometer with seeds showing the ImageJ counting overlay. In addition, crystals were fragmented with either 
0.1 mm (d-f) or 0.5 mm (g-i) beads and quantified with a haemocytometer. Nominal 15x zoomed images revealed 
significantly higher detectable concentrations of seeds from 0.5 mm bead fragmentation (h) versus 0.1 mm beads 
(e). Seeding experiments show that over a one week duration, seeds generated from 0.1 mm beads (f) show no 
crystals while 0.5 mm bead fragments (i) grew crystals (Scale bars: (a,b) 200 μm; (c,d) D 75 μm; (e,f) 100 μm).  
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Although crystals with nanometer-sized dimensions were present in our fragmented 
samples (as visualized by TEM), it was not possible to count these crystals due to the resolution 
limits of the UV-microscope. Thus, we tested whether nanometer sized nuclei contributed to the 
observed crystal growth during seeding experiments. The use of 0.1 mm beads for crystal 
fragmentation of the Pol II – TFIIB – DNA complex resulted in no detectable crystal fragments 
by UV-microscopy, and seeding experiments using this sample did not yield detectable crystals 
when compared to drops seeded with the 0.5 mm bead solution over a one week period (Figure 
37D-I).  
 
Figure 38. Brightfield images of microseeding experiments with corresponding post- seeded diffraction 
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(a) Microcrystals (left panel) of a complex composed of Pol II, TFIIB and a nucleic acid scaffold were fragmented 
and used for microseeding experiments to obtain larger, well-ordered crystals (middle panel) which showed high-
resolution diffraction (right panel).  (b) Nanocrystals from granular aggregates (left panel) of a complex between 
Pol II-CD3∆ were used to generate nanoseeds used in nanoseeding experiments to generate microcrystals (middle 
panel) which diffracted to high resolution at the synchrotron (right panel). (Scale bars: (a) 100 µm; (b) 50 µm. 
Diffraction rings: 15, 7.6, 5.1 and 3.7 Å). 
 
 We next tested whether nanocrystals with high quality crystal lattices visualized by TEM 
could be used for nanoseeding experiments. Given the small size of nanocrystals from granular 
aggregates, it was not possible to count these samples using UV-microscopy; therefore, no serial 
dilutions were made since the concentration of nanoseeds (fragmented nanocrystals) was 
typically low. For the Pol II – CD3∆ complex, ~50 nL of nanoseed solution was deposited into 
fresh 1 µL crystallization drops as previously described. After three successive rounds of 
nanoseeding from fragmented nanocrystals, microcrystals identifiable by UV-microscopy were 
produced, which were then used to generate diffracting crystals (Figure 38B). Overall, these data 
suggest that 1) TEM identifiable nanocrystals from granular aggregates might lead to an 
increasing number of conditions that promote crystal growth, 2) UV-detectable crystal fragments 
provide a better medium to generate larger crystals, and 3) quantification of such fragments leads 
to highly reproducible results.  
3.4 Generation of crystal catalogues for XFEL experiments 
To test whether we could generate homogenously sized crystal catalogues for use at CXI or XPP, 
we utilized quantified seed solutions with varying precipitant-to-sample dilutions for the Pol II – 
TFIIB – DNA sample. Our results indicate that by varying the precipitant-to-protein 
concentration ratio and the number of UV-quantified seeds, we could control the size and 
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quantity of crystals (Figure 39A). Moreover, crystal drops with different ratios of protein-to-
precipitant volume, seeded with equal amounts, generated collections of homogeneous crystal 
sizes (Figure 39B), while such patterns were absent for non-seeded drops. This suggests that 
generating crystal catalogues consisting of finely tuned crystal sizes may be attainable and 
reproducible, however additional trials will be needed to establish a protocol. 
 
Figure 39. Creating crystal catalogues 
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Fragmented crystals were prepared using 0.5 mm beads as described in main text section 2.2 (a) Comparison of the 
effect of varying the precipitant to sample ratio with the effect of quantified seed concentration. (b) Refinement of 
crystal sizes was performed by varying the precipitant to protein ratio. In all cases the same amount crystalline 
slurry was added to the crystallization drop.   
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5.4 DISCUSSION  
The process of crystallization remains the most significant challenge in the structure 
determination of macromolecules by x-ray crystallography. In a collaborative and 
comprehensive approach, we demonstrated the utility of TEM for the visualization, evaluation, 
and optimization of the crystallization process. Negative stain TEM analysis of nanocrystals or 
crystal fragments provides a visual method to evaluate qualitatively the characteristics of the 
crystal lattice and can be performed in most research institutions. In this work we provide 
protocols to perform these experiments in a quick and efficient way.  
First, TEM images revealed details of the crystal lattice that appeared to be good 
indicators of the potential diffraction of the crystal at the synchrotron. Given the large number of 
crystals (from a wide range of “biologically relevant” protein samples) employed in our study, it 
is feasible to conclude that negative-stain TEM images of fragmented crystals bearing well-
ordered lattices (by visual inspection) and at least third order Bragg spots have a significant 
possibility to diffract at the synchrotron (Table 4 and Figure 26). We provide up to 12 examples 
where observation of third order Bragg spots on nanocrystals or crystal fragments yielded at least 
4 – 5 Å resolution diffraction. We did not observe useful X-ray diffraction for crystals that had 
disordered lattices of less than 1-2 order Bragg spots. Moreover, this correspondence was also 
observed for crystals diffracting anisotropically (Figure 30). Thus, the qualitative information 
gained by analysis of nanocrystals or crystal fragments should allow the experimenter to decide 
whether a crystallization condition should be explored further and optimized or discarded, saving 
valuable time during crystallization efforts. 
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A physical reason for such behavior might be that highly ordered lattices could withstand 
better the effects of negative staining (i.e. dehydration, the damaging effect of the stain itself and 
imaging at room temperature). Such behavior may explain the anisotropic diffraction observed 
for Pol II – GFP crystals in Figure 31. It is possible that the larger number of crystal contacts 
along the isotropic direction could withstand the effects of crystal dehydration while the 
direction with fewer contacts collapses. Conversely, we believe that the fragmentation protocol 
itself has probably little effect on the quality of the lattice itself for two reasons: 1) protocols for 
fragmentation of crystals for nanocrystallography at free electron lasers have been employed and 
such crystals diffract at comparable resolution to their larger counterparts (175, 179), and 2) 
lattice comparison of grown nanocrystals with fragmented microcrystals show no difference (in 
terms of quality) when visualized with negative-stain TEM (180). 
Secondly, we demonstrated the utility of TEM to identify crystal pathologies that 
contribute to poor growth and x-ray diffraction data. Similar to experiments utilizing atomic 
force microscopy (181, 182), crystal pathologies revealed by TEM included: 1) crystal 
“contamination” by heavy protein aggregates and micro-crystal nuclei (Figures 25H-I & 29A-C); 
2) anisotropic diffraction (Figure 30); and 3) crystal lattice defects (Figures 31D & 32B). 
Detection of lattice defects in some crystals could point to the presence of samples containing 
protein contaminants, aggregates or partially proteolyzed protein as well as discrepancies in the 
stoichiometry of the sample. Similarly, identifying crystals that possess anisotropic diffraction 
may indicate that steps to improve crystal contacts, such as altering or adding reagents to the 
crystallization conditions (183) or modification of the protein itself, may be advisable. The 
presence of heavy protein aggregation or nanocrystal nuclei indicates that increased protein 
solubility or decreased crystal nucleation may be useful to improve diffraction.  
 100 
Third, TEM enabled a qualitative estimation of crystal solvent content and permitted us 
to explore the effect of lattice dehydration on crystal diffraction. This application was 
particularly noteworthy since 1) crystal dehydration protocols have proven very useful in the 
improvement of X-ray diffraction (173, 184), and 2) negative-staining with uranyl acetate 
provides very high contrast between solvent channels and biological macromolecules. 
Furthermore, decreasing the solvent content for Pol II Δ4/7 and dGTPase crystals (13% and 5% 
decreases as calculated by Matthew’s coefficient, respectively) showed improvement in the order 
of Bragg reflections (Figure 33), which correlated with improved x-ray diffraction (Figure 34). 
Although our assessment of solvent content was qualitative, TEM images provide a means to 
accurately estimate crystal solvent content through evaluation of the crystal symmetry observed 
in FFTs and measured protein particle size, as described elsewhere (185). Such information could 
potentially guide post-crystallization protocols to help improve x-ray diffraction.   
Furthermore, our work demonstrates a comprehensive approach to seeding through: 1) 
TEM identification and evaluation of crystal lattices, and 2) the use of UV-microscopy to 
quantify seed concentration using conventional cell counting protocols. While the use of granular 
aggregates have provided suitable starting material for microseeding experiments (159), success 
of applications like MMS will benefit greatly from methods which are capable of detecting 
crystalline material. Semi-automated applications such as SONNIC and UV fluorescence 
techniques are capable of visualizing nano-meter sized crystals, but they lack the ability to 
provide information on the quality of the starting seeding material. For instance, crystallization 
experiments of Pol II-TFIIF, PTHR1 and Sindbus virus yielded nano- and microcrystals for all 
samples; however TEM analysis allowed identification of lattice defects (Figures 25C,F, 27B 
and 28), which suggested that these crystals were unlikely to succeed as seeding nuclei.  
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In contrast, nanocrystals identified by TEM from a crystallization screen for the Pol II-
CD3∆ complex which showed 2nd order Bragg reflections (168), produced diffraction quality 
crystals after multiple rounds of iterative microseeding (Figure 38). Such cases as these suggest 
that exploring multiple conditions within a screen may lead to higher quality starting material for 
microseeding experiments to optimize crystal growth. Ideally, an analytical procedure involving 
identification by SONICC or UV fluorescence of protein nano-crystals, followed by scoring 
through TEM analysis would greatly aid the crystallographer. Indeed, such a procedure was 
utilized after UV fluorescence identification of APOBEC crystals from a matrix crystallization 
screen. TEM analysis of crystals generated from different crystallization conditions, 
demonstrated the utility of TEM in distinguishing ordered crystal lattices from crystals with 
lattice defects (Figure 36). In our experiments, a direct correlation between seed quality and the 
appearance of high quality crystals in seeded drops was easily established and corroborated by 
X-ray diffraction data (Figure 38).  
Finally, critical to our TEM analysis was the development of a crystal fragmentation 
protocol that produced homogenously sized crystal fragments. While fragmentation protocols 
have been used to generate homogenously sized crystals that diffract to high-resolutions at XFEL 
sources (179), homogeneous sample preparation for both XFEL and microED techniques is an 
active research area (180, 186-188). Quantification of crystal fragments by UV microscopy, 
allowed for highly reproducible seeding experiments (Figure 38A) and generation of 
homogenously sized crystal catalogues through manipulation of crystallization conditions 
(Figure 39). Application of this protocol to batch crystallization methods, like those commonly 
used for sample preparation in SFX or microED experiments, would likely generate the high 
quantity of uniform crystals required for these experiments. Moreover, such experiments can be 
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complimented by TEM analysis to ensure sample homogeneity, monodispersity, and quality 
prior to conducting experiments, thus increasing the chances of success.  
Overall, we established a reproducible protocol using TEM to qualitatively visualize 
fragmented crystals, with nano- to micro-meter dimensions, to study details of the crystallization 
process. TEM analysis allows for the direct comparison of the quality of crystal lattices among 
different crystallization conditions, thus guiding the experimenter’s selection of crystallization 
conditions that promote well-ordered crystal growth and high-resolution diffraction. In order to 
probe the real limits of diffraction of such nanocrystals or crystal fragments, TEM experiments 
using cryo methods and the use of special detectors to probe electron diffraction would be 
needed. Overall, we believe that the screening methods described here provide a rationalized 
approach to meet the challenges associated with obtaining suitable crystals for macromolecular 
crystallography experiments at both synchrotron and XFEL sources. 
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6.0  SERIAL FEMTOSECOND CRYSTALLOGRAPHY USING A X-RAY FREE 
ELECTRON LASER  
In recent years, efforts to design X-ray light sources with unique radiation properties and pulse 
capabilities has revolutionized biological and physical sciences. The advent of the X-ray free 
electron laser (XFEL) provides extremely bright pulses on femtosecond timescales, allowing for 
the probing of biological samples without the conventional radiation damage accrued at 
synchrotrons. In the remainder of this work, the investigation of methods to improve SFX 
experiments will be explored. In addition, preliminary results of experimental SFX data collected 
at LCLS for Pol II transcribing complexes is presented (see chapter 8). 
6.1.1 The advent of XFEL light sources 
X-ray crystallography using synchrotron radiation has been a primary tool for structural studies 
of large macromolecules. The recent advent of the X-ray Free Electron Laser (XFEL) has 
advanced the field of x-ray crystallography beyond what is possible from synchrotrons. The 
Linac Coherent Light Source (LCLS) at Stanford University was the first XFEL to operate in the 
hard X-ray regime, and came online in 2009 (189). XFELs are capable of producing highly 
brilliant pulses of femtosecond duration and full spatial coherence (189). Early thought 
experiments that simulated the interaction between ultra-short x-ray pulses and biological 
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molecules suggested that a pulse duration of 10 fs should be short enough to obtain a diffraction 
pattern while the sample remains intact (190). In practice, the high intensity of the X-ray pulse 
completely destroys the sample upon impact, but the short pulse duration allows for the 
collection of data before the rearrangement of atoms in the sample can negatively affect the 
diffraction pattern. This process is referred to as ‘diffract-before-destroy’, where an interpretable 
diffraction pattern of nanocrystals, without structural or global radiation damage can be obtained 
(169, 191). 
 
 
Figure 40. Comparison of peak brilliance and SFX experimental setup 
(a) Peak brightness versus photon energy for conventional lasers and higher harmonic generation sources (Lasers, 
blue envelope), synchrotrons (grey envelope), and XFEL pulses (red envelope). The green line represents the 
current spectral range for LCLS beamlines (adapted from Ullrich J, 2012). (b) Schematic of an SFX experimental 
setup, for the delivery of a continuous stream of nanocrystals across the XFEL source (adapted (191)). 
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These experiments are often carried out in a serial mode using liquid injectors or other 
devices to deliver uncompromised crystal volumes to the XFEL pulse (Figure 40).  Unlike more 
conventional goniometer-based crystallography experiments carried out at synchrotrons, SFX 
experiments are contingent upon several thousand indexable diffraction patterns collected from 
hundreds to thousands of crystals in random orientations to complete a dataset (169, 191, 192). 
As a result of the overall setup of the experiment (weak intensities, random orientations and still 
images) estimation of structure factors is significantly different than rotational X-ray data 
processing from synchrotrons. Current methods to process SFX data are continuously under 
development by several groups. One major difference when compared to conventional X-ray 
experiments is integration with the Monte Carlo method (192, 193), where a large quantity of 
individually integrated hkl intensities of symmetrically unique reflections from different crystals 
is averaged to correctly estimate structure factor amplitudes. While original data processing 
methods required hundreds of thousands of diffraction images, improvements in the analysis of 
sparse datasets (194-198), have greatly enhanced the ability to solve structures from XFEL 
sources.  
6.1.2 Delivery of crystalline material 
Delivery of nanocrystal slurries into the XFEL path is a dynamic research area with several 
groups involved in their development (199-204). Comparison of the different delivery techniques 
has been extensively described with great detail elsewhere (205, 206). This approach has been 
highly successful for atomic resolution structure determination yielding several high profile 
structures (169, 179, 191, 194, 204, 207). The most commonly used of these injectors is the gas 
dynamic virtual nozzle (GDVN) (208), that has a volumetric flow rate typically between 1-10 
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µL/min. Briefly, these injectors provide a continuous small diameter stream of nanocrystal (NC) 
containing slurry, minimizing background scatter and providing fresh material to each X-ray 
pulse (delivered at a frequency of 120 Hz at the LCLS). A major drawback of these techniques is 
that a large percentage of injected material is often wasted passing by between pulses. However, 
injectors are particularly well suited for time resolved experiments and while most time resolved 
experiments at XFELs have used lasers to trigger reactions within crystals (173, 209-211), a 
number of mixing injectors are also being developed (199, 202, 203, 212). Low flow rate crystal 
injectors utilizing viscous media such as lipidic cubic phase (LCP), agarose, glycerol and grease 
(204, 213-215) have decreased sample consumption. Moreover, a combination of these slower 
flow injectors with the intense X-ray micro-beams at micro-focus undulator beam lines and the 
emergence of fast frame rate area detectors (216, 217) have made injector-based diffraction 
experiments at the synchrotron (186, 218, 219) feasible.  
 Although these developments are promising, a number of issues still complicate the use of 
injectors, severely compromising experimental success. In particular, injector technologies often 
require the optimization of carrier solutions to reduce bubbling, crystal clumping and clogging.  
In many cases crystal slurries are filtered and forced through tiny orifices at high pressures. 
When these experiments fail to produce diffraction, it is difficult to determine if the problem is 
related to the inherent quality of the NCs or is a result of solution modifications or the injector 
protocols employed. In the case of the GDVN injector our previous TEM experiments have 
shown that the pressures involved in the injection process can be damaging to delicate NCs of 
multi-protein complexes while other types of NCs, such as of lysozyme, emerge unharmed (175). 
Notwithstanding the proven success of the injector setups, two possible drawbacks of this 
methodology commonly arise. First, injector setups often require large amounts of protein to 
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produce several milliliters of the slurry (containing 20-30% crystals). For some proteins this is a 
viable option, however for some challenging proteins that require special conditions for 
expression and purification, this is not practical. Second, there is potential damage that crystals 
could sustain during the injection process (175). Goniometer based fixed-target approaches at the 
XFEL are advantageous for data collection using delicate crystals, crystals in limited supply, 
large crystals or for crystal quality screening to prepare for injector-based experiments. The 
goniometer-based setup (220, 221), positions individual crystals into the beam path. However, 
since the intensity of the beam can create a damaged area around the target spot (20 to 30 µm in 
diameter depending on the beam diameter), the number of useful diffraction images per crystals 
is limited. As a consequence, data collection can be time consuming as many crystals need to be 
positioned and exposed. Efficient grid-based methods have been developed that hold crystals of 
from 5 to 200 µm in diameter in known locations, in relation to reference marks, for fully 
automated positioning and data collection (205, 222).  However, these approaches require careful 
and often very tedious sample loading steps that could damage delicate crystals.  For smaller 
crystals, areas of sample mounts are often exposed sequentially to search for positions containing 
crystals (218, 223), a time consuming process. Furthermore, crystal non-isomorphism is a serious 
problem when combining data from multiple crystals.  
In the following chapters, research is presented that addresses to concerning areas for 
both injector-based and fixed target SFX experiments. First, understanding the intrinsic 
characteristics of NC slurries and their amenability to the injection process is a crucial step to 
optimize sample preparation and injection protocols for successful SFX experiments and ensure 
efficient use of the limited beam time available at XFEL sources. To this end, TEM was used to 
analyze crystalline samples and provide immediate feedback for sample preparation methods to 
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improve data collection efficiencies. Next, development of an automated approach to efficiently 
expose low micron sized crystals that conserves crystals and beam time by mapping crystals in 
random orientations in relation to known reference points on multiple crystal holders (MCHs) is 
presented. These novel methodologies enabled fast data acquisition and efficient structure 
solution using minimal sample consumption, while reducing beam time requirements at 
oversubscribed XFEL and micro-focus synchrotron beam lines. 
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7.0  ASSESSMENT OF METHODS TO IMPROVE SERIAL FEMTOSECOND 
CRYSTALLOGRAPHY EXPERIMENTS  
7.1 SUMMARY 
Serial femtosecond crystallography (SFX) employing high-intensity X-ray free-electron laser 
(XFEL) sources has enabled structural studies on microcrystalline protein samples. However, the 
identification and optimization of methods to deliver well diffracting microcrystals with 
relatively high efficiency remains an experimental challenge. Here, we report improvements in 
the delivery of microcrystals for both liquid-jet and fixed-target SFX experiments. First, parallel 
liquid-jet SFX and transmission electron microscopy (TEM) experiments using fragmented 
microcrystals of wild type (WT) homoprotocatechuate 2,3-dioxygenase (HPCD) and an active 
site variant (H200Q) revealed traits necessary for efficient sample delivery.  Despite identical 
crystallization conditions and morphology, as well as similar crystal size and density, the 
indexing efficiency of the diffraction data collected using the H200Q variant sample was over 7-
fold higher compared to the diffraction results obtained using the WT sample. TEM analysis 
revealed an abundance of protein aggregates, crystal conglomerates and a smaller population of 
highly ordered lattices in the WT sample as compared to the H200Q variant sample. While not 
reported herein, the 1.75 Å resolution structure of the H200Q variant was determined from ~16 
minutes of beam time, demonstrating the utility of TEM analysis in evaluating sample 
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monodispersity and lattice quality, parameters critical to the efficiency of SFX experiments. In a 
second set of experiments, we applied novel fixed-target serial femtosecond crystallography 
methods at the XPP instrument of the Linac Coherent Light Source (LCLS) to reveal the 
structure of Escherichia coli dGTP triphosphohydrolase (dGTPase). We successfully determined 
the hexameric apo-dGTPase structure from 221 still images to 3.2 Å revealing clear Mn2+ 
coordination via the enzyme’s HD-motif.  These experiments applied UV-fluorescence 
microscopy, video analysis and highly automated goniometer-based instrumentation to map and 
rapidly position individual crystals randomly-positioned on fixed target holders. As a result, we 
achieved the highest indexing-rates observed for a serial femtosecond crystallography (SFX) 
experiment using randomly positioned micro-crystals. 
 
This work presented in this chapter was adapted with permission from Elsevier Publishing and work pending 
publication: 
 
Barnes CO*, Kovaleva EG*, Fu X, Stevenson HP, Brewster AS, DePonte DP, Baxter EL, Cohen AE and Calero G. 
(2016) Assessment of microcrystal quality by transmission electron microscopy for efficient serial 
femtosecond crystallography. Arch Biochem Biophys.  602, 61-68. doi: 10.1016/j.abb.2016.02.011 
 
Barnes CO, Wu Y, Song J, Lin G, Baxter EL, Brewster AS, Nagarajan V, Holmes A, Soltis M, Ahn J, Cohen AE, 
Calero G. (2016) Structural basis of enzymatic specificity and inhibition of the dGTP triphosphohydrolase 
from Escherichia coli revealed by XFEL and chemical cross-linking. (submitted) 
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7.2 EXPERIMENTAL METHODS 
7.2.1 Quantification of 2,3 – HPCD microcrystal slurries 
To quantify the microcrystals, samples were diluted in mother liquor 300 – fold and a 10 μL 
aliquot was applied to a bright-line hemocytometer (Hausser Scientific). Using a Jan Scientific 
Jansi UVEX microscope with nominal 5-, 15-, and 40x magnifications the sample chamber grids 
were visualized using brightfield and UV fluorescence with exposures of 0.1 and 5 seconds, 
respectively. Images were evaluated using the Jan Scientific CrystalDetect software and nominal 
15x magnification images were recorded (Infinity 2-3C Camera, Lumenera Scientific). Manual 
quantification was achieved using the Vi-CELL XR 2.03 software program (Beckman Coulter). 
A crystal was defined as having a minimum dimension of 6 pixels (~2.5 µm), with intensity 
values 3 standard deviations above the background threshold. 
7.2.2 Mounting dGTPase crystals on multi-crystal holders (MCHs) 
Purification, assembly, and crystallization of wild-type E. coli dGTPase was followed as 
previously described (Stevenson et al., 2016). To mount crystals onto MCHs (see schematic 
Figure 46), crystals were first cryo-protected with increasing concentrations of mother liquor. 
Crystal drops were increased to ~10 µL to prevent dehydration during the loading protocol, and 
MCHs were used to penetrate the drop and extract the randomly oriented crystals. For larger 
dGTPase macro-crystals (300 x 300 x 200 µm), 8 µL of cryo-solution were pipetted onto the 
MCH, followed by manual mounting onto the MCH via loop transfer or pipetting. To improve 
visualization and decrease background diffraction from solvent, excess fluid was carefully 
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removed from MCHs using filter paper. Optimization of this step is crucial, as wicking of excess 
solvent may also result in the loss of sample. 
7.2.3 Brightfield and UV-microscopy imaging and crystal identification 
Brightfield and UV microscopy was employed to identify and locate crystals in relation to the 
MCH reference points. To this end, MCHs were placed on the stage of the JANSi UVEX UV-
microscope, and after focus adjustment, brightfield and UV images covering the entire area of 
the MCH were acquired with the nominal 5X objective using 0.1 and 1 s exposure times, 
respectively. After image acquisition, the crystals and MCHs were immediately flash-cooled in a 
liquid nitrogen bath and transferred into a SSRL cassette. A macro to detect crystals was 
developed using ImageJ, a public domain, Java-based image processing program developed by 
the NIH (224).  The macro detects by bright areas that indicate UV-visualized crystals, and 
outputs crystal profiles and a list specifying crystal size and centroid position (in x-y jpeg pixel 
coordinates). Optimization of threshold detection, size, circularity and erode parameters are 
essential for accurate crystal detection. The pixel coordinates of the four MCH reference points 
were identified in relation to the crystal coordinates through examination of a corresponding 
brightfield image.  A file containing the coordinates of the crystals and the reference points for 
each MCH was saved in Excel format for input into Blu-ice/DCSS.  
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7.2.4 Automated data collection using MCHs at the LCLS and dGTPase structure 
refinement.  
Prior to the experiment, a reference file containing crystal coordinates and coordinates of four 
reference points for each MCH stored in a 96 sample pin storage cassette was read into the 
DCS/BLU-ICE beam line control software (225). During the day of the experiment, the SAM 
mounted each MCH onto the beamline goniometer.  The experimenter performed a semi-
automated alignment procedure where the MCH is rotated face on to the on-axis microscope and 
the four reference markers are clicked in a specific order from within a video display of the 
software interface. Following this procedure the location of the crystal coordinates are displayed 
over the video image of the mount (Figure 45). The calculated positions are visually inspected 
and if necessary a graphical interface enables the experimenter to shift the location of the 
reference points to improve accuracy. A ‘start’ button is clicked to begin automated data 
collection.  A crystals is translated into the beam position between each X-ray pulse. This 
process was repeated for each MCH in the cassette.   
Diffraction experiments on dGTPase and Pol II complexes were done using 9.5 keV X-
ray pulses with 40 fs duration and an 8 µm beam focus at the X-ray interaction point. Diffraction 
images were recorded on a Rayonix MX325 detector and processed using the cctbx.xfel software 
package (195, 226). Synchrotron based X-ray diffraction experiments of single dGTPase crystals 
were performed on SSRL beamline BL12-2, APS beamlines 22ID and 23IDD. Data were 
processed using XDS and SCALA software packages (227). Single anomalous diffraction 
experiments of selenium methionine labelled dGTPase crystals were collected at 12.656 keV 
with inverse beam every 15° of oscillation data.  
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 Selenium substructure determination was performed using SHELXD, with a resolution 
cutoff of 4.4 Å corresponding to a CCanom = 0.301. Substructure solutions were utilized in the 
CRANK2 pipeline (CCP4) resulting in an initial structure of dGTPase which was then manually 
built in Coot and refined in BUSTER. Subsequent dGTPase apo (XFEL) was solved by 
PHASER (177) using the Se-Met structure as a search model. All structures were refined using 
Phenix (228) and BUSTER (105), followed by several cycles of manual refinement in Coot 
(109). All figures were rendered in PyMOL. 
7.2.5 Transmission electron microscopy 
Microcrystal samples were analyzed by transmission electron microscopy as previously 
described (168). Briefly, 10 µL of sample was applied to glow charged 400 square mesh copper 
grids with a continuous carbon film (Electron Microscopy Sciences). Following sample 
incubation on the grid for 30 seconds, excess liquid was removed and the grid stained with 2% 
(w/v) uranyl acetate. Protein crystallinity of each sample was determined by screening for the 
presence of lattices. Lattice quality was evaluated by performing a fast Fourier transform of the 
lattice to obtain the reciprocal lattice reflections or Bragg spots. Bragg spot order of three or 
above was considered to be of high quality. A single-tile specimen holder was used to deliver 
samples to a FEI Tecnai T12 electron microscope. The microscope was operated at 120 kV and 
images were captured with a 2k x 2k Gatan UltraScan 1000 CCD camera. 
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7.3 RESULTS 
7.3.1 Preparation and SFX data collection of HPCD microcrystalline samples 
In our first study, we collaborated with the lab of Dr. Aina Cohen at Stanford University to study 
microcrystalline suspensions of two HPCD stocks, a WT enzyme and an H200Q variant (see 
Appendix B). The single isosteric substitution in the active site (H200Q) has no effect on the 
crystal morphology (rod-like), spacegroup, unit cell dimensions or diffraction quality as 
established previously in structural synchrotron-based studies using macrocrystals at cryo-
temperatures (229). Therefore, these enzyme stocks were used to account for prep-to-prep 
variability for optimization of the batch crystallization procedures.  
Due to rod/needle-like morphology of HPCD crystals and much faster crystal growth in 
one dimension, fragmentation was required to reduce the length of microcrystals and improve 
uniformity for injector-based studies. In addition to vortexing (a commonly used fragmentation 
method described in section 5.0) sonication, and centrifugation fragmentation methods were 
tested (see experimental procedure section). However, because of the limited amount of beam 
time allocated for this project, diffraction experiments for only two bulk fragmentation methods 
(centrifugation or vortexing, for H200Q and WT samples respectively), were carried out on the 
CXI instrument (LCLS) using the gas dynamic virtual nozzle (GDVN) injector (230).  
Diffraction data for both samples were collected using the same experimental settings, as 
described in section Appendix B. All still diffraction images acquired during beam time were 
used for indexing and integration with ccbtx.xfel (Table 5). Therefore, to enable comparison 
between samples (Figure 41A,B), the overall “indexing efficiency” is defined here as a 
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percentage of the total images, collected at the repetition rate of 120 Hz, which could be indexed 
successfully.  
 
Table 5. Comparison of physical properties and processing characteristics for the HPCD samples used for 
SFX data collection 
  (H200Q HPCD)  (WT HPCD) 
Density (crystals/ml)a 1.2 x 108 (±0.1) 1.53 x 108 (±0.07) 
Size distributionb   
a ~ b  (μm) 2.5 (±0.5) 2.6 (±0.6) 
c        (μm) 11.7 (±5.6) 10.4 (±4.1) 
Number of Bragg Spotsc 4th order 3rd order 
Indexing efficiency (%)d 12.2 1.7 
2nd lattice hits (%)e 16.1 8.4 
a Values for crystal density quantification using nominal 15x magnification (n=12) as described in Experimental 
Procedure. b Size distribution for fragmented microcrystal samples was determined manually from UV imaging 
data at nominal 15x magnification (n=15). Mean values for short (a, b) and long (c) dimensions for rod-like 
morphology. c Bragg Spot order calculated from FFT transforms of observable lattices (median derived from 
n=8). d The percentage of collected images that contained indexed patterns (single hits and 2nd lattices). e  
Percentage of double hits in the total number of indexed patterns. 
 
During 6.7 min of data collection using the WT enzyme sample (which showed a high 
tendency of nozzle clogging), a total of 814 diffraction patterns were indexed, corresponding to 
1.7% of the total images collected (Table 5). The observed indexing efficiency of 1.7% for the 
WT enzyme sample compares well with the typical values from previously published SFX 
studies, where 0.5 – 4% of the still diffraction images acquired at the same repetition rate (120 
Hz) were successfully indexed and merged (169, 173, 187, 191, 194, 195, 231). In contrast, 
12.2% of the total images acquired using the H200Q enzyme sample during 15.6 min of beam 
time were successfully indexed (Table 1).   
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Figure 41. Representative observed indexing rates and crystal density quantification for both H200Q and WT 
HPCD slurries 
A plot of the number of indexable patterns observed during a representative 6 minutes of data collection using the 
GDVN injector with the H200Q HPCD microcrystal sample (a) and with the WT HPCD microcrystal sample (b) 
illustrates the reduced hit rate observed for the WT sample.  The number of indexable hits/second from cctbx.xfel 
processing are plotted, where the blue trace indicates total number of indexable images per second and the red 
trace is the averaged indexing rate every 11 sec. Representative hemocytometer quadrants, reconstructed from 4 
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separate images using a 15x objective on a JanScientific Jansi UVEX microscope, illustrate fairly similar crystal 
densities for H200Q (c) and WT (d) slurries. Crystal quantification was achieved for both slurries using manual 
counting with ImageJ software (see experimental section, scale bars – C,D: 50 µm) (n=12). 
 
7.3.2 Characterizing microcrystalline density and size distribution 
We next examined whether differences in the crystal density and size of the microcrystalline 
slurries could explain the 7.3-fold difference in indexing efficiency of H200Q vs WT, as these 
are important considerations for sample delivery and sample consumption in liquid injector-
based experiments. Previously, crystal densities of ~109 crystals/mL have been proposed as the 
benchmark to attain high hit rates while reducing the occurrence of double hits during GDVN 
experiments (191, 210, 232), although sample densities of 1010 to 1011 crystals/mL are frequently 
used as well (173, 195). Therefore, in order to quantify accurately the number of crystals for both 
H200Q and the WT slurries, we applied crystal slurries to a hemocytometer and determined the 
number of crystals/ml from images obtained during UV-microscopy (Figure 41C,D). Both 
samples showed similar crystal densities of ~108 crystals/ml (Table 5), suggesting that crystal 
density between slurries was not a contributing factor to the ~7-fold difference in the indexing 
rate between them. The occurrence of a second lattice was found in 16.1% and 8.4% of indexed 
images for the H200Q and the WT samples, respectively (Table 5). This data suggests that lower 
crystal densities may be practical for liquid injector-based experiments. 
Furthermore, we examined the crystal size distribution using brightfield and UV 
microscopy for the WT and the H200Q variant samples (Table 5).  In an effort to reduce 
clogging of the GDVN injector nozzle, samples are typically filtered to limit the maximum 
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crystal size.  If the crystal size distribution of the two samples was significantly different, the 
different indexing rates observed during data collection could potentially be attributed to 
increased clogging of the GDVN nozzle, which focuses the crystal slurry to a stream of about 5 
μm in diameter. However, our analysis revealed no size difference between the WT and the 
H200Q variant samples (Table 5).  Many of the crystals from both samples were long needles 
with a significant fraction retaining a length of 10 – 20 μm following the fragmentation and 
filtration procedures. 
 
7.3.3 Analysis of crystal lattice quality and monodispersity with TEM 
The homogeneity and intrinsic order of microcrystals are critical parameters for SFX studies that 
also cannot be assessed effectively by bright-field microscopy. Similarities between crystal 
morphology, size, and density raise the possibility that observed differences in the indexing 
efficiency may be attributed to the quality of the crystal lattice in the two samples. Negative-stain 
TEM analysis, conducted on the two microcrystalline samples of HPCD, revealed both major 
differences in the lattice quality and homogeneity (Figure 42).  In addition to higher order Bragg 
spots (> 4th order) observed in H200Q crystals, the EM landscape indicated a highly 
monodispersed sample (Figure 42A,B). In contrast, WT microcrystals showed a high degree of 
sample aggregation, protein conglomerates, and a limited number of crystal lattices with > 3rd 
order Bragg spots (Figure 42C,D). Moreover, delivery of the WT sample was prone to nozzle 
clogging, which would be consistent with the high degree of protein aggregation observed by 
TEM and the low indexing rate for this sample (Figure 41B).  
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Figure 42. Negative-stain TEM images of HPCD microcrystals 
(a,b) Representative TEM sampling of H200Q crystals, illustrates sample monodispersity (A), with high quality 
crystal lattices (B) as determined from its FFT profile (inset). On average, 4th order Bragg spots were recorded for 
H200Q crystals. (c,d) Representative TEM sampling of WT crystals, illustrates sample aggregation or crystal 
conglomerates (C), typically not seen with brightfield or UV microscopy. Lattice quality was of high quality (D), 
with an average of 3rd order Bragg spots observed for WT samples. (Scale bars – A,C: 0.5 µm;  B,D: 50 nm). 
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Since bulk fragmentation of the WT and H200Q microcrystals differed, we performed 
TEM experiments on the fragmentation protocols to determine its effects on sample 
monodispersity, lattice quality and crystal aggregation. While we observed no major differences 
in the lattice quality among HPCD samples prepared by different fragmentation methods, we did 
observe minor differences in the amount of crystal aggregation. TEM analysis revealed fewer 
aggregates for crystals fragmented via centrifugation or vortexing (with a glass bead cocktail) 
when compared to crystals prepared by sonication, irrespective of the characteristics of the 
starting material prior to fragmentation (Figures 43 and 44). Given that cryo-cooled 
macrocrystals generated for fragmentation of both H200Q and WT show no difference in 
diffraction or crystal quality (229), the observed variance in the indexing rates between the two 
otherwise similar samples could stem from the differences in monodispersity and degree of 
protein or crystal aggregation generated during protein sample preparation or crystallization 
experiments. The extent and influence of these factors are speculative and will require additional 
testing to demonstrate a clear significant correlation.  
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Figure 43. Negative-stain TEM analysis of bulk fragmentation methods for rod-like 2,3 – HPCD 
microcrystals 
(a,b) TEM images of H200Q (A) or WT (B) crystals after fractionation with centrifugation. (c,d) TEM images of 
H200Q (C) or WT (D) crystals after fractionation with vortexing. (e,f). TEM images of H200Q (C) or WT (D) 
crystals after fractionation with sonication. Lattice quality was evaluated when single crystals were observed and 
with median values of 3rd order Bragg spots (not shown) for all samples across the varying fragmentation protocols. 
(Scale bars – A-F: 1 µm). 
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Figure 44. Negative-stain TEM analysis of bulk fragmentation methods for needle-like 2,3 – HPCD 
microcrystals 
(a,b) TEM images of H200Q (A) or WT (B) crystals after fractionation with centrifugation. (c,d) TEM images of 
H200Q (C) or WT (D) crystals after fractionation with vortexing. (e,f). TEM images of H200Q (C) or WT (D) 
crystals after fractionation with sonication. Lattice quality was evaluated when single crystals were observed and 
with median values of 3rd order Bragg spots (not shown) for all samples across the varying fragmentation protocols. 
(Scale bars – A-F: 1 µm). 
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7.3.4 Mounting, detection, and collection of dGTPase microcrystals on Multi-Crystal 
Holders (MCHs)  
In our second set of experiments using the fixed-target setup at XPP, it was imperative that we 
develop a device capable of holding 20-100 crystals to eliminate the void time associated with 
single loop mount/dismount (222). We developed a Multi-Crystal Holder (MCH) (Figure 45A,B) 
capable of holding microcrystals under native- or cryo- crystallization conditions and compatible 
with with UV microscopy illumination for crystal identification. 
 
Figure 45. Design and identification of crystals mounted on Multi Crystal Holders 
(a) AutoCAD DXF schematic illustrating the dimensions of MCHs for laser printing onto Mylar sheets.(b) Assembly 
of MCHs achieved by epoxying laser-printed MCHs onto the pin-base aperture of a Hampton loop. (c) Brightfield 
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and, d) UV microscopy images of Pol-Spt4/5-DNA mounted crystals. Green outlines indicate the crystal positions 
determined after particle analysis in ImageJ (ref###). e) BluIce Image of Pol-Spt4/5 crystals mounted at MFX 
endstation. Coordinates generated in ImageJ (see Table S1) were uploaded, and after identification of reference 
fiducial marks (red asterisks), beam positions were assigned to each crystal (green boxes). 
 
 Depending on the sample type, the MCHs held 1-2 dozen large size crystals (200-300 µm) to 
several hundred micro-crystals. The pointed end and large area of the MCH allowed for easy 
extraction of crystals from the crystallization drops. Brightfield and UV-microscopy imaging 
was performed at room temperature. Given the high contrast of the UV signal of crystals versus 
solvent background, detection of crystals on MCHs was easily achieved (Figures 45C and 46B), 
even for crystals with <10 µm dimensions (Figure 47A-C).   
 
Figure 46. Loading and mapping of crystals on MCHs 
(a) Schematic representation of MCH loading as detailed in the experimental methods section, (b) UV microscopy 
image of Pol-Spt4/5 mounted crystals. Fiducial marks are illustrated as red asterisk. (c) Reciprocal space 
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representation of the basis vectors of 221 indexed dGTPase images demonstrating the lack of preferential alignment 
when mounting in MCHs. 
 
 UV-microscopy images of the MCHs were analyzed to identify bright areas corresponding to 
the location of individual crystals ((Figure 45C,D). For crystals greater than 100 µm along one 
dimension (Figure 47D-F), multiple coordinates were recorded, spaced sufficiently to ensure 
translation into uncompromised regions of the crystal between each X-ray exposure (Figure 
47E,F).  Algorithms previously incorporated into the Blu-Ice/DCSS experimental control system 
to position grid-based sample holders and microfluidic traps at LCLS-XPP (205, 222) were 
adapted to automatically position crystals in random locations based on their relationship to 4 
reference coordinates of the MCH for efficient serial diffraction experiments.   
 
Figure 47. Size distribution of crystals mounted on MCHs 
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(a-c) Depiction of greater than 500 E. coli dGTPase microcrystals <10 µm in size, identifiable by UV fluorescence 
microscopy when mounted on MCHs. and 15x (B) nominal UV magnification images, with ImageJ identification (C) 
of E. coli dGTPase crystals, measuring <10 µm in size, mounted on MCHs. (d-f) Large crystals of Pol II – TFIIB – 
DNA illustrating the multi-shot strategy with user specified spacing along the crystals surface. 
 
This protocol was used successfully with various crystals of complexes mounted on 
MCH (Figures 46 and 47).  Diffraction data collected in an automated fashion using crystals of 
dGTPase and RNA Polymerase II complexes, resulted in improved intensities of high angle 
Bragg reflections (Figure 49A), consistent with previous results (220). In addition, larger crystals 
of the Pol II – TFIIB – DNA complex, which utilized a multi-shot strategy with angular offsets 
for each position (Figure 47D-F), produced indexable still diffraction images. The shots were 
spaced 50 µm apart, consistent with previously reported spacing protocols (221, 233). Overall, 
application of MCHs resulted in highly accurate microcrystal hit rates (>80%) for efficient data 
collection with minimal background scattering preserving weak Bragg reflections.  
Moreover, data processing with cctbx.xfel produced complete datasets using from 100-
1000 crystals, suggesting the micro-crystals oriented randomly on the MCHs. To demonstrate 
this, we analyzed the reciprocal basis vectors for indexed dGTPase and Pol II crystals that were 
singly exposed for one MCH (Figure 48) and for the entire dGTPase dataset (Figure 46C) using a 
method derived from recent observations of a GNNQQNY peptide needle (234).  Unlike 
previous goniometer-based XFEL datasets that showed symptoms of preferential alignment of 
crystals in loops (221, 233), our results revealed a spherical-like projection indicative of 
randomly oriented crystals. As a result, >90% complete datasets were obtained for all datasets to 
high-resolution, with only 221 still images being required to solve the structure of the apo-
dGTPase enzyme. 
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Figure 48. Reciprocal axes analysis of individual grids for tested complexes 
Reciprocal space representation of the basis vectors of indexed crystals that were singularly exposed for (a) Ec-
dGTPase, (b) RNA Polymerase II T834P variant, c) RNA Polymerase II – TFIIB – DNA, and d) RNA Polymerase II 
– Spt4/5 – DNA crystals. 
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7.3.5 Escherichia coli dGTPase structure and active site metal coordination 
The XFEL structure determination of the E. coli dGTPase apo-enzyme to 3.2 Å was solved from 
221 still images captured from ~150 crystals exposed to the XFEL beam (Figure 49), 
representing the fewest number of still images used to process non-helical data from a 
goniometer-based XFEL experiment. Initial phases were generated by molecular replacement 
using a previous selenium-methionine SAD phased structure from our lab as an initial search 
model. The global fold and unit cell dimensions of our XFEL structure were consistent with 
previously published dGTPase structures (PDB:ID 4XDS) (235), and our synchrotron based apo-
structures, with an average root mean squared deviation for Cα positions ranging between 0.33 to 
0.42 Å when aligned against the refined XFEL structure.  
These observed similarities between the Cα positions allowed for the direct comparison 
of residues involved in active site metal coordination. dGTPase is part of the HD family of 
nucleases (236)with residues H69, H117, D118, and D268 participating in metal coordination within 
the catalytic site. The occupancy for Mn2+ divalent cations was set to zero and simulated 
annealing omit maps were computed for the XFEL data set, to remove model bias for metal ion 
location based on our starting model. The radiation damage-free XFEL structure showed clear 
electron density (F0-Fcalc map contoured at 3 σ) for the divalent Mn2+ ion and coordination by the 
four residues involved in the HD motif (Figure 49B). Most notably, D118 was on average 0.5 – 
0.7 Å closer to the Mn2+ ion across all six monomers when compared to PDB:ID 4XDS (Figure 
49C), and our Se-Met apo-structure which had an averaged absorbed x-ray dose of 3.4 MGy 
(237). This observed difference, while slight, suggests that at even fairly low x-ray doses, 
radiation damage is accrued site-specifically around metal centers, possibly through the 
decarboxylation of the neighboring aspartic acid residue.   
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Figure 49. The hexameric dGTPase XFEL crystal structure 
(a) The use of an 11 µm focused beam at XPP extended the resolution of 200 µm crystals from E. coli dGTPase 
beyond 2.6 Å. (b) Cartoon backbone representation of the hexameric dGTPase XFEL crystal structure solved using 
221 still images from randomly oriented crystals, (c) Shown in gray is the 2Fobs – Fcalc map contoured at 1.5σ for 
residues comprising the HD motif and in green the Fobs – Fcalc omit map contoured at 5.0σ for the Mn2+ cation. H-
bond interactions are indicated with black dashes, all representing distances less than 3.0 Å (d) Differences in Mn2+ 
coordination for XFEL (gray) and synchrotron (blue) structures. 
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7.4 DISCUSSION 
7.4.1 TEM optimization of samples for injector SFX experiments 
Successful SFX experiments require consistent delivery of well diffracting single crystals into 
the XFEL beam path. For liquid-jet experiments, the inherent diffraction quality of the 
microcrystals, crystalline monodispersity and the compatibility of the sample to the injection 
process are all important factors. Our parallel SFX and TEM experiments with HPCD 
microcrystals illustrate that the use of optimized samples with the GDVN injector, such as the 
ordered monodispersed H200Q variant microcrystals, will result in efficient SFX experiments. 
While not reported herein, approximately 16 minutes of protein crystal screening time at CXI 
(LCLS) resulted in an enzyme structure at 1.75 Å resolution, which is one of the most rapidly 
collected SFX datasets at atomic resolution using a GDVN injector. In contrast, the presence of 
protein aggregates or crystal conglomerates can greatly decrease the occurrence of useful 
diffraction images (even if the crystal lattice is of high quality), requiring much longer data 
collection time and increased sample volumes to acquire enough data for a complete dataset. 
Therefore, pre-characterization of samples to identify and optimize conditions that promote 
monodispersity with highly ordered crystal lattices prior to XFEL beam time would lead to 
increased efficiency and higher-quality SFX data.  
The application of TEM is particularly advantageous in this regard, for systems where 
crystals are too small (< 5 μm) for X-ray diffraction screening measurements at micro-focused 
synchrotron beamlines. X-ray powder diffraction (XPD) is a commonly used tool to assess the 
diffraction capability of microcrystalline preparations, but much like TEM, powder patterns will 
not exhibit the same resolution to which single crystals diffract at XFEL sources (231). Thus, 
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while this information would be useful where TEM is not accessible, it would not provide details 
beyond the crystallinity of the sample. The usefulness in TEM compared to other sample 
preparation tools (I.E. dynamic light scattering, SONICC, UV-fluorescence, XPD, etc.) is that it 
not only is capable of identifying crystalline material, but also provides the experimenter with 
additional information about further optimizing or discarding crystals grown under certain 
conditions (238). 
In addition to microcrystal quality, our data also raises the possibility that crystal density 
may play a greater role in data collection efficiency than previously thought. Assessment of our 
data and previously published results illustrate negative correlation between increasing overall 
indexing efficiency with decreasing crystal densities (169, 173, 179, 191, 195, 231, 234).  
 
Table 6. Comparison of indexing efficiency for similarly solved SFX systems 
Sample Crystal shape/size Density Number of still images % indexed Reference 
  (crystals/ml) Collected Indexed   
Lysozyme Box, 1 x 1 x 3 µm3 1 x 1011 1,471,615 
1,997,712 
12,247 
10,575 
0.8 
0.5 
Boutet et al., 2012 
PS I Box, 4 x 4 x 13 µm3 1 x 109 1,850,000 15,445 0.8 (Chapman et al., 
2011) 
PS II Box, 2-5 x 15 µm N/A 1,492,634 
586,903 
4,663 
1,848 
0.3 
0.3 
(Kern et al., 2013) 
PYP Needle, 1 x 5 µm 5 x 1010 2,049,294 
1,024,684 
64,696 
31,255 
3.2 
3.1 
(Tenboer et al., 
2014) 
Thermolysin Box, 2 x 3 x 1 µm3 2 x 1010 651,793 11,647 1.8 (Hattne et al., 
2014) 
TbCathepsin B Needle, ~0.9 x 11 µm 2 x 109 3,953,201 178,875 4.5 (Redecke et al., 
2013) 
2,3 – HPCD Needle, ~2 x 12 um 1.2 x 108 119,040 14,547 12.2 this work 
 Needle, ~2 x 11 um 1.5 x 108 47,882 814 1.7 this work 
 
Furthermore, when considering the monodispersed H200Q sample (as visualized by 
TEM) which had lower crystal densities than those routinely used for GDVN based experiments, 
we still observed ~20% double lattice hits for indexed images. This raises the possibility that 
lower crystal densities may be advantageous and practical for liquid-jet experiments. However, 
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since TEM experiments to analyze monodispersity and overall quality of crystal lattices were not 
performed for previously published samples, we cannot rule out that these factors played a role 
in their overall indexing hit rates. Yet taken together, these data suggest that monodisperse 
samples analyzed by TEM with crystal densities of 108 crystals/mL may improve efficiency and 
lessen sample consumption, which is applicable to challenging protein targets (I.E. membrane 
proteins, multi-protein complexes, etc.). 
7.4.2 Improved hit-rate efficiencies using MCHs at fixed-target SFX setups 
Notwithstanding the proven success of the injector setups, two possible drawbacks of this 
methodology commonly arise. First, injector setups often require large amounts of protein to 
produce several milliliters of the slurry, and second, there is potential damage that crystals could 
sustain during the injection process either from incompatibility with carrier solutions or the shear 
forces involved in the process (175). Goniometer based fixed-target approaches at the XFEL are 
advantageous for data collection using delicate crystals, crystals in limited supply, large crystals 
or for crystal quality screening to prepare for injector-based experiments. Our data presents a 
highly efficient fixed target data collection methodology that provides greater than 90% crystal 
hit rates for serial crystallography using randomly oriented micrometer-sized crystals. While 
crystals in MCHs were mapped prior to the experiment using UV-microscopy at the home 
laboratory, future experiments will incorporate a UV-imaging capability on the beamline 
goniometer for on-the-fly crystal identification and mapping.  This will improve the precision of 
crystal positioning, and providing a straightforward means to fully automate these fixed target 
SFX experiments using a variety of MCH form factors. As UV-microscopy imaging is broadly 
applicable to identify a wide-range of macromolecular crystals, the general crystallographic 
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community may easily adopt this fully automated approach for multi-crystal experiments at both 
synchrotron and XFEL sources.  As crystals in random locations may be automatically 
positioned, this method supports methods combining in situ growth and data collection. 
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8.0  STRUCTURAL BASIS OF THE GAIN OF FUNCTION POL II T834P VARIANT 
REVEALED BY A XFEL 
8.1 SUMMARY 
Goniometer-based serial femtosecond crystallography (SFX) employing high-intensity X-ray 
free-electron laser (XFEL) sources has enabled structural studies of crystals in the 20-100 µm 
range revealing highly significant protein targets. Here we present preliminary results for the use 
of an automated, highly efficient data collection protocol for fixed-target SFX experiments, 
enabling the collection of several RNA Polymerase II transcribing complexes, including the gain 
of function (GOF) allele T834P Pol II, with resolution to ~3.3 Å. Using both synchrotron and 
XFEL sources for data collection on Pol II microcrystals, three independent datasets show that 
T834P allows capture of Pol II with a kinked bridge helix (BH), induced by the proline 
substitution, and traps the TL in closed conformation with a matched NTP substrate at the 
highest resolution observed so far. Our structure reveals stronger TL-BH interactions, a 
rearrangement of Met1079 in the TL hydrophobic pocket, and other changes in our closed TL 
relative to published structures. These structures, in conjunction with future molecular dynamics 
(MD) and biochemical studies may reshape our basic understanding of TL function and reinforce 
the need for new structures at higher resolution.   
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8.2 BACKGROUND  
Since the pioneering works of the Kornberg lab in the early century, our wealth of knowledge on 
eukaryotic RNA Polymerases has exponentially increased from structures revealing the 
underlying mechanism of transcription.  The transient interplay between nucleic acids, Pol II and 
the transcription factors that regulate transcription activity have been illuminated in recent years 
from both X-ray crystallography (80, 81, 239) and single particle cryo-EM models (90-93). As 
the molecular mechanisms of transcription initiation and elongation are emerging, questions still 
remain regarding the allosteric role these factors play in the nucleotide addition cycle (NAC) and 
translocation. Specifically, it remains to be seen how the basal transcription machinery might 
affect trigger loop (TL) activity during early transcribing events.  
As previously discussed in the above chapters, the TL is a highly conserved loop 
comprising Rpb1 residues 1078-1097, and plays a fundamental role in the NAC (56, 57, 59, 
240). Evidence from single molecule studies on Pol II indicates that alteration of TL residues 
influences Pol II translocation properties, consistent with models presented in Chapter 3 (241). 
In particular, TL opening is proposed to be a critical step during Pol II translocation across the 
DNA template, and as we previously showed, over 40 potential H-bonds across the NAS must be 
disrupted for this to occur. Our previous work also revealed that interactions with the non-
transcribing DNA strand (NTS) and the C-terminal proximal region of the TL (termed the U-
loop) may play a role in TL stability in an open state. In addition, it is possible that the numerous 
transcription factors which engage the NTS (ie. TFIIB or TFIIF in the early initiation 
complexes), may also influence TL conformational states, as evident by the partially folded TL 
in the presence of TFIIF in a Pol II transcribing complex (241).   
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Moreover, the importance of interactions between Pol II proximal domains and TL 
conformational states has emerged in recent years. Kinking of the highly conserved bridge helix 
(BH), which exists in all multi-subunit Pols, has been proposed to support translocation. In the 
archaea Methanocaldococcus jannaschii (Mja) RNAP, substitutions of Met808 or Ser824 for a  
proline at two hinge-proximal residues resulted in gain of function (GOF) phenotypes, 
suggesting that the introduction of a proline residue kinks the helix, resulting in increased 
translocation or catalysis (52, 242, 243).  A recent study in S. cerevisiae with BH mutants 
analogous to Mja RNAP variants (Rpb1 Met818 and Thr834) showed gain of function phenotypes 
with similar transcriptional properties as Mja RNAP (198). The higher rate of in vitro elongation 
suggests that these single substitutions promote a TL conformation similar to the closed state. 
Thus, structurally understanding how distinct TL conformations or interactions are linked to 
different functions in transcription, possibly by incorporating signals from the rest of Pol II or 
Pol II bound factors (198, 244), is important in revealing TL dynamics. 
In this preliminary work, we sought to identify the mechanism which governs gain of 
function transcriptional activity of the Pol II T834P variant in the presence of a complete and 
short nucleic acid scaffold. Owing to the the importance of the metal ion in nucleotide catalysis 
(46, 49, 240), Pol II T834P crystals were a suitable candidate for data collection at the Linac 
Coherent Light Source (LCLS) to garner a radiation damage-free structure. Herein, we describe 
the utilization of MCHs, to solve the high-resolution crystal structure of the radiation-damage 
free Pol II – T834P variant in the presence of ATP to 3.3 Å, revealing the closed TL. 
Furthermore, coupling changes in the closed TL state with atomic-resolution data collected at the 
synchrotron for Pol II-T834P crystals in the closed and open TL states, we provide detailed 
mechanistic insights into TL function and dynamics. Our structures reveal stronger TL-BH 
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interactions, a rearrangement of Met1079 in the TL hydrophobic pocket, and other changes in our 
closed TL relative to published structures. In addition, we demonstrate improvements to data 
resolution and electron density map quality for radiation-sensitive crystals of RNA Polymerase II 
(Pol II) complexes collected at the LCLS, consistent with our previously observed results.  
8.3 EXPERIMENTAL METHODS 
8.3.1 Protein purification, assembly, and crystallization 
The single point mutation T834P was introduced into rpb1 using site-directed mutagenesis as 
previously described (56, 198). Wild type Pol II and T834P variant were purified as described 
above (section 3.1.1). The transcription factor IIB and elongation factors Spt4/5 were purified as 
previously described (220, 238). To assemble Pol II transcribing complexes, synthetic 
oligonucleotides shown in Table 1 (i+5 NAS for TFIIB and Spt4/5), containing a single stretch 
of non-complementary bases and a 9-mer RNA (5’ – AUCAGAGGA – 3’ for Spt4/5) or 5-mer 
RNA (5’ – GAGGA – 3’) TFIIB construct) were annealed above their melting temperatures and 
allowed to cool slowly to 4º C. Synthetic oligonucleotides were similarly annealed for Pol II – 
T834P complexes with the following sequences, TS: 5’-
CTACCGATAAGCAGACGTCCCTCTCGATG, NTS:  5’-CTGCTTATCGGTAG, and a  10-
mer RNA with 3´- end dG (5’ – AUCGAGAGG/3´dG/ for T834P variant). The resulting nucleic 
acid scaffolds (NAS) were mixed with Pol II (3:1 molar ratio) and excess scaffold was removed 
using size exclusion chromatography (Superdex200, GE LifeSciences) against Buffer A (25 mM 
Hepes pH 7.5, 100 mM NaCl, 5 mM DTT, 0.5 mM EDTA, 10 µM ZnCl2). A 2.5-molar excess of 
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TFIIB or Spt4/5 was mixed with the Pol II-TIC in the presence of 1M NaCl, and dialyzed 
overnight at 4º C against Buffer A. Removal of excess TFIIB or Spt4/5 was carried out using a 
second size exclusion step (Superdex200, GE LifeSciences) against Buffer A. Purified 
assemblies were concentrated to 6-8 mg/mL and crystallized in the following conditions:  
 
Table 7. Pol II complex crystallization conditions for SFX experiments 
Complex Crystallization condition 
Pol-II-T834P-s10 25-27 % Tacismate pH 7.0, 0.1M Hepes pH 7.0, 1% glycerol, 5mM MgCl2 
Pol-II-TFIIB-DNA 28-30 % Tacismate pH 7.0, 0.1M Hepes pH 7.0, 1% glycerol 
Pol-II-Spt4/5-DNA 10-12% Peg 4000, 75 mM MgCl2, 0.1 M MES, pH 6.0 
^ All conditions include 10 mM DTT or 5mM TCEP, and where cryo-protected with increasing concentrations of 
mother liquor and glycerol. 
 
 
For the addition of matched nucleotide into Pol II – T834P – s10 crystals, prior to cryo-cooling 
15 mM ATP was added to the cryo-buffer to initiate TL folding. Crystals were soaked in the 
presence of ATP for ~15 minutes before flash-freezing in liquid N2.  
8.3.2 XFEL data collection and processing  
Crystals of Pol II complexes were mounted onto MCHs as described in section 7.2.2. Diffraction 
experiments were carried out at XPP and MX beamlines (LCLS) on Pol II complexes using 9.5 
keV X-ray pulses with 40 fs duration and an 8 µm beam focus at the X-ray interaction point. 
Diffraction images were recorded on a Rayonix MX325 detector and processed using the 
cctbx.xfel software package (195, 197). To improve the accuracy of our data, a grid search of 
spot-finding parameters on an image-to-image basis was performed to maximize the success of 
indexing and integration (245). Diffraction images were then divided into individual clusters 
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based on their crystal symmetry and unit cell parameters using hierarchical clustering with 
default (5%) and a very narrow cutoff of 0.5% tolerance for unit cell parameters (246, 247). 
Using the largest cluster, we employed post-refinement as implemented in the program PRIME 
(248) to generate a merged diffraction data set. Synchrotron based X-ray diffraction experiments 
of single Pol II - T834P – s10 crystals were performed on SSRL beamline BL12-2 and APS 
beamline 23IDB using an X-ray energy of 12.665 keV. Data were processed using XDS and 
SCALA software packages (227). 
8.3.3 Structure refinement and analysis 
The structures were solved by molecular replacement (MR) using 12-subunit Pol II PDB:ID 
5C4A (241) for Pol II-T834P or Pol II-Spt4/5 complexes, or PDB:ID 4BBS (81) for Pol II-TFIIB 
complex in Phaser (104). MR models were initially refined in CNS (108) using rigid body and 
B-group refinement, followed by atomic displacement parameter (ADP) restraints. Pol II-T834P 
models were iteratively built with B-factor sharpening in COOT (109, 110) and further refined in 
the programs Buster (105), and Phenix (228) using TLS and ADP restraints. All figures were 
rendered using PyMOL (The PyMOL Molecular Graphics System, Version 1.5.0.4 Schrödinger, 
LLC). 
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8.4 PRELIMINARY RESULTS AND DISCUSSION 
8.4.1 Pol II crystals benefit from higher XFEL intensities at fixed goniometer setups 
As previously described, we successfully used TEM to identify (168), assess (175, 238), and 
optimize (249) crystallographic studies of nanocrystals. Therefore, initially, we tested the ability 
of Pol II complex nanocrystals to diffract using liquid-jet delivery methods as described in 
chapter 7. Utilizing nanocrystals of the Pol II – TFIIB – DNA complex and the GDVN delivery 
method (208, 230), crystals were diffracted at the CXI endstation of LCLS. While diffraction 
was observed (Figure 50A,B), resolution was typically limited to 4.0 Å or less. This was 
surprising given that slightly larger sized crystals diffracted to 3.7 Å with long exposure times 
(40 seconds) and the use of a 10 X 10 µm beam size using a synchrotron light source. These 
results suggested that 1) diffraction was dose dependent and 2) the possibility of accumulating 
crystal damage during jet injection due to the high solvent content of the crystals, as we 
previously observed (175). 
However, given the ability to generate larger crystals (Figure 38B), we next tested 
whether improvements in resolution could be achieved from cryo-cooled crystals mounted on 
MCHs at fixed-goniometer XFEL endstations. Remarkably crystals of the Pol II – TFIIB – DNA 
complex diffracted beyond 3.2 Å (Figure 50C,D), while crystals of the Pol II – Spt4/5 – DNA 
complex also saw improvements in the observation of high-angle Bragg reflections. On average, 
improvements of 0.3 – 0.6 Å resolution were observed, consistent with previously observed work 
(220, 233). In addition, crystals of the Pol II T834P variant soaked with a matched nucleotide 
were also collected, with consistent diffraction to 3.3 Å or better.  
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Figure 50. Diffraction of Pol II - TFIIB - DNA crystals at XFEL sources 
(a) Fragmented crystals of Pol II – TFIIB – DNA complex were prepared and injected using the GDVN. (b) 
diffraction of nano-crystals on a CSPAD detector at CXI. (c) Representative diffraction of Pol II – TFIIB – DNA 
crystals at XPP endstation, with higher resolution (d) being clearly observed beyond 3.2 Å.  
 
 
 145 
8.4.2 Analysis of data collection methodologies, merging statistics, and initial map 
features of SFX generated data 
As described in section 8.3.3, cctbx.xfel was used to index, integrate and merge our XFEL data 
(195, 197). To determine the efficiency of data collection using MCHs, we defined hit rate as the 
number of images with observable diffraction (using a cutoff of 100 Bragg reflections during 
image-by-image grid search in IOTA (245) against the total number of previously unfiltered 
images for each dataset. Our observed hit rates of ~90% are among the highest hit-rates ever 
reported for single-shot XFEL diffraction experiments (Table 8). 
 
Table 8. Data collection and processing statistics for Pol II SFX experiment 
 Pol II – T834P 
– s10 + ATP 
(LCLS - XPP) 
Pol II – Spt4/5 
DNA (TB25) 
(LCLS - XPP) 
Pol II – Spt4/5 –  
DNA (TB18) 
(LCLS – XPP) 
Pol II – TFIIB – 
DNA 
(LCLS – XPP) 
Experimental 
Parameters 
    
Average Crystal Size 
(a x b, µm) 
80 x 80 60 x 100 40 x 70 100 x 100 
Total Number of 
Images 
1085 613 807 574 
Total Hits (% of total 
images) 
984 (90.6) 523 (85.3) 643 (79.7) 507 (88.3) 
*Indexed/Merged (% 
of total images) 
883 (81.4) 421 (68.7) 594 (73.6) 394 (68.6) 
Space Group C2221 P212121 P212121 P21 
Resolution (Å)b 35-3.3 35-3.85 35-3.5 35-3.4 
*Completeness (%) 97.9 (91.3) 98.3 (97.5) 99.8 (97.2) 91.6 (90.7) 
Redundancy 7.3 (3.3) 7.8 (5.4) 9.3 (6.1) 5.5 (3.3) 
<I/σI> 6.1 (0.8) 5.7 (0.4) 4.8 (0.3) 4.6 (1.0) 
Rsplit (%) 37.3 (85.2) 32.9 (88) 34.9 (98) 56 (106) 
*Merging with default unit cell tolerance of 5%     
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Using the largest cluster of indexed images, we employed post-refinement as 
implemented in PRIME (248) to estimate structure factor amplitudes. When using a default 
setting of 5% unit-cell tolerance and inclusion of negative intensities (197, 250), 10-20% of 
images were rejected, resulting in >90% complete datasets for all complexes collected (Table 8). 
However, due to the non-isomorphism of the crystal samples, standard deviations along the a, b, 
& c axes were extremely high (10-15 Å on average, as high as 28 Å for Spt4/5 and TFIIB 
datasets along the longest axis), negatively affecting map features of mobile elements (Figure 
51). As a result, subsequent hierarchal clustering of images was restricted to a unit cell tolerance 
of 0.5% to improve crystal isomorphism, but at the detriment of dataset completeness. Such 
narrow cutoffs rejected on average 50-60% of images from the original merged datasets, with 
only the Pol II – T834P dataset showing >90% completeness better than 4Å resolution (Table 9). 
Yet, this approach was critical to reveal the complete TL in the Pol II – T834P transcribing 
complex as shown in Figure 51C,F.  
 
Figure 51. Map quality improvements as a function of unit cell tolerance 
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Improvements in electron density were observed for all complexes tested when unit cell tolerance was restricted 
from the default 5% (a-c) to a user-defined setting of 0.5% (d-f). (a,d) 2Fobs – Fcalc initially refined map contoured at 
1σ  for TFIIB cyclin domain, (b,e) ) 2Fobs – Fcalc map contoured at 1σ  for nucleic acid scaffold in Pol II – Spt4/5 
crystals, and (c,f) ) Fobs – Fcalc difference electron density contoured at 2σ  for the trigger loop (green mesh) in Pol 
II – T834P crystals. The matched ATP nucleotide is shown in orange.  
 
Table 9. Pol II T834P data reduction and refinement statistics 
  Pol II – T834P – s10 
+ATP 
(LCLS - MX) 
Pol II – T834P – s10 
+ATP 
(SSRL - 12-2) 
Pol II – T834P – s10 
(no ATP soak) 
(APS - 23IDB) 
 
Data Collectiona 
    
PDB:ID  n/a n/a n/a 
Space Group  C2221 C2221 C2221 
Unit cell (Å)  220.2, 392.5, 280.9 221.1, 391.6, 279.9 221.0, 393.9, 283.2 
α, β, γ (°)  90, 90, 90 90, 90, 90 90, 90, 90 
Wavelength (Å)  1.304 0.9798 0.9798 
Resolution (Å)b  35-3.3 40-3.67 40-3.45 
Unique Reflections  188,170 133,292 162,143 
Completeness (%)  97.9 (91.3) 100 (100) 99.8 (99.7) 
Redundancy  7.3 (3.3) 9.3 (9.1) 10.2 (8.8) 
CC1/2 (%)  82.8 (25.5) 99.0 (28.9) 99.8 (60.1) 
<I/σI>  6.1 (0.8) 4.7 (0.9) 5.5 (0.7) 
Mosaicity (º)   0.2 0.35 
Rmerge (%)  64.7 (84.5) 29.9 (248) 33.7 (302) 
Rpim (%)  37.3 (85.2)c 10.2 (86.5) 12.2 (94.1) 
Data Processing 
Program 
 
 cctbx.xfeld XDS/Scala XDS/Scala 
Refinement 
 
    
No. Atoms  31,984 32,035 31,461 
Rcryst/Rfree (%)  29.5/31.1 18.9/22.5 22.6/25.5 
Refinement Program  Phenix/CNS Buster/CNS Buster/CNS 
aNumbers in parentheses correspond to the highest resolution shell 
bResolution limits were extended to include weak intensity data (Karplus and Diederichs, 2012). Using the 
traditional criterion of I/σI > 2.0, the resolution limit is 3.72 Å, 3.95 Å and 3.82 Å, respectively. 
cValue represents Rsplit (%) for data collected at XFEL source, not Rpim.  
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8.4.3 Structure of Pol II - T834P variant: Bridge helix and trigger loop conformation 
Prior to XFEL data collection, single crystal diffraction experiments of a Pol II – T834P 
transcribing complex soaked with a matched nucleotide were collected at beamlines GM/CA 
(APS) and 12-2 (SSRL) to 4.0 Å and 3.65 Å, respectively.  These structures were solved by 
molecular replacement using PDB:ID 5C4A. To prevent model bias during initial refinement, 
Rpb1 residues 670-740 (Funnel helices), 815-850 (Bridge Helix, BH), and 1072-1100 (Trigger 
Loop, TL) were removed from the molecular replacement model. The refined 3.65 Å structure 
was subsequently used for molecular replacement of the XFEL data, followed by simulated 
annealing using DEN refinement (251) in CNS. The models were further refined using the 
programs Buster (105), Phenix (228) and manual building with B-factor sharpening in COOT 
(109, 110).  
The BH and TL domains were iteratively built into the Fobs-Fcalc electron density map 
using the characteristic features of bulky aromatic side-chains as register (Figure 52A,B). Initial 
analysis of the BH reveals a kinked conformation, not only in the crystals with the matched ATP 
present (Figure 52A), but also for a recently collected single crystal dataset of T834P without 
ATP soaking (Figure 52B). Overlay between these data, with BH domains from previous TL on-
state (PDB:ID 2E2H, (49)) or TL off-state (PDB:ID 5C4J, (241)) revealed that the T834P 
substitution promotes a BH conformation similar to TL-on state, even when a matched 
nucleotide is not present (Figure 52C,D). This suggests that the T834P variant does not undergo 
a conformational change (kink to straight) in the BH when transitioning from the TL on/off 
states.  
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Figure 52. Comparison of Bridge Helix conformations 
(a) Fobs – Fcalc electron density map contoured at 3σ  of Rpb1 residues 815-845 for T834P crystals soaked with ATP 
(blue), (b) and without ATP (green). (c) Overlay between the two datasets reveal strikingly similar conformations, 
with only slight deviation in Cα positions. (d) In comparison, overlay with PDB:ID 2E2H (orange) and 5C4J 
(magenta), shows that the Pol II T834P variant does not undergo a conformational change between TL-on (orange) 
to off (magenta) states as does the wild type enzyme. 
8.4.4 Met1079 remains buried during on-state transition 
As mentioned above, the Fobs – Fcalc electron density map showed characteristic features of the 
TL on-state when a matched ATP nucleotide was present in the active center (Figure 51F). The 
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final refined 2Fobs – Fcalc electron density contoured at 1.5σ revealed in great detail the TL 
(Figure 53A). 
 
 
Figure 53. TL density and comparison with previous on-state structure 
(a) The final refined 2Fobs – Fcalc electron density map of TL residues (grey mesh) captured in the on-state engaging 
the matched ATP nucleotide (orange) in the A site with divalent Mg cations. Template strand DNA (cyan) and 
neighboring RNA nucleotides (red) are also shown. (b) Overlay of our structure (blue) with PDB:ID 2E2H 
(orange), illustrating the similarities in TL and BH residues. (c) Ribbon representation of overlay active site 
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residues showing that local similarities do not extend to surrounding Pol II domains. (d) VMD analysis of Cα 
deviations of our structure aligned against 2E2H.  
In addition to continuous density for TL residues, we also observed strong density for ATP 
occupying the A site (Figure 53A,B) as previously reported (49, 60). Overlay between our 
structure with PDB:ID 2E2H (49) showed a similar architecture of the BH and TL domains 
(Figure 53B). However, while the global fold of the active site was similar average root mean 
squared deviations for Cα positions ranged from 0.44 – 5.8 Å (Figure 53C,D), with the funnel 
helices showing some of the largest deviations (average deviation of 2.4 Å).  
Strikingly, the observation of Rpb1 residues 1355-1364 in a closed conformation was 
surprising given that this loop acts as a lid to a highly conserved hydrophobic pocket at the core 
of the TLB (241). Our structures revealed the presence of Met1079 situated in the hydrophobic 
pocket at the core of the TLB (Figure 54A), a feature that underscores previous observations that 
the burying of Met1079 inside this pocket is indicative of the TL-off state (49, 55, 57, 59, 241). 
Genetic interactions and gene expression profiling of substitutions of Rpb1 Ala1076, Gly1097 and 
Leu1101 with residues that disrupt the Rpb1 Met1079 hydrophobic pocket (127), support a model 
where the integrity of the pocket is critical for stabilization of the off state in eukaryotic and 
archaeal polymerases. Such substitutions are highly related to those that hamper off state 
conformations by destabilization of the C-terminal TL hinge region; therefore, these substitutions 
are similarly predicted to alter translocation rate and catalysis (Kaplan et al., 2012; Kaplan et al., 
2008; Kireeva et al., 2012; Malagon et al., 2006; Wang et al., 2006). So while pocket integrity is 
necessary for the stabilization of TL off-state, our data suggest that disruption of the TLB pocket 
is sufficient, but not necessary for TL-on state conformational transitions.  
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Figure 54. Position of Met1079 and interactions with ATP 
(a) Overlay between our structure (blue) and 2E2H shows that our structure was able to capture the TL on-state 
without disruption of the TLB core. Indeed, Met1079 stays buried in the hydrophobic pocket, stacking against a loop 
connecting TLB helices 4&5. (b) Interactions between residues of the TL and proximal Rpb1 domains with ATP in 
the A site.  
 
 While surprising, this observation is not without precedence. Previous structures 
(PDB:ID 4A3F) for a partially folded TL in the presence of a matched nucleotide in the A site 
showed a nucleotide interacting region (NIR) similar to our structure, without disruption of the 
TLB by Met1079 (60). Moreover, the structure of an elongating T. thermophiles bacterial enzyme 
in the presence of a matched nucleotide also showed a homologous leucine buried in the 
hydrophobic pocket of the TLB, despite an on-state TL conformation (47). It is possible that we 
trapped an intermediate in which the observed H-bonding between Asp1359 of the TLB loop with 
Lys1093 of the TL C-terminus maintains pocket integrity, which is supported by TL simulation 
models in which the Lys-Asp interaction is considered a transition intermediate directly before 
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the on-state is reached (252). While speculative, further simulations and biochemical data should 
be considered to gain a better understanding of TL dynamics.  
8.4.5 Functional observations of TL nucleotide interacting region (NIR) 
The trigger loop engages in a network of interactions with ATP in the A site along with proximal 
Rpb1 domains lining the active site (Figure 54B). Trigger loop residues in the nucleotide 
interacting region (NIR) including His1085, Asn1082, Leu1081, and Gln1078 all directly engage the 
ATP (Figure 54B). Coordination of the ATP phosphate region by His1085 engaging the β-
phosphate, while Aspartic resdiues 481, 483, and 485 of Rpb1 coordinate the two metal ions. 
Interestingly, while the first metal was discovered to engage the α-phosphate, metal two was 
found in the corresponding C-metal site coordinating the γ-phosphate, as previously observed 
(25, 49).  While the roles of NIR residues are unchanged in the moieties they recognize 
compared to our understanding of active site architecture, our structure revealed a different H-
bonding network compared to previous structures of a fully folded TL (Figure 55) (49). 
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Figure 55. LigPlot analysis of NTP interactions in our structure versus 2E2H 
(a) LigPlot analysis of interactions between Pol II with ATP in our structure, and (b) Pol II with GTP in PDB:ID 
2E2H.  
 
In addition to the metal positions, Asn1082 and Arg446 were shown to engage the ribose 3´-OH 
and 2´-OH groups respectively, a feature not seen in 2E2H. Engagement by the 2´-OH by Arg446, 
along with Asn479 (not seen in our structure), was observed previously in the partially folded TL 
structure in the presence of a matched ATP analog (60). In addition to Asn479 and Arg446, Gln1078 
is positioned to engage the 2´-OH group, which could couple the presence of a correctly matched 
nucleotide in the A site with the closing of the trigger loop. Such architecture could explain the 
LOF phenotypes observed when mutating this residue in yeast (57) consistent with a key role of 
this residue in NTP/dNTP discrimination, and may provide an explanation on the GOF 
phenotype of T834P. Preliminary comparison of the TL on-state with the off-state structure of 
T834P suggests that the NIR of the TL is partially folded and is situated closer to the A site. 
Thus, the position of Gln1078 might be critical since on the one hand, it constitutes part of the 
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nucleotide selection mechanism (Fouqueau et al., 2013; Yuzenkova and Zenkin, 2010), while on 
the other hand, displacement of Gln1078 could trigger extraction of the neighboring Met1079 from 
its hydrophobic pocket, initiating a cascade of events that would lead into the full on state. Our 
observation of a buried Met1079 raises the possibility that T834P may also have a reduced 
selectivity against dNTP since movement of Gln1078 is unlikely to occur while Met1079 is buried. 
However, this is only speculative since residues Asn479 and Arg446 also contribute to dNTP 
discrimination. Future experiments will need to be conducted with different substrates, since 
there is evidence that experimental design influences the architecture of the active site, which 
may also explain the differences in observed contacts with NTP (49, 60).  
Moreover, coupling of BH kink conformation with our observations of the TL suggest 
that increased activity may be due to favoring of either the pre- or post-translocated state as 
hypothesized previously (52). The Brownian ratchet model suggests that during the NAC an 
equilibrium between pre- and post-translocation states exist as rearrangements of TL and BH 
domains occurs for directional movement of polymerase along the DNA (53-58). Thus, it is 
feasible that the conformational landscape is suited for a post-translocation state, which would 
provide prolonged contacts with the TL and nucleotide for catalysis (52, 59, 130). Evidence to 
support this is T834P’s ability as a GOF mutant to weakly suppress some lethal LOF TL variants 
(198). However, this will need to be further explored using molecular dynamic simulations and 
validation with in vivo transcription assays.   
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9.0  CONCLUSIONS, SIGNIFICANCE, AND FUTURE DIRECTIONS 
The work presented in this dissertation has provided a more detailed understanding of Pol II 
function and methodologies to expand the field of structural biology. Our structure revealing a 
complete nucleic acid scaffold to high resolution detailed the first complete transcription bubble 
and upstream DNA duplex bound to Pol II (Figure 10). In addition to DNA/RNA hybrid 
interactions in the active site, Pol II engages with the minor grooves of upstream/downstream 
DNA duplex and defines the architecture of the upstream fork of the TB. These interactions gave 
insight into how an elongating Pol II may function independently during translocation. Since 
TLB, Rpb5 and Rpb2 regions could be coupled, through extensive observed interactions, it is 
possible that local TL conformational changes are transferred allosterically to downstream and 
upstream duplexes to assist global translocation. Furthermore, revelation of a partially folded off-
state conformation of the TL, that is stabilized through interactions with the non-template strand 
and proximal Pol II domains (or allosterically through TFs that stabilize the NTS) increases our 
understanding of TL dynamics during the NAC. Although speculative this could suggest that TL 
“off/on” transitions are allosterically coupled to “latch and release” events of the non-template 
strand phosphate chain by Pol II residues.  
To further examine the role, structurally, of the TL and BH during translocation and 
catalysis, we characterized the GOF T834P variant of Pol II, which biochemically shows a 3-fold 
increase in elongation rates (198). Structural studies of T834P in the presence of a matched 
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nucleotide revealed the complete TL in the on-state, a conformation only observed previously in 
two datasets at low resolution (49). Our preliminary analysis suggests that kinking of the BH 
(observed in both off/on state TL structures) potentially shifts equilibrium into the post-
translocation state during the NAC, which would prolong interactions of the NIR and tip residues 
of the TL with the matched nucleotide in the insertion site, explaining T834P’s ability to 
suppress LOF alleles. A surprising revelation of this structure, however, was the observation of 
Met1079 remaining buried during the off/on state transition (Figure 54). Such a conformation may 
alter our understanding of off/on state TL transitions from previously observed structures. Since 
on the one hand, the burying of Met1079 is seen as a critical step for stabilizing TL off state 
conformation, but on the other hand, our structures reveal that removal of Met1079 from the 
pocket is not a necessary step for the TL on-state conformation transition.  
In the future, characterization of T834P in the context of a full NAS and alternative 
scaffolds will be necessary, as this may alter NTP positioning in the active site. More 
importantly, characterizing TL dynamics in the context of other TF which may allosterically play 
a role in its activity will also be instrumental in our understanding of the NAC. To better 
understand these interactions, high resolution information is necessary. In this work, we also 
provided methodologies which will aid in the crystallization of highly relevant, and challenging 
protein targets, including multi-protein complexes of the transcriptional machinery. Our TEM 
guided methods are applicable to not only optimizing crystallographic trials through analysis of 
crystal lattices, but also in assessing samples prior to experiments at XFEL sources. The latter of 
which has significantly advanced experiments in our lab, by extending the resolution of Pol II 
complexes beyond the capabilities at the synchrotron due to the high solvent content and 
radiation sensitivity of the crystals. As such tracing of novel TF bound to Pol II is now possible. 
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However, improvements in isomorphism are necessary to maintain complete datasets to high 
resolutions, as well as utilize native zincs for de novo phasing of XFEL data.  
Nevertheless, such capabilities will undoubtedly allow us to address remaining questions 
concerning the Pol II nucleotide addition cycle and translocation. For one, what are the roles of 
the initiation factors, TFIIF and TFIIB, in stabilizing DNA during transcription bubble loading  
in early transcribing complexes? Moreover, what conformational changes are necessary for 
TFIIB promoter escape and transitioning of the upstream DNA duplex from contacts with the 
TFIIB cyclin domains to engage the Rpb2 wedge domain after TFIIB ejection? During early 
transcribing events, how do TFIIB and TFIIF contribute to the NAS? Do these factors play a role 
in overcoming promoter pausing of stalled polymerases, and how might they influence TFIIS 
activity during arrest/abortive transcription at the promoter? After escape, what changes occur 
that contribute to NTS stability when TFIIF is replaced by the elongation factor Spt4/5, and 
again, how might Spt4/5 allosterically affect the NAC and TL dynamics? 
We could gain further insight into TL dynamics by using time-resolved SFX experiments 
of the T834P variant through the addition of a matched nucleotide. The recent advancements in 
mixing jet technologies will allow for the observation of off/on state transitions of the TL. If 
successful, this would greatly enhance our understanding of the NAC, as we could potentially 
examine pre- and post-translocation states of an elongating Pol II.  
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APPENDIX A 
BIOCHEMICAL VALIDATION OF RPB2 WEDGE 
Biochemical validation and analysis of Rpb2 wedge interactions (see Chapter 3) were 
performed in collaboration with Dr. Indranil Malik from the lab of Dr. Craig Kaplan. Dr. Malik 
was responsible for the following experimental methods: 
In vitro elongation assay 
Pol II enzymes for in vitro assays were purified from yeast strains expressing wild type or mutant 
rpb2 gene from a low copy plasmid, as previously described above. In vitro elongation assays 
were performed as described in (56, 57) with minor modifications in the amount of nucleic acids 
and Pol II used for elongation complexes. In brief, an RNA-DNA hybrid was formed by 
annealing 20 pmol of the 81 nt template oligo, CKO223, with an equimolar amount of a γ-32P-
ATP end-labeled 9-mer RNA (RNA9), in 10 µl of in vitro transcription buffer (TB, 20 mM Tris 
pH 8.0, 40 mM KCl, 10 mM MgCl2, 10% glycerol, 0.25 mg/ml bovine serum albumin, 2 mM 
DTT). 2.5 µl hybrid were incubated with 2.5 µg of Pol II (2.5 µl) at room temperature for 5 
minutes followed by an incubation with 40 pmol of non-template oligo, CKO222, for 5 minutes 
at room temperature. Resulting complexes were diluted in 1X TB and used for time course 
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reactions as described (57). Time course products were resolved in 13.5% acrylamide-
bisacrylamide (19:1) gel containing 1X TBE and 7M urea. Run-off transcripts were quantified as 
fraction of total signal per lane for transcripts 10 nucleotides and above, using Image Lab (Bio-
Rad) software. Half-times and maximum elongation rates were determined using GraphPad 
Prism 5.0, as described previously in (56).  
Chromatin Immunoprecipitation (ChIP) assays 
Chromatin immunoprecipitation experiments for in vivo elongation rate determination were 
performed as described previously in (253), with slight modifications. Epitope-tagged 
(RPB3::3XFLAG::kanMX) wild type or mutant strain containing a galactose inducible YLR454w 
reporter (kanMX::GAL1p::YLR454w) gene were used for ChIP assays. Overnight grown cultures 
were used to inoculate larger cultures of YP-Galactose (1% yeast extract, 2% bacto-peptone, 2% 
galactose) to amplify. At mid-log phase, pre- glucose shut-off samples were taken for the 0 
minute time point and cross-linked with formaldehyde (1% final, v/v), followed by the addition 
of glucose (4% final) to shut-off transcription. Aliquots were removed after 2, 4, 6 and 8 minutes 
time points and cross-linked as above. Chromatin preparations, followed by 
immunoprecipitations with anti-FLAG M2 beads (M8823, SIGMA) were done as in (57), with 
the exception of using Bioruptor 300, Diagenode (manufacturer guidelines) for shearing cross-
linked chromatin. Input or immunoprecipitated DNAs were analyzed by quantitative PCR using 
CFX96 (Bio-Rad). A non-transcribed telomeric region was used for normalization to obtain fold-
enrichment values (253). 
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Northern blotting and primer extension analysis 
Northern blotting was performed as previously described (56) essentially following the 
instructions of GeneScreen hybridization membranes (Perkin-Elmer) with minor modifications. 
Twenty micrograms total yeast RNA purified as described (254) was prepared in Glyoxal sample 
load dye (Ambion). Prehybridization solution was made without SSC or SSPE buffers, but 
contained 50% formamide, 5X Denhardt’s solution, 10% Dextran sulfate, 1M NaCl, 50mM Tris-
HCl pH7.5, 0.1% sodium pyrophosphate, 0.1% SDS and 500 µg/ml denatured salmon sperm 
DNA. Probes for northern blots were radiolabeled with 32P-dATP using the Decaprime II kit 
(Ambion) according to manufacturer’s instructions. Blots were washed twice each- in 2x SSC for 
15 minutes at 42˚C, in 5X SSC with 0.5% SDS for 30 minutes at 65˚C, and in 0.2x SSC for 30 
minutes at room temperature. Primer extension assays were performed as described (56), which 
is a modified version of (255). 30 µg total yeast RNA was annealed with 32P end-labeled oligo in 
a 15 µl reaction volume. Reverse transcription reaction was done by M-MLV Reverse 
Transcriptase (Fermentas) supplemented with RNase Inhibitor (Fermentas), in a total reaction 
volume of 45 µl. Extension products were separated on 8% polyacrylamide gels (19:1 
acrylamide:bisacrylamide, Bio-Rad) containing 1X TBE and 7M urea. Northern blots and primer 
extension gels were visualized by phosphorimaging (Bio-Rad or GE Healthcare) and quantified 
using Quantity One (Bio-Rad) and ImageQuant 5.0 (GE), respectively. Primers and probe 
sequences are available upon request. 
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APPENDIX B 
HOMOPROTOCATECHUATE 2,3-DIOXYGENASE EXPERIMENTS 
Data presented in Chapter 7 was done in tandem with Dr. Elena Kovaleva in collaboration with 
the lab of Dr. Aina Cohen. Dr. Kovaleva was responsible for 2,3 – HPCD sample preparation, 
data collection, and processing as described below: 
Enzyme purification and crystallization 
Recombinant homoprotocatechuate 2,3-dioxygenase from B. fuscum was expressed in E.coli and 
purified using procedures described previously (256, 257). The enzyme preparations used in this 
study included a wild type (WT) enzyme and an active site variant with His200 substituted for Gln 
(H200Q). Previously published crystallization conditions and procedures that produce diffraction 
quality macro-crystals of 2,3-HPCD enzymes (258) were modified for injector-based 
experiments to scale up production of micro-crystal slurries using an over-nucleation approach. 
Protein solutions (7 – 10 mg/ml) were gently mixed in a 1:1 ratio with crystallization solution 
consisting of 12 – 14% PEG6000, 0.1 M calcium chloride, and 0.1 M MES pH 5.8, ensuring that 
no precipitate forms at these concentrations of components. After a few minutes of equilibration, 
a 20 μl aliquot of the 1:1 stock mixture (protein and crystallization solution) was seeded with a 
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few roughly crushed macro-crystals in an eppendorf tube, and growth of many needle-like 
crystals was observed after a few hours of incubation at 20 °C. Every 2 – 4 hours 50-200 µL of a 
fresh mixture of protein and crystallization solution was added into the crystallization tubes to 
maintain maximal growth of needle-like crystals, followed by a final 12 hour period of growth to 
achieve saturation in a total of 2 – 3 ml volume. The WT enzyme preparation produced slightly 
larger population of initial crystals (thin rods), whereas the H200Q variant preparation produced 
slurries with needle-like crystals.  
2,3 – HPCD sample preparation for liquid-jet SFX experiments 
A mixture of glass beads (0.1 and 0.5 mm) was used to crush the crystals to achieve a smaller 
and more uniform sample size for injector-based studies. The WT sample, consisting of thin 
rods, was vortexed with the glass beads mixture several times at medium to high speed for 60 
seconds, followed by a 10-minute rest period. Slurries of needle-like crystals of the H200Q 
variant were concentrated by centrifugation at 2,000 rpm for 5 to 10 minutes prior to the addition 
of the glass beads mixture and additional centrifugation for 2 minutes. The efficiency of crystal 
crushing using either the vortexing or microcentrifugation methods were monitored qualitatively 
by light microscopy, and by visually observing the light scattering of sample medium using a 
flashlight. Crushed samples were passed through a 20 μm filter to remove particulates and larger 
crystalline material prior to loading into the sample reservoir for diffraction studies. 
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2,3 – HPCD liquid-jet SFX data collection, processing and refinement  
Diffraction data were collected at the CXI end station of LCLS using 8.8 keV X-ray pulses with 
40 fs duration and 1 μm beam focus at the X-ray interaction point. Sample delivery using gas 
dynamic virtual nozzle (GDVN) was carried out at a flow rate of 20 μl/sec at 16 °C. Diffraction 
images were collected at 120 Hz using a CSPAD detector and processed using ccbtx.xfel 
software package (195, 226). The WT enzyme sample resulted in 814 indexable images during 
6.7 min of data collection. A total of 15.6 min of data collection using the H200Q variant sample 
resulted in a dataset based on 14026 merged images. During indexing, secondary lattices 
indicative of multiple crystals were identified by first indexing, then removing primary lattices 
and then attempting to index the remaining bright reflections (195, 226). 
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